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Cobalamin, more commonly known as vitamin B12, is a highly complex molecule 
whose biosynthesis in bacteria and archaea involves around 30 enzyme-mediated 
steps.  The biosynthesis of vitamin B12 occurs by one of two distinct pathways, which 
are referred to as the aerobic and the anaerobic routes.  The work described in this 
thesis relates to the aerobic pathway, and is mainly focussed on two enzymes 
responsible for the amidation of the corrin ring component of cobalamin, CobB which 
is the enzyme responsible for the amidation of HBA to its product HBAD and CobQ 
which amidates cobyrinic acid a, c-diamide to cobyrinic acid. These enzymes amidate 
the peripheral carboxylic acid sidechains of the corrin moiety, and produce 
hydrogenobyrinic acid (HBA) and adenosylcobyrinic acid a, c-diamide, respectively.  
CobB, amidates the a and c side chains attached to C2 and C7 of the corrin ring, of 
HBA.  The product of this multi-functional enzyme is initially hydrogenobyrinic acid c-
monoamide (HBAM) followed by hydrogenobyrinic acid a, c-diamide (HBAD).    
The gene encoding CobB was cloned from Brucella melitensis, overexpressed and 
its encoded protein purified. After crystallisation of the B. melitensis CobB, the first X-
ray crystal structure of this enzyme was solved using selenomethionine labelled 
protein to 1.6 Å resolution. Further high resolution structures were obtained containing 
substrate and co-factors. 
To complement the structural information, kinetic data was acquired for the binding of 
CobB with its substrates, using stopped flow analysis. This kinetic approach helped 
identify a two-phase binding process, indicating that the initial HBA molecule binds 
quickly to the dimeric enzyme, whilst the second HBA molecule binds at a much 
slower rate. Collectively, the binding data suggest that CobB undergoes a 
conformational change upon binding the first HBA substrate that alters the binding 
affinity of the second HBA-binding site. 
 4 
CobH, the enzyme prior to CobB in the cobalamin pathway, is known to bind its 
product (HBA) very tightly, which poses the question as to how CobB interacts with 
CobH in order to access its substrate.  To investigate if CobB and CobH interact a 
model was constructed to determine if the two enzymes could form a complex that 
facilitates direct metabolite channelling.  Evidence for direct metabolite transfer was 
obtained from fluorescence spectroscopy, where fluorescence emission was used to 
monitor changes associated with substrate transfer of HBA from CobH to CobB Co-
crystallisation trials to obtain a complexed crystal structure of CobH/HBA/CobB was 
attempted, but this approach resulted only in the generation of CobH crystals.   
CobQ, the second enzyme in the amidation process, was also produced 
recombinantly and purified. This enzyme amidates positions b, d, e and f on the corrin 
ring.  Crystallisation trials were attempted, and a low resolution data set was collected 
(4.5 Å).  However, the structure was not determined due to the poor quality of the 
data. 
CobB and CobQ are key enzymes involved in the amidation process in the vitamin 
B12 pathway. To date there is no structural information in the literature as to how these 
enzymes function. Obtaining a crystal structure of either CobB or CobQ would 
enhance our knowledge on these multi-functional enzymes, enabling a clearer 
understanding on how they bind their substrates, and how these enzymes pass their 
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The most glorious moments in your life are not the so-called days of success, but 
rather those days when out of dejection and despair, you feel rise in you a challenge 




The adventure of life is to learn. The purpose of life is to grow. The nature of life is to 
change. The challenge of life is to overcome. The essence of life is to care. The 
opportunity of life is to serve. The secret of life is to dare. The spice of life is to 
befriend. The beauty of life is to give.  
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1.1 Macrocyclic tetrapyrroles - the pigments of life  
Macrocyclic tetrapyrroles are a family of compounds that are essential for life. They 
are composed of four pyrrole rings that are arranged in a circular manner whereby 
the individual pyrrole rings are connected by methene bridges. Organisms synthesize 
these compounds either de novo or scavenge them from their environment. 
The pyrrole rings of the tetrapyrrole framework are labelled A-D in a clockwise 
direction (Figure 1.1). Modified tetrapyrroles occur widely in nature and are involved 
in many critical biological processes such as electron and oxygen transport, 
photosynthesis, methanogenesis, sulphite and nitrite reduction and many enzymatic 
reactions. Naturally occurring tetrapyrroles include haem, sirohaem, haem d1, 
chlorophyll, coenzyme F430 and cobalamin (vitamin B12) (Figure 1.2) (Dailey 2013) 
(Banerjee and Ragsdale 2003a; Battersby 2000). Haem is responsible for the 
transport of oxygen (Hamza and Dailey 2012), while chlorophyll is pivotal for the 
transformation of light into chemical energy in plants during photosynthesis (Bollivar, 
2006). In humans, cobalamin plays a key role in homeostatic functions and acts as 
cofactor and coenzyme for the enzymes methionine synthase and methylmalonyl-
CoA, respectively. Methionine synthase is involved in the recycling of methionine 
whilst methylmalonyl CoA mutase is associated with the breakdown of certain amino 




Figure 1.1: Structure of uroporphyrinogen III. Diagram shows the structure of the 
tetrapyrrole primogenitor uroporphyrinogen III and the numbering system for the mainframe 
carbons (red:1-20). The meso-bridge carbons are labelled 5, 10, 15 and 20, and the rings are 
labelled A-D in a clockwise direction.  
Modified tetrapyrroles are found in all domains of life and are involved in many 
essential biological reactions. They are able to chelate metal ions in the ring system 
and these ions (Fe, Ni, Co and Mg) determine their function (Figure 1.2). It is this 
variation in the nature of the chelated metal ion and the oxidation state of the 
macrocycle that not only gives them their distinctive colour (Battersby 2000) but also 
determines their role within this family of molecules (Senge 2015) (Frankenberg, 







Figure 1.2: Cyclic tetrapyrroles derived from common precursor. Figure shows the main 
biological macrocyclic tetrapyrroles that originate from uroporphyrinogen III. The central metal 
ions are coloured to highlight the metallo tetrapyrrole. (Figure is taken from Dailey 2013).  
Coenzyme F430 is a unique nickel containing tetrapyrrole involved in methyl - 
coenzyme M reductase activity. In the cobalamin pathway HBA is amidated at position 
C2 and C7, by CobB to form hydrogenobyrinic acid a, c – diamide. F430  Ni
2+ - 
sirohydrochlorin is amidated also at positions C2 and C7 to form Ni - sirohydrochlorin 
a, c -diamide. Both of these pathways although completely different require Mg/ATP 
and Gln for enzyme activity. Although F430 is involved in methanogenesis and 
Cobalamin in cellular metabolism, two completely different processes, as with the 
other tetrapyrroles are all derived from a common precursor (uroporphyrinogen III)    
(Moore et al. 2017).   
 
 34 
The aim of this thesis is to obtain structural and biophysical information on two 
enzymes involved in the aerobic biosynthesis pathway, leading to the production of 
vitamin B12. The aerobic pathway has been studied extensively due to the relative 
stability of its pathway intermediates. However, even in this pathway there are still a 
number of enzymes which have been difficult to obtain structural information on. The 
two enzymes of specific interest to this research project are involved in amidation of 
the corrin ring. CobB, the first enzyme, amidates the corrin ring at position C2 (side 
chain a) and C7 (side chain c). The second enzyme CobQ is involved in the final stage 
of the aerobic branch of the pathway. This enzyme is involved in the amidation of the 
side chains (three propionic acids and one acetic acid) labelled b, d, e and g on the 
corrin ring.  
 1.2 Cobalamin   
Cobalamin along with other corrinoids which contain cobalamin are unique due to the 
fact they do not have a methane bridge between rings A and D (Friedmann & Thauer, 
1992). This molecule is the most complex of all the tetrapyrroles, and is the only 
tetrapyrroles to have an upper and lower ligand. The lower ligand is a nucleotide loop 
formed of dimethylbenzimidazole, and an upper axial ligand which can be 
aquacobalamin, methylcobalamin, adenosylcobalamin or cyanocobalamin. The two 
active forms of cobalamin are methyl and adenosyl-cobalamin. These two active 
forms use the properties of the cobalt carbon bond to promote a range of enzymatic 
properties such as rearrangement, methylation and reductive dehalogenation 
reactions (Banerjee and Ragsdale 2003a). 
1.3 Haems  
Heme is an iron containing porphyrin known as protoporphyrin IX. Haems are widely 
distributed and are found in eukaryotes, most bacteria and some archaea and has 
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been used as a cofactor for over 3,000 years. In the Bacteria, de novo biosynthesis 
of haem developed very early in the evolutionary path. However, there is an absence 
or incomplete pathway in some bacterial pathogens which may be due to secondary 
gene loss (Dailey et al. 2017)  There are four types of haem a, b, c and o. The four 
types are all derived from haem b which is also referred to as protehaem (Kranz et al. 
2009). 
1.4 Chlorophylls  
The most abundant of all tetrapyrroles in nature are the chlorophylls. Chlorophylls 
and  bacteriochlorophylls are structurally related porphyrin compounds, and are 
indispensable components of the photosynthetic apparatus used by plants and 
bacteria to harvest energy and convert it to chemical energy (Reinbothe et al. 1996). 
Although the two are structurally related, in the later stage of the pathway the two 
porphyrin compounds use different enzymes to convert pro-tochlorophyllide to 
chlorin. It is therefore, suggested that bacteriochlorophyll is the bacterial equivalent 
of chlorophyll and may be representative of the evolutionary ancestor of chlorophyll 
(Reinbothe et al. 1996). 
1.5 Sirohaem  
Sirohaem is considered to be one of the most simplest tetrapyrroles, as after the 
synthesis of uro’gen III there are very few modifications. These modifications involve 
a two methylation step, oxidation and ferrochelation to form sirohaem. Sulphur and 
nitrogen are two elements that are essential for life, these compounds must be 
reduced to sulphate and ammonium. Sirohaem is an iron containing isobacteriochlorin 
and is a cofactor involved in the reduction of nitrite and sulphite (Dailey et al. 2017; 
Lobo et al. 2015; Tripathy, Sherameti and Oelmüller 2010). 
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1.6 Coenzyme F430 and haem d1  
Of all of the tetrapyrroles coenzyme F430  and d1 are the most elusive as there is very 
little known about their synthesis. Coenzyme F430 is a nickel containing tetrapyrrole 
which is yellow in colour. This molecule is a cofactor of methyl-coenzyme M reductase 
and is involved in methanogenesis (Dailey et al. 2017; Moore et al. 2017; Thauer and 
Bonacker 2007).  
Despite being named haem d1 this molecule is not a member of the haem family and 
therefore is not a true porphyrin. It is in fact an iron containing isobacteriochlorin. 
Cytochrome cd1 nitrate reductase is involved in the conversion of nitrite to nitric oxide 
in denitrifying bacteria, where haem d1 is a cofactor for this reaction (Dailey et al. 
2017; Moore et al. 2017; Thauer and Bonacker 2007). 
The research described in this thesis deals with an important aspect of cobalamin 
biosynthesis and hence this chapter will focus largely on the corrin macrocycle. The 
biological forms of cobalamin are found with a range of different upper ligands. 
methylcobalamin (transfer of methyl groups between compounds), 
adenosylcobalamin and hydroxycobalamin (reductive dehalogenases) (Bridwell-
Rabb, Grell and Drennan. 2018). Interestingly, cyanocobalamin, the commercial form 
of cobalamin, is a chemical artefact reflecting the purification of the nutrient from large 
scale bacterial cultures (Jahn. 2013; Martens et al. 2002) . Cobalamin is defined as a 
cobinamide which has 5, 6-dimethylbenzimidazole as a lower axial ligand. 
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Figure 1.3: The structure of adenosylcobalamin. Structure shows the upper ligand 
(adenosyl) bound to cobalt, and the lower ligand 5, 6-dimethylbenzimidazole (DMB). 
Alternative upper ligands are shown on the right hand side. 
1.7 History of Cobalamin (Vitamin B12)  
It was in 1926 that two scientists (Minot and Murphy) discovered that by feeding 
patients with whole liver extracts they could control a condition known as pernicious 
anaemia (Minot and Murphy 1926). Another scientist, Whipple, also studied anaemia 
in dogs. His research involved bleeding dogs until they were anaemic, and then 
feeding them on special diets to note how quickly they recovered. Whipple found that 
dogs who ate large amounts of liver recovered quickly (Robscheit et al. 1920). In 1934 
Minot, Murphy and Whipple were awarded the Nobel Prize for demonstrating that liver 
contained an anti-pernicious anaemia factor that was termed vitamin B12 (Moore et al. 
2012). Researchers were therefore keen to isolate and characterise the anti-
pernicious anaemia factor, with interest from Glaxo in the UK, led by a research team 
headed by Lester Smith (Smith L. 1948), and Merck in the USA, with a research team 
led by Karl Folkers (Rickes et al. 1948). This work was very difficult as the nutrient in 












In 1944 Mary Shorb, a microbiologist who worked on Lactobacillus lactis Dorner 
(LLD), similarly discovered that this bacterium would only grow in medium containing 
liver extract. Shorb suggested that L. lactis required the anti-pernicious anaemia 
factor too and that the bacterium could be used for its detection in various liver 
extracts. In 1947 she collaborated with Karl Folkers and his co-workers at Merck 
where her L. lactis assay was used to identify the presence of the anti-pernicious 
anaemia factor from liver fractions, which helped in the purification of vitamin B12. For 
this discovery, Mary Shorb and Karl Folkers were co-recipients of the Mead Johnson 
Award from the American Society of Nutritional Sciences in 1949 (Shorb 1948). 
Around the same time Lester Smith & Karl Folkers (Smith L. 1948) (Rickes et al. 
1948), using chromatographic procedures, also isolated vitamin B12, from which they 
were able to grow deep red coloured crystals (Rickes et al. 1948). The fact they could 
only isolate a few micrograms of the compound at a time initially hindered the 
experimental progress. Despite the isolation of purified vitamin B12, its 
characterisation and chemical structure remained elusive as it was a compound quite 
unlike anything else that had previously been studied. It was, in fact, the application 
of X-ray crystallography by Dorothy Hodgkin that solved the problem (Hodgkin et al. 
1955). This was a remarkable achievement to gain structural data on this complicated 
molecule. At the time she explained that “A great advantage of X-ray analysis as a 
method of chemical structure analysis is its power to show some totally unexpected 
and surprising structures with, at the same time, complete certainty” (Battersby 2000). 
The total chemical synthesis of vitamin B12 was achieved in the 1970’s by two groups 
headed by Woodward and Eschenmoser (Woodward 1973.; Eschenmoser and 




1.8 Vitamin B12 
Vitamin B12 is an essential nutrient that is required in mammals but is only produced 
by bacteria that are found in soil and water. In nature there is a limited number of 
bacteria which produce vitamin B12. Three of these bacteria are also used for 
commercial production of this vitamin (Pseudomonas denitrificans, Bacillus 
megaterium and Propionibacterium freudenreichii). Since this vitamin cannot be 
produced by the body it imperative that it is acquired from the diet. The B12  producing 
organisms that live in soil are ingested by animals such as cows and other free grazing 
animals, therefore, providing humans with a source of vitamin B12.. Vitamin B12 when 
ingested binds to a protein called haptocorrin (R-factor), which is secreted by the 
salivary glands. After binding, the complex is then carried to the small intestine where 
pancreatic enzymes cleave the B12-haptocorrin complex. Intrinsic factor, which is a 
glycoprotein secreted by the gastric parietal cells, binds B12 and the complex then 
binds receptors in the ileum where B12 is absorbed (Gherasim, Lofgren and Banerjee 
2013). Poor absorption results in impairment of metabolic processes that have 
neurological and hematologic function (O’Leary and Samman 2010). 
1.9 Cobalamin-dependent enzymes 
B12 and other cobalt containing corrins are essential cofactors in numerous biological 
processes required by both eukaryotic and prokaryotic organisms. The central cobalt 
atom is responsible for the biological activity. This cobalt ion has the ability to form 
organo-metallic bonds which are stable (Banerjee and Ragsdale 2003a). There are 
two different forms of cofactor, firstly where the cobalt is bound to a methyl group 
(methyl cobalamin), and secondly where the cobalt is bound to 5’ -deoxyadenosine 
(adenosylcobalamin). These two cofactors are utilised by B12 dependent enzymes 
(Ludwig, Drennan and Matthews 1996). The key to the reactivity is this unique Colll-C 
bond was revealed by x-ray diffraction (Lenhert and Hodgkin 1961). The most studied 
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of cobalamin is the B12 coenzymes, adenosylcobalamin and methylcobalamin. These 
two coenzymes are the bioactive forms of vitamin B12 and are involved in the catalysis 
of rearrangement reactions. These coenzymes are involved in the rearrangement 
reactions involving reversible cleavage of the Co – C bond to generate an organic 
radical Coll which result in the eventual formation of a radical intermediate. This 
intermediate can then re-bind and reform the bond to Coll resulting in the regeneration 
of the coenzyme (Broderick 2001).   
Adenosylcobalamin is the co-enzyme for the enzyme  methylmalonyl-CoA mutase, 
which is found in the mitochondria and is involved in the conversion of methylmalonyl-
CoA to its isomer succinyl-CoA this reaction is catalysed by methylmalonyl-CoA 
mutase, and results in catabolism of odd chain fatty acids and branched amino acids. 
The C-Co bond in this molecule is relatively unstable and can result in catalytic 
cleavage forming and adenosyl radical (E. Neill. Marsh and Gabriel D. Roman 
Melendez 2012). Accumulation of methylmalonic acid (MMA) is usually observed in 
patients who are vitamin B12 deficient. Excess of MMA can result in neurological 
damage (Briani et al. 2013). 
Methylcobalamin is the second organometallic derivative, and is the cofactor of 
methionine synthase. This biosynthesis is important to both humans and bacteria. 
The enzyme is involved in the conversion of homocysteine to methionine, and plays 
an important role in metabolism. This reaction requires methyl-tetrahydrofolate (M-
THF) which is cleaved to tetrahydrofolate (Ragsdale 2011). This reaction is linked 
with folate metabolism, which involves the recycling of methyl-tetrahydrofolate this 
involves the transfer of a methyl group to cobalamin which results in methylcobalamin  
1.10 Biosynthesis of Cobalamin 
Tetrapyrroles are synthesised along a branched biosynthetic pathway. The common 
precursor in the synthesis of all of the above molecules is 5-aminolevulinic acid (ALA) 
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(Kikuchi et al. 1958). This molecule can be synthesised biologically by one of two 
distinct pathways. The C4 pathway, which involves the condensation of succinyl-CoA 
and glycine, is typically known as the Shemin pathway (Shemin and Kikuchi 1958). 
This route is commonly used by mammals, fungi and the "-group of the 
proteobacteria. The other route involves the transformation of glutamate into ALA and 
is referred to as the C5 pathway. The C5 pathway is used by plants, archaea and 
most bacteria (Beale and Castelfranco 1973).  
1.10.1 The C4 pathway 
The C4 pathway is also known as the Shemin pathway as it was discovered in the 
1940’s by David Shemin. Shemin used labelled 15N to follow the uptake of nitrogen 
into haem. To do this he ingested 66 g of labelled [15N]-glycine over a period of 3 days 
before extracting and analysing his own blood. He and his co-worker David Rittenberg 
assessed the 15N content of the haem group by mass spectrometry (Shemin and 
Kikuchi 1958). These results showed that glycine was incorporated into 
protoporphyrin. He then went on to look at which of the carbons of glycine were used 
in porphyrin synthesis. He discovered that 8 of the carbons came from the # carbon 
of glycine and that the remaining 26 came from succinate. From this work Shemin 
suggested that ALA was formed from succinyl CoA and glycine, which was confirmed 
when the enzyme ALA synthase (ALAS) was identified (Shemin and Kikuchi 1958). 
The C4 pathway is the simplest of the two pathways for the generation of ALA and 
represents a condensation between glycine and succinyl-CoA (Figure 1.4). This 
reaction is a pyridoxyl-5 phosphate (PLP) dependent reaction. ALAS has been 
purified from many bacteria and eukaryotic sources and has been biochemically 
characterised (Ferreira and Gong 1995). The full length X-ray crystal structure of 
ALAS has been solved from Rhodobacter capsulatus, allowing a molecular insight 
into the mechanism of this enzyme (Astner et al. 2005). This structure reveals that the 
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protein exists as a homodimer with PLP bound to the two active sites via a conserved 
lysine (K248). The PLP forms a covalently bound Schiff base in the absence of 
substrate or product. A second crystal structure was obtained by soaking crystals of 
ALAS/PLP with glycine. The structure shows that the glycine undergoes a 
transaldimination, allowing the PLP to bind directly to the glycine instead of the lysine. 
A third crystal structure was obtained when ALAS/PLP crystals were soaked with 
succinyl-CoA. By superimposing the two structures (bound glycine and succinyl-CoA) 
Astner was able to show that both substrates can bind simultaneously within the 
active site, without incurring steric clashes. The last step in this process involves the 
decarboxylation of the glycine moiety, which eventually yields ALA bound to PLP 
ready for release (Astner et al. 2005).  
1.10.2 The C5 pathway 
In 1973 a second pathway for the synthesis of ALA was discovered  (Beale and 
Castelfranco 1973). This was called the C5 pathway (Beale pathway) (Figure 1.4) and 
occurs in higher plants, algae, archaea and bacteria (Jahn and Heinz 2009; Murooka 
et al. 2005). In evolutionary terms it has been suggested that the C5 pathway 
represents the primordial route for ALA synthesis (Figure 1.5). It involves the 
transformation of glutamate to ALA in a multi-enzyme pathway. The pathway 
proceeds from glutamate via glutamyl-tRNA (delta-aminolevulinic acid-synthesizing 
enzymes need an RNA moiety for activity) (Huang et al. 1958). This represents one 
of the few reactions where a tRNA is used in something other than protein 
biosynthesis. The next step in this reaction is the reduction of the activated glutamate 
by the NADPH-dependent enzyme glutamyl-tRNA reductase (GluTR). This yields 
glutamate-1-semialdehyde (GSA). Glutamate-1-semialdehyde aminotransferase 
transfers an amino group using PLP as a cofactor, which results in the formation of  




Figure 1.4: Diagram showing the C5 and the C4 (Shemin) pathways. The C5 pathway 
involves the transformation of the intact glutamate carbon backbone into ALA in three 
consecutive steps. The C4 pathway involves a single enzyme-mediated step whereby glycine 
and succinyl CoA are combined to generate ALA with the release of CoA and CO2. 
 
 
Figure 1.5: Biosynthesis pathway of 5-aminolaevulinic acid (ALA) via the C5 pathway. 
Three consecutive steps, step (i) the charging of tRNA with glutamate (ii) reduction to 
semialdehyde in a catalysed reaction of glutamyl-tRNA synthase (iii) transamination to form 
ALA.   
This pathway utilises glutamate, ATP and NADPH as co-substrates. In tetrapyrrole 
biosynthesis it is believed that the synthesis of ALA is the rate limiting step reflecting 
the fact that tetrapyrrole biosynthesis is tightly regulated by feedback inhibition (Shin 
et al. 2007). 
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The structure of the Methanopyrus kandleri glutamyl-tRNA reductase has been 
solved. This structure revealed the enzyme to be a homodimer, which has a unusual 
V-shaped topology (Moser et al. 2001). The X-ray crystal structure of glutamate-1-
semialdehyde aminomutase was solved in 1997 (Hennig et al. 1997). This structure 
revealed that the enzyme belongs to the aspartate aminotransferase family. Using the 
glutamyl-tRNA reductase structure Moser et al modelled glutamate-1-semialdehyde 
aminotransferase into the groove. Based on the model he concluded that a complex 
was formed which would allow direct metabolite transfer between the two enzymes 
(Moser et al. 2001).  
1.11 The synthesis of uroporphyrinogen (uro’gen III) 
The biosynthesis of the uro’gen III macrocycle from ALA requires the successive 
participation of three enzymes, 5-aminolaevulinic acid dehydratase (ALAD), 
porphobilinogen deaminase (1-hydroxymethylbilane synthase) and uro’gen III 
synthase. Uro’gen III is the major precursor found in all biological systems that are 
involved in the synthesis of tetrapyrroles. The first step in this process requires the 
enzyme catalysed condensation of two molecules of ALA. ALAD is the enzyme which 
dimerises two ALA molecules to generate porphobilinogen in a Knorr type 
condensation reaction (Jordan and Berry 1981). 
 
Hydroxymethylbilane synthase then takes four molecules of porphobilinogen and 
polymerises them into hydroxymethylbilane, a linear tetrapyrrole (bilane) structure 
(Louie et al. 1992). The third enzyme in this pathway is uro’gen III synthase, which 
cyclises the linear tetrapyrrole and at the same time inverts ring D to generate the 
type III isomer of uro’gen (Battersby 1978; Mathews et al. 2001) (Figure 1.6). This is 
the last common precursor for all the natural tetrapyrroles. It is at this point that the 
tetrapyrrole biosynthetic pathway diverges (Leeper 1987).  
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Figure 1.6: Diagram showing formation of uro’gen III from ALA. Porphobilinogen 
deaminase (PBG deaminase) and Uro’gen III synthase are responsible for the coming 
together of four molecules of porphobilinogen (PBG), to form uro’gen III. This pathway is 



















































































1.12 The aerobic biosynthesis of cobalamin 
  
Figure 1.7: Aerobic pathway for the biosynthesis of cobalamin. The steps show the 
enzymes involved in the biosynthesis of adenosylcobyric acid from uroporphyrinogen III 
(uro’gen III). (Figure is taken from Warren et al. 2002).  
There are two known pathways for the biosynthesis of adenosylcobalamin, which 
differ in their requirement for molecular oxygen and the timing of cobalt insertion. The 
two routes are referred to as the aerobic and anaerobic pathways (Blanche et al. 
1993). The aerobic pathway has been studied mostly in Pseudomonas denitrificans 
(Debussche et al. 1993), whilst the anaerobic pathway has been studied in 
Adenosyl
Cobalamin
CobD, P, U and V
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Salmonella typhimurium, Bacillus megaterium, and Propionibacterium shermanii( 
Warren et al. 2002; Roth et al. 1993).  
This thesis will focus on the aerobic pathway, however, it is worth mentioning the 
major differences between the two routes. The anaerobic pathway has no 
requirement for molecular oxygen and cobalt insertion occurs early on. By way of 
contrast, the aerobic pathway requires oxygen and cobalt insertion occurs late on. 
The two pathways diverge after the production of precorrin-2 and then re-join at the 
level of adeonsylcobyrinic acid a, c-diamide (Martens et al. 2014).   
Uro’gen III is transformed into precorrin-2 by the action of an enzyme called S-
adenosylmethionine uroporphyrinogen III methyltransferase (SUMT), which was 
found to be encoded by cobA (Blanche et al. 1991). The enzyme is sometimes also 
referred to as CobA. It methylates uro’gen III at positions C2 and C7 to give the 
dimethylated intermediate precorrin-2 and requires S-adenosyl-L-methionine (SAM) 
as a co-substrate and source of the methyl groups. The initiation of a methyl group at 
position C20 on the ring system is the first unique step in the aerobic pathway. This 
generates the trimethylated intermediate precorrin-3A (Warren et al. 1992). The 
enzyme involved in this is CobI, which was first identified in P. denitrificans (Thibaut 




1.12.1 Precorrin-3B synthesis 
One of the most interesting steps in the biosynthesis of the corrin framework is that 
associated with the ring contraction process, where a carbon atom is removed from 
the macrocyclic ring. In the aerobic pathway the ring contraction process is initiated 
with the enzyme CobG (precorrin-3B synthase), which generates a hydroxylactone 
intermediate. In this reaction CobG introduces a hydroxyl group at C20, with oxygen 
coming from molecular oxygen (Spencer et al. 1993; Scott et al. 1993) (Figure 1.8). 
The actual ring contraction process is performed by CobJ, which methylates at 
position C17 and extrudes the C20 carbon to form precorrin-4 (Debussche et al. 
1993). This reaction is believed to be a concerted process in which it is likely that ring 
contraction follows methylation (Scott et al. 1993; Debussche et al. 1993). In order for 
C20 ring-contraction to occur it was noted that this molecule had to be first converted 
into a tertiary alcohol (Eschenmoser 1988). This stabilises the molecule and prevents 
the irreversible tautomerisation to a 20-oxo  
1.12.2 Precorrin-5 synthesis 
The synthesis of precorrin-5 involves the methylation of the C11 position on the corrin 
ring. This wasn’t discovered till Debussche et al took an oxidised form of precorrin-3A 
and incubated it with cell extract from a P.denitrificans strain, that overproduced the 
enzymes CobG, CobJ and CobM (Debussche et al. 1993). This resulted in the 
production of a new intermediate compound with a newly incorporated methyl group. 
In cobalamin this methyl group is attached to the C12 position, however, in this 
intermediate compound it was found attached to C11 (Figure1.7). The positioning of 
this methyl group was confirmed by NMR of the octamethyl ester derivative of 
precorrin-5 (Min et al 1993). This confirmed that a further enzymatic activity is required 
to allow the migration of the methyl group from C11 to its final position on C12. The 
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crystal structure of CobM from R. capsulatus was solved in 2010 to high resolution (1 
Å) (Seyedarabi et al. 2010).  
1.12.3 Precorrin-6A and Precorrin-6B synthesis 
Precorrin-5 is converted to pecorrin-6A by CobF, a bifunctional enzyme that was first 
isolated from a P. denitrificans strain that overproduced CobF. One of the functions 
of this enzyme involves the deacetylation of the C1 methyl ketone, which is released 
as acetic acid. The second function is that of a SAM-dependent methyltransferase 
that results in the methylation at the C1 position (Debussche et al. 1993) (Figure 1.7).  
The following enzyme in the pathway converts precorrin-6A to precorrin-6B. This is a 
NADPH-dependent reaction resulting in a change in the oxidation state of the 
macrocycle (Blanche et al. 1992; Moore et al. 2013). The enzyme involved in this 
transformation is CobK, where the double bond between C18 and C19 is reduced by 
hydride transfer from the HR position of the NADPH cofactor onto C19 with the 
additional proton required at C18 being obtained from the solvent. The crystal 
structure for this enzyme has been solved (Gu et al. 2015) (Figure 1.7). The crystal 
structure revealed that five conserved basic residues of CobK bind the carboxylates 
of the tetrapyrrole very tightly (Jahn and Heinz 2009).  
1.12.4 Precorrin-8 synthase 
The synthesis of precorrin-8 is catalysed by a multifunctional enzyme called CobL. 
CobL is involved in SAM dependent methylations at C5 and C15, as well as the 
decarboxylation of the acetic acid side chain at C12 (Blanche et al. 1992) (Figure 1.7).  
The protein is composed of two distinct domains, an N-terminal domain, which has a 
typical canonical methyl transferase fold and the C-terminal a non-canonical methyl 
transferase domain. There is crystal structure of the C-terminal of CobL from R. 
capsulatus which diffracted to 1 Å resolution (Deery et al. 2012). It has, however, been 
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noted that in some organisms CobL is encoded by two separate genes, this implies 
that cobL  may have arisen from a gene fusion event (Roth et al. 1993).  It has now 
been shown that the C-terminal domain of CobL initially decarboxylates precorrin-6B 
and methylates at C15 to give precorrin-7. Precorrin-7 is then methylated at C5 by the 
N-terminal region of CobL to generate precorrin-8 (Deery et al, 2012). 
1.12.5 Hydrogenobyrinic acid (HBA) synthesis 
The next step in the biosynthesis of the corrin macrocycle produces hydrogenobyrinic 
acid (HBA) (Thibaut et al. 1992). This reaction is catalysed by CobH and involves the 
migration of the SAM-derived methyl group at C11 to C12 (Figure 1.7). The migration 
of the methyl group results in a change in the conjugated $ − system, which result in 
a colour change from yellow to pink. CobH is a relatively small homodimeric, protein 
of ~23 kDa, which contains a highly conserved histidine residue (His-43). This 
conserved histidine residue is believed to be involved in playing a critical role in the 
catalytic mechanism of CobH by protonating the nitrogen of ring C. The crystal 
structure of this molecule has been solved with bound substrate to high resolution 





Figure 1.8: Mechanism in which Precorrin 8 is converted to HBA. Showing how the SAM 
derived methyl group on C11 moves to position C12 on the tetrapyrrole ring. 
1.12.6 Hydrogenobyrinic acid a, c-diamide (HBAD) synthesis 
HBA is next modified to HBA a, c-diamide. This represents the first stage in the 
amidation of the carboxylic acid side chains of the corrin ring. Cobyrinic acid has 
seven carboxyl groups which are labelled a, b, c, d, e, f, and g. All of these are 
amidated with ammonia apart from side chain f, which is amidated by (R)-1-amino-2-
propanol. The first two amidation steps are catalysed by the enzyme CobB, which is 
known to amidate positions a and c on the ring system. The remaining amidations are 
catalysed by CobQ.  
CobB is a multi-functional enzyme in that it is able to deaminate Gln and transfer the 
released ammonia group for incorporation into another compound (Debuscche et al. 
1990). The initial report on CobB described how researchers were able to purify the 
protein and to characterise the reaction products. This involved the development of 
an HPLC assay that was used to determine the specificity and the order in which the 
amidations took place. It was found that amidation first took place on the side chain 
(c) attached to C7 of the ring. However, it was not known whether the second 


















































just rotated 90° within the active site. When evaluating the rate of the reaction it was 
found that the amidation of the c position was 5-7 fold faster than the that of a 
carboxylic acid side chain attached to C2. The activity of this enzyme was also 
monitored and it was shown that in order to go to completion that ATP/Mg2+/Gln were 
required (Km = 30.2 µM), with the preferred amide group donor being Gln (Km = 20.3 
µM). Gln could be replaced by ammonia but the reaction was much weaker with a Km 
= 12 mM (Debuscche et al. 1990).  
CobB is a homodimer with a subunit molecular mass of 47 kDa. CobB contains two 
distinct binding sites; an N-terminal ATP binding site and a C-terminal Gln binding 
site. There is no crystal structure of this enzyme, although a model was constructed 
based on the structure of the dethiobiotin synthetase (PDB entry 1DAK). This model 
relied on the fact that there is sequence conservation between CobB and CobQ, and 
that both are related to the MinD family of ATPases. Using the structure of dethiobiotin 
synthetase active site as a guide, Galperin and Grishin were able to develop a model 
for the interaction of CobB and CobQ for their respective substrates (Figure 1.8) 





Figure 1.9: Model of CobB and CobQ based on the dethiobiotin synthetase structure . 
(a) CobB (b) CobQ (c) sequence showing conserved regions (red) for both Cob and CobQ. 
Yellow and blue show alpha helices and beta sheets respectively. Long insertions in the 
potential substrate-binding region of CobQ (b) are shown in purple. Mg-binding residues are 
shown in green. Catalytic lysine residue (Lys37 in dethiobiotin synthetase) is black. The figure 
was prepared using Bobscript,63 modified version of Molscript. (Galperin and Grishin 2000). 
 
CobB is believed to belong to the Triad family of amidotransferases that contain C-
terminal Gln amidotransferase domains. This family of proteins contain three residues 
which form a catalytic triad, Cys-His-Glu. However, the Glu residue of this triad is 
missing in CobB. 
In all of the aminotransferases studied so far the acceptor substrate is located at a 
distance from the Gln site, or even on a different domain or polypeptide chain 
(Raushel, Thoden and Holden 1999). With more and more X-ray crystal structures of 
these aminotransferases available it has been noted that enzymes that have multiple 
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active sites utilise molecular tunnels that connect the active sites (Raushel, Thoden 
and Holden 2003). 
1.12.7 Cob(II)yrinic acid a, c,-diamide synthesis 
Insertion of cobalt into the ring-contracted tetrapyrrole is a complex process requiring 
chelation of the cobalt atom to generate cob(II)yrinic acid a, c-diamide. This reaction 
is dependent on the presence of ATP and Mg2+ and is catalysed by the 
cobaltochelatase. The enzymes responsible for this reaction forms a large protein 
complex consisting of CobN, CobS and CobT (Debussche et al. 1992b). The largest 
of these subunits is CobN with a molecular mass of 140 kDa. This domain is believed 
to contain the binding site for both the hydrogenobyrinic acid a, c-diamide and the 
Co(II) ion. However, it is not clear whether CobN forms a complex with the two other 
enzymes but it is known that CobS and CobT do interact together. What is clear is 
that all three subunits are required for activity, and this proceeds in an ATP dependent 
manor (Debussche et al. 1992a; Heldt et al  2005). 
A low resolution three-dimensional structure of the Brucella melitensis CobST 
complex has been published using single particle electron microscopy. From the 
structure these enzymes look to form a chaperone type complex, which is similar to a 
class of proteins called AAA+ (ATPases Associated with a variety of cellular activities) 
class of proteins (Lundqvist et al. 2009). AAA+ proteins often perform chaperone like 
functions that are involved in the assembly, operation or disassembly of protein 
complexes. The structure of CobST shows two rings stacked together where each of 
the individual rings contains six subunits, which form a trimer of dimers. There is an 
ATP binding domain on the CobS subunit that contains the Walker A and B motifs, 
which is common to ATP binding motifs (Walker et al. 1982). This system of cobalt 
insertion displays sequence identity to the magnesium chelatase that is involved in 
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the biosynthesis of chlorophyll (Reid and Hunter 2002; Waker, C. J and Willows, R. 
D, 1997).  
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1.12.8 Cobalt reduction 
After insertion of the cobalt the next step is the attachment of an upper ligand. Before 
this bond can be formed it is necessary to reduce the Co(II) to Co(I). This involves a 
single electron reduction of the cobalt ion to form cob(I)yrinic acid a, c-diamide. This 
reaction is considered energetically unfavourable, however, an enzyme was isolated 
from P. denitrificans which contained a flavin mononucleotide (FMN) cofactor that 
catalysed the reduction in a range of Co(II)-corrin compounds in an FAD-dependent 
manor (Blanche et al. 1992). 
The gene encoding this enzyme (cobR) was also identified in B. melitensis. This 
protein was recombinantly overexpressed and purified, which enabled structural 
analysis and mechanical studies to be carried out. The structure of CobR was solved 
to 1.6 Å resolution (Figure 1.9). The structure identified a bound flavin cofactor, which 
was identified as FAD. Kinetic and electron paramagnetic resonance (EPR) spectra 
analysis provided evidence for the enzyme proceeding via a semiquinone form, 
proposing that it may react with the adenosyltransferase to overcome the large 
thermodynamic barrier required for co(II)rrin reduction (Lawrence et al. 2008a). It was 
also noted that CobR shared basic homology with the cobalamin reductase PduS, 
which is involved in the metabolism of 1, 2-propanediol (Sampson, Johnson and Bobik  




Figure 1.10: Crystal structure of CobR. (a) Stick representation of CobR with FMN. (b) 
electron density showing isoalloxazine ring of the bound FMN (c) superimposition of flavin 
reductase and CobR showing isoalloxazine rings of the flavin shown in stick representation 
(d) FMN and NAD binding in CobR showing key interactions. (Lawrence et al. 2008a). 
1.12.9 Adenosylcobyrinic acid a, c-diamide synthesis 
The adenosyltransferase, CobO, is involved in the attachment of the upper ligand to 
the centrally chelated cobalt ion. This enzyme catalyses the ATP-dependent 
adenosylation of cob(I)yrinic acid a, c-diamide into its co-enzyme form adenosyl 
cobalamin cob(III)yrinic acid a, c-diamide (Figure 1.10). CobO is a homodimer and 
has a subunit molecular mass of 28 kDa (Crouzet et al. 1991). There are three 
classified groups of adenosyltransferases that have been identified, which are 
referred to as the CobA type, PduO type and EutT type. The CobA group contains 
adenosyltransferases CobA, CobO and ButR, all of which have a high degree of 
sequence identity (Suh and Escalante-Semerena 1993; Johnson et al. 2001).  
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The Co(I) of the cob(I)yrinic acid a, c-diamide is a powerful nucleophile. The corrin 
substrate is in close proximity to the ATP, which is the other substrate. CobO 
catalyses the transfer of an adenosyl group from the ATP to the cobalt. This allows 
the Co(I) nucleophile to attack the C5’ ribose carbon of ATP, forming the Co(III) 
adenoslylcob(III)yrinic acid a, c-diamide and triphosphate as the only product (Figure 
1.10) (Debussche et al. 1991).  
 
 
Figure 1.11: Mechanism of the adenosyl transferase CobA. Adenosylation of Cob(I)yrinic 
acid a, c-diamide occurs via a nucleophilic Co1+ species to form adenosylcob(III)yrinic a, c-
diamide.  
1.12.10 Adenosylcobyric acid synthesis 
The final amidation step is carried out by the enzyme CobQ, which amidates position 
b, d, e and g, to produce adenosylcobyric acid (Warren et al. 2002; F Blanche et al. 
1991). CobQ is a homodimer, with a subunit molecular mass of 57 kDa. As with the 
CobB, CobQ requires ATP, Gln and Mg2+ for activation (Blanche et al. 1991). The 
reaction is carried out in a stepwise process with the sequential order being e, d, b 
and g. Experimental evidence suggested that ATP is used to activate carboxylate 
groups on the ring system to form a phosphorylated intermediate. This was supported 
Adenosyl transferase
Cob(I)yrinic acid a, c-diamide Adenosylcob(III)yrinic acid a, c-diamide
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by labelling the ATP with [γ-18O4] resulting in [γ-18O4]-ATP. The enzyme in this 
reaction was CbiP from the anaerobic pathway, which is equivalent to CobQ in the 
aerobic route. This enzyme catalysed the positional isotope exchange of the βγ-bridge 
oxygen with the two β-nonbridge oxygens (Fresquet, Williams and Raushel 2007). 
CobQ is a multifunctional enzyme that catalyses four separate reactions on a single 
substrate. As with CobB it is unknown whether this reaction is dissociative, where at 
each amidation site the substrate leaves the active site rotating and re-joining, or 
whether it rotates within the active site (Fresquet, Williams and Raushel 2007). 
Following the synthesis of adenosylcobyric acid the aerobic and anaerobic pathways 
then converge. Figure 1.7 shows the vitamin B12 pathway starting from the synthesis 
of uroporphyrin III to adenosylcobyric acid (ado-cobyric acid) synthesized by CobQ. 
1.12.11 Synthesis of adenosylcobalamin from 
adenosylcobyric acid 
The final phase in the biosynthesis of cobalamin involves the synthesis and 
attachment of the lower nucleotide loop. This is initiated with the formation of 
adenosylcobinamide phosphate, which involves the attachment of an aminopropanol 
phosphate linker to the propionic side chain (f) that is found on ring D (Figure 1.11). 
The aminopropanol phosphate is derived from threonine. To begin with, threonine is 
phosphorylated in an ATP-dependent manner to form L-threonine O-3-phosphate. 
This reaction is catalysed by a kinase encoded by the pduX gene (Fan and Bobik 
2008). Threonine phosphate is converted into aminopropanol phosphate by the action 
of CobC, which is a PLP-dependent enzyme that mediates the decarboxylation of 
threonine phosphate. The aminopropanol phosphate is next attached to the corrin 
framework in a reaction mediated with CobD, generating an amide linkage with the f 
side chain. It seems likely that CobC and CobD form a complex (Figure 1.11) (Blanche 
et al. 1995).  
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The construction of the lower loop is continued by the action of a GDP transferase 
called either CobP (P. denitrificans) or CobU (S. enterica).  The enzyme uses GTP as 
a substrate and results in the formation of adenosylcobinamide GDP (Figure 1.11). 
The lower nucleotide within cobalamin contained an unusual base called 5, 6-
dimethylbenzimidazole (DMB), which is incorporated into the nucleoside alpha-
ribazole 5’-phosphate. This reaction is catalysed by CobU (P. denitrificans) (Cameron 
et al. 1991) or CobT (S. enterica) (Trzebiatowski et al 1994), by the transfer of a 
phosphoribosyl moiety (Figure 1.11). 
The final stage of the lower loop assembly involves the formation of 
adenosylcobalamin 5’ -phosphate (Figure 1.11). The enzyme responsible for this 
conversion is CobV (P. denitrificans) or CobS (S. enterica). The last enzyme in the 
pathway is CobC, which removes the 5’-phosphate to generate cobalamin (Figure 






Figure 1.12 Late stage nucleotide assembly of adenosylcobalamin. Amino propanol 
phosphate is attached to adenosylcobyric acid to form adenosylcobinamide phosphate. 
Activation of the adenosylcobinamide with GTP results in the formation of adenosylcobinamide 
GDP. The GDP moiety is replaced with the alpha ribazole nucleoside to give 
adenosylcobalamin 5’ -phosphate. CobC then removes the phosphate to give 
adenosylcobalamin.   
1.13 Objectives 
Obtaining structural and biophysical information on both CobB and CobQ was the 
primary objective. A crystal structure of CobB and CobQ was modelled on the 
dethiobiotin synthetase structure in the paper from M. Galperin and N. Grishin. 
However as this was a model it could not be considered as a true representation of 
the crystal structure (Galperin and Grishin 2000).  Specifically, that a crystal structure 
of CobB could be determined to provide the first insights into this class of enzyme 
associated with cobalamin biogenesis. Stopped-flow analysis was used to gain kinetic 





































































































































































acid c-monoamide (HBAM) and HBAD its product. In particular, it was hoped that 
such an approach would give insights into conformational changes that may take 
place during substrate binding and catalytic turnover and to relate such findings to the 
structure of the enzyme. 
Finally, it is speculated that a number of the pathway enzymes within the B12 pathway 
operate a form of direct metabolite transfer, where the product of one enzyme is 
passed directly onto the next enzyme. It is already known that CobH binds it product 
very tightly. This product, HBA, is the substrate for CobB and it was hoped that a 
structure for CobB would allow imaging of interaction with CobH. All of these aims 
and objectives are described in more detail in the main experimental sections of this 

























Genomic DNA of Brucella melitensis strain ATCC 23456 was provided by Prof. J. J. 
Letesson from the Laboratoire d’Immunologie et de Microbiologie, URBM, Facultes 
Universitaires Notre-Dame de la Paix, Namur, Belgium. For Rhodobacter capsulatus 
genomic DNA strain SB1003 and Allochromatium vinosum genomic DNA DSM180 
provided by Dr. Evelyne Deery, University of Kent. 
All genes were cloned into pET14b (creating a N-terminus His6 fusion) from genomic 
DNA using either NdeI or AseI and SpeI restriction enzymes (see Table 2.1). FastStart 
high fidelity polymerase (Roche) was used for all PCRs. T4 DNA ligase and restriction 





Table 2.1 Plasmids used 
List of plasmids Gene product Source Restriction 
enzymes 
pET14b  Novogen   
pET14b- Bmei cobH Precorrin-8 (11-12) 
methyl-mutase from 
Brucella melitensis 
E. Deery Nde/Spe 
pET14b- Bmei cobB HBA:L-Gln amido-
ligase from Brucella 
melitensis 












E. Deery Spe 
pET14b- Bmei cobQ Ado-cobyrinic acid 
ac diamide:L-
glutatamine amido-
ligase from Brucella 
melitensis 
E. Deery Ase 






E. Deery Nde/Spe 










Most of the chemicals, DEAE-sephacel and antibiotics were purchased from Sigma-
Aldrich Ltd. Other materials were purchased from manufacturers as follows: IPTG and 
ampicillin from Melford Laboratories Ltd; chelating fast flow sepharose, disposable 
PD10 columns from GE Healthcare; Tryptone, yeast and bacterial agar from Oxiod 
LTD. Crystallisation screens and additive screens were purchased from Molecular 
dimensions and Hampton Research. 
2.1.2 Media and solutions used for bacterial work 
Luria-Bertani (LB) broth: 
Tryptone (10 %) 10 g/L 
Yeast extract (8 % 5 g/L 
NaCl 86.2  mM 
     
Made up to 1L with dH2O and autoclaved. 
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2YT broth (2 x Yeast/Tryptone) 
Tryptone (40 %) 16 g/L 
Yeast extract (16 % 10 g/L 
NaCl 86.2 mM 
        
Made up to 1L with dH2O and autoclaved. 
2YTNN (2 x Yeast/Tryptone Na/NH5Cl) 
Tryptone (40 %) 16 g 
Yeast extract (16 %) 10 g 
NaCl  86.2 mM 
Na2HPO4 50 mM 
NaH2PO4 20 mM 
NH5C 20 mM 
        
Made up to 1L with dH2O and autoclaved. 
Mg2+ stock solution: 
MgCl2(H2O) 10 mM 
MgSo4(H2O)6 10 mM 
                                                  
Made up to 10 mL with H2O. 
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For SOC media Tryptone and yeast extract were dissolved in 967.5 mL of H2O and 
autoclaved prior to the addition of the other components. All components that were 
not autoclaved were passed through a sterilised filter (0.2 µm pore size) prior to use. 
Luria Bertani agar: 
15 g of Bacterial agar was added to 1 L LB broth before autoclaving. 
10x M9 salts 
KH2PO 222 mM 
Na2HPO4 478 mM 
NH4Cl 187 mM 
NaCl 86.2 mM 
 
Make up to 1L with dH2O and autoclaved. 
Trace elements solution: 
EDT 18 mM 
FeCl3.6H2 0.02 nM 
ZnSO4.7H2O 0.01 nM 
CuCl2.2H2O 0.06 nM  
Co(NO3)2.6H2O 0.03 nM 
(NH4)6MO7O24.4H2 0.008 nM 
 
All metals were dissolved separately in a small quantity of dH2O before being mixed,  
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pH was adjusted to 7.00 and made up to 1 L. The solution was then autoclaved before 
use. 
Selenomethionine labelling media 
10x M9 salt (stock) 100 mL 
Trace elements (stock) 10 mL 
Glycerol (50% (v/v)) 20 mL 
MgSO4 (1 M) 1 mL 
CaCl2 (1 M 0.4 mL 
Biotin (1 mg mL) 1 mL 
Thiamine (1 mg mL) 1 mL 
Ampicillin (100 mg mL) 1 mL 
Selenomethionine 25 mg 
 
Add chemicals to dH2O 865.6 mL.  
All solutions were made up separately and autoclaved (M9 salts, trace elements,  
glycerol) or filter sterilised (MgSO4, CaCl2, biotin, thiamine, ampicillin; 0.2 µm pore 
size) prior to mixing. 
IPTG solution 1M 
2.38 g of IPTG were dissolved in 10 mL dH2O, filter sterilised (0.2 µm), aliquoted 
into 0.4 mL and stored at -20 °C. The final working concentration was 0.4 mM. 
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Table 2.2 Additives and antibiotics 
Additives Stock concentration Final concentration 
IPTG 1 M in dH2O 100 mM 
Ampicillin 100 mg mL in dH2O 100 µM/mL 








2.1.3 Solutions used for protein work 
2.1.3.1 Solutions for nickel affinity chromatography 
Binding buffer: 
Tris-HCl, pH 8.00 20 mM 
NaCl 500 mM 
Imidazole 20 mM 
 
Wash buffer:       As above 
Elution buffer:  
Tris-HCl, pH 8.00 20 mM 
NaCl 500mM 
Imidazole 1 M 
 
                         
2.1.3.2 Solutions for PD10 de-salting column 
Transfer buffer: 
Tris-HCl, pH 8.00 20 mM 
NaCl    150mM 
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2.1.3.3 Solutions for ion exchange 
Binding buffer: 
Tris-HCl pH 8.00 20 mM 
NaCl 150 mM 
 
Elution buffer: 
Tris-HCl pH 8.0 20 mM 
NaCl 1 M 
 
Protein elutes at 300 mM. 
PBS Buffer: 
NaCl 5 mM 
KC 30 mM 
Na2HPO4 100 mM 
KH2PO4 20 mM 
 
2.1.3.4 Size exclusion chromatography 
Tris-HCl pH 8.00 20 mM 
NaCl 100 mM 
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2.1.3.5 Solutions for protein polyacrylamide gel 
electrophoresis 
10 x running buffer: 
Tris-HCl 250 mM 
Glycine 2 mM 
 
10mL/L 10% (v/v) SDS added to 1 x running buffer for SDS gel. 
2 x SDS sample buffer:  
Tris-HCl, pH6.80 (0.5M 6 mL 
Glycerol (100 %) 4.8mL 
SDS 10% (v/v) 9.6 mL 
Bromophenol blue 0.05% 1.2 mL(v/v) 
dH2O 24 mL 
            
14uL B-mercaptoethanol added per mL 2x SDS sample buffer. 








CBD-Mxe Intein-2CBD 45,000 





Coomassie blue stain: 
Trichloroacetic acid (100%) 250.00 mL 
Coomassie blue R250 0.60 g 
SDS (1 M) 0.10 g 
Tris-HCl (1 M) 0.25 g 
Glycine (1 M) 0.15 g 
 
Make up to 500 mL with dH2O. 
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Table 2.3 Running gel SDS Gel 
SDS     
Running gels 12.5% 15% Stacking gel 5% 
dH2O 3.4 2.2 dH2O 3.4 
30% Acrylamide (mL) 
Acryl/Bis 29:1 




1.5 M Tris-HCl pH8.8 
(mL) 
3.8 3.8 1.5M Tris-HCl pH6.8 
(mL) 
1.9 
10% (v/v) SDS (mL) 1.5 1.5 10% (v/v) SDS (mL) 0.75 
10% APS (v/v) (mL) 0.15 0.15 10% APS (v/v) (mL) 0.075 
TEMED (mL) 0.01 0.01 TEMED (mL) 0.01 
 
 
TAE x 50 0.2 ml 
dH2O 3.1 mL 
30% Acrylamide (mL) 
Acryl/Bis 29:1 
6.6 mL 
10% APS (v/v) (mL) 0.100 µL 
TEMED (mL) 5 µL 
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2.1.3.6. Solutions for Cobalt insertion and amidation of HBAD 
and HBAH 
Cobalt insertion 0.5 M cobalt acetate (Co(CH3CO2)2) pH 6.00  
Rhodium insertion (glove box).   
23 mg of anhydrous NaCl in acetic acid (2 mL). 
2.5 mg of rhodium(1) dicarbonyl chloride (Rh2Cl2(CO)4) dimer in 800 µL tertiary 
butanol. 
2.1.3.7 Solutions for gel filtration chromatography (FPLC) 
Sample buffer A 1 L: 
Tris-HCl, pH 8.0 20 mM 
NaCl 150 mM 
 
Sample buffer B 1 L: 
Tris-HCl, pH 8.0 20 mM 
NaCl 1  M 
 
All solutions were filtered before use.   
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2.1.3.8 Solutions for HPLC-MS 
Tetrapyrrole HPLC-MS analysis: 
Solution A:             Triflouroacetic acid(v/v)         0.1% 
Solution B:             Acetonitrile         100% 
 
Protein HPLC-MS analysis. 
Solution A:               Trifluoroacetic acid (v/v)       0.05% 
Solution B:                                      Acetonitrile (v/v)           80% 
                                                                                    Trifluoroacetic acid (v/v)      0.045% 




2.1.3.9 Solutions for crystallisation 
Table 2.4 Molecular dimension screen 1: Screen contains common salts, 
precipitants and buffers used for initial screening of all proteins. This screen was used 
in an attempt to crystallise CobB.  
Condition  Salt Precipitant Buffer 





0.1 M Na Acetate 
trihydrate pH 4.6 




0.1 M Na Acetate 
trihydrate pH 4.6 




0.1 M Na Acetate 
trihydrate pH 4.6 
4  2.0 M Sodium 
formate 
0.1 M Na Acetate 
trihydrate pH 4.6 
5  2.0 M Ammonium 
sulphate 
0.1 M Na Acetate 
trihydrate pH 4.6 
6  8% (v/v) PEG-
4000 
0.1 M Na Acetate 
trihydrate pH 4.6 




0.1 M tri-sodium 
citrate dihydrate 
pH 5.6 









9  20% (v/v) 2-
propanaol, 20% 
(v/v) PEG 4000 
0.1 M tri-sodium 
citrate dihydrate 
pH 5.6 
10  1.0 M Ammonium 
dihydrogen 
phosphate  
0.1 M Na citrate 
pH 5.6 




0.1 M Na acetate 
pH 4.6 
12  1.4 M Na acetate 
trihydrate 
0.1 M Na 
Cacodylate pH 
6.5 
13 0.2 M tri-sodium 
citrate dihydrate  
30% (v/v) 2-
propanol 
0.1 M Na 
Cacodylate pH 
6.5 




0.1 M Na 
Cacodylate pH 
6.5 
15 0.2 M Magnesium 
acetate 
tetrahydrate 
20% PEG 8000 0.1 M Na 
Cacodylate pH 
6.5 













 1.0 Sodium 
acetate trihydrate 
0.1 M Imidazole 
pH 6.5 




0.1 M Na 
Cacodylate pH 
6.5 





0.1 M Na 
Cacodylate pH 
6.5 




0.1 M Na HEPES 
pH 7.5 





0.1 M Na HEPES 
pH 7.5 




0.1 M Na HEPES 
pH 7.5 
23 0.2 M Calcium 
chloride dihydrate 
28% PEG 400 0.1 M Na HEPES 
pH 7.5 
24 0.2 M MgCl2 
hexahydrate 









0.1 M Na HEPES 
pH 7.5 
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26  0.8 M K, Na 
tartrate 
tetrahydrate 
0.1 M Na HEPES 
pH 7.5 
27  1.5 M Lithium 
sulphate 
monohydrate 
0.1 M Na HEPES 
pH 7.5 












 1.4 M tri-sodium 
citrate dihydrate 
0.1 M Na HEPES 
pH 7.5 




0.1 M Na HEPES 
pH 7.5 
31  10% (v/v) 2-
propanol, 20% 
(v/v) PEG 4000 
0.1 M Na HEPES 
pH 7.5 
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32  2. M Ammonium 
sulphate 
0.1 M Tris HCl 
pH 8.5 




0.1 M Tris HCl 
pH 8.5 




0.1 M Tris HCl 
pH 8.5 





0.1 M Tris HCl 
pH 8.5 




0.1 M Tris HCl 
pH 8.5 




0.1 M Tris HCl 
pH 8.5 
38  8% (v/v) PEG-
8000 
0.1 M Tris HCl 
pH 8.5 
39  2.0 M Ammonium 
dihydrogen 
phosphate 
0.1 M Tris HCl 
pH 8.5 
40  0.4 M K, Na 
Tartrate 
 















44  2.0 M Ammonium 
sulphate 
 
45  4 M Sodium 
formate 
 







47  30% (v/v) PEG 
1500 
 












Table 2.5 Molecular Dimension Additive used in crystallisation: This screen 
contains all of the necessary additives that can be used to improve initial crystals 
obtained from Molecular dimensions screen 1.  
Well  Chemical name  known as/for  Concentration  
A1  
 




PEG 20000  precipitant  20.00  % v/v  
A3  
 
PEG 500 MME  precipitant  40.00  % v/v  
A4  
 
PEG 8000  precipitant  20.00  % v/v  
A5  
 
Ethylene glycol  cryoprotectant  40.00  % v/v  
A6  
 
PEG 4000  precipitant  20.00  % v/v  
A7  
 
Glycerol  cryoprotectant  40.00  % v/v  
A8  
 
MPD  cryoprotectant  25.00  % v/v  
A9  
 
PEG 1000  precipitant  25.00  % v/v  
A10  
 
PEG 3350  precipitant  25.00  % v/v  
A11 MES monohydrate  buffer (acid)  0.50  M  
A12  
 
Imidazole  buffer (base)  0.50  M  
B1  
 
MOPS  buffer (acid)  0.50  M  
B2  
 
Sodium HEPES  buffer (base)  0.50  M  
B3  
 




Trizma® base  buffer (base)  0.50  M  
B5  
 





nucleant  0.60  M  
B7  
 
Sodium fluoride  phasing  0.60  M  
B8  
 
Sodium bromide  phasing  0.60  M  
B9  
 
Sodium iodide  phasing  0.60  M  
B10  
 




dibasic dihydrate  
precipitant  0.30  M  
B12  
 
Ammonium sulphate  precipitant  0.60  M  
C1  
 
1-Butanol  precipitant  0.40  M  
C2 
  
1,4-Butanediol  precipitant  0.40  M  
C3  
 
1,2-Propanediol  precipitant  0.40  M  
C4  
 
1,3-Propanediol  precipitant  0.40  M  
C5  
 
2-Propanol  precipitant  0.40  M  
C6  
 
1,6-Hexanediol  precipitant  0.40  M  
C7  
 




Triethylene glycol  precipitant  0.60  M  
C9  
 
Tetraethylene glycol  precipitant  0.60  M  
C11  
 
N-Acetyl-D-glucosamine  stabiliser  0.40  M  
C12  
 
Fucose  stabiliser  0.40  M  
D1  
 
D-Galactose  stabiliser  0.40  M  
D2  
 
D-Glucose  stabiliser  0.40  M  
D3  
 
D-Xylose  stabiliser  0.40  M  
D4  
 
D-Mannose  stabiliser  0.40  M  
D5  
 
Ammonium acetate  precipitant  0.40  M  
D6  
 
Sodium oxamate  precipitant  0.40  M  
D7 
  




tartrate tetrahydrate  
precipitant  0.40  M  
D9 
  
Sodium citrate tribasic 
dihydrate  











stabiliser  0.40  M  
D12  
 
DL-Alanine  stabiliser  0.40  M  
 
 
Table 2.6 Molecular Dimension Additive screen 2: This screen contains all of the 
necessary additives that can be used to improve initial crystals obtained from 
Molecular dimensions screen 1.  
Well  Chemical name  known as/for  Concentration  
E1  
 
Glycine  stabiliser  0.40  M  
E2  
 
DL-Serine  stabiliser  0.40  M  
E3 PEG 3000  precipitant  30.00  % v/v  
E4  
 
1,2,4-Butanetriol  cryoprotectant  40.00  % v/v  
E5  
 
NDSB 256  surfactant  4.00  % v/v  
E6  
 
1,2,6-Hexanetriol  cryoprotectant  40.00  % v/v  
E7  
 
1,5-Pentanediol  cryoprotectant  40.00  % v/v  
E8  
 
Trimethylolpropane  cryoprotectant  50.00  % v/v  
E9  
 
NDSB 195  surfactant  4.00  % v/v  
E10 MOPSO  buffer (acid)  0.50  M  
E11 Bis-Tris  buffer (base)  0.50  M  
E12 BES  buffer (acid)  0.50  M  
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F1 TEA  buffer (base)  0.50  M  
F2  
 
Gly-Gly  buffer (acid)  0.50  M  
F3  
 
AMPD  buffer (base)  0.50  M  
F4 Lithium sulphate  precipitant  0.60  M  
F5 Sodium sulphate  precipitant  0.60  M  















nucleant  0.02  M  
F10  
 
Zinc acetate dihydrate  nucleant  0.02  M  
F11  
 
Barium acetate  phasing  0.02  M  
F12 Cesium acetate  phasing  0.02  M  
G1 Rubidium chloride  phasing  0.02  M  











phasing  0.01  M  
G5  
 
Sodium orthovanadate  phasing  0.01  M  
G6  
 




















phasing  0.01  M  
G11  
 
Xylitol  cryoprotectant  0.40  M  
G12  
 
D-Fructose  cryoprotectant  0.40  M  
H1  
 
D-Sorbitol  cryoprotectant  0.40  M  
H2 
  
L-Rhamnose monohydrate  cryoprotectant  0.40  M  
H3  
 
myo -Inositol  cryoprotectant  0.40  M  
H4  
 









DL-Threonine  stabiliser  0.40  M  
H7  
 











stabiliser  0.20  M  
H10 
  



















2.1.3.10 Heavy Atom Derivatives 
Table 2.7 Heavy atoms 
Heavy atom Stock concentration 
Mercury Chloride 1 M 




Iodine-dATP 100 mM 





2.2 Microbiological methods 
2.2.1 Sterilisation 
Unless stated otherwise storage media and buffers were sterilised for 15 min at 121 
°C and 1 bar pressure in an autoclave. Temperature sterilised substances were 
filtered through a 0.2 µm pore size filter. 
2.2.2 Preparation of E. coli competent cells 
Competent E. coli cells were prepared based on a method previously described by 
Sambrook et al (1989). A bacterial overnight starter culture derived from a single 
colony was incubated in 10 mL of fresh LB broth and grown to an OD600 of 0.3. The 
cells were cooled on ice for 15 minutes on ice then centrifuged at 1,252 x g 
temperature of 4 °C. The pellet was gently resuspended in 25 mL of ice cold 0.1 M 
CaCl2 and incubated on ice for 30 min. Cells were centrifuged for a second time and 
resuspended in 0.25 mL of 0.1 M CaCl2 containing 26% glycerol v/v. Aliquots of 30 
µL were frozen rapidly using nitrogen and stored at -80 °C. 
2.2.3 Transformation of E. coli competent cells 
Compotent cells were defrosted on ice for 20 min before addition of 1 µL of plasmid 
DNA. The mixture was incubated on ice for 30 min and then heat shocked at 4 °C  for 
90 sec, the mixture was then placed on ice for a further 30 min. After the addition of 
200 µL of NTY broth the cells were incubated at 37 °C	 for 2 hr to allow antibiotic 
resistance expression. The mixture was then spread on an LB plate containing the 




2.2.4 Storage of bacteria 
For long time storage of bacteria, glycerol stocks were prepared. Glycerol was added 
to an overnight bacterial culture to a final concentration of 25 % (v/v). The culture was 
then frozen at -80 °C 
2.2.5 Liquid cultures 
Liquid cultures were incubated at 28 °C for CobB and 37 °C  for CobQ, overnight. A 
scraping of bacteria from glycerol stock at -80 °C was transferred to a 50 mL falcon 
tube containing 2 x 2YT with antibiotics and glucose. The liquid cultures were shaken 
at 160 rpm. 
2.2.6 Transformation of E. coli competent cells  
Compotent cells were placed on ice and allowed to thaw for 15 min before adding 1 
µL of plasmid DNA. The mixture was incubated on ice for 20 min and then heat 
shocked for 90 sec at 42 °C, before being transferred to ice and left for a further 10 
min. SOC media (200 µL) was added to the cells and depending on protein, was left 
at 28 °C or 37 °C .	The mixture was then spread onto an agar plate containing the 
appropriate antibiotics and incubated at the appropriate temperature. 
2.2.7 Recombinant protein overproduction in E. coli  
The E. coli strain BL21 (DE3) pLysS was transformed with a vector containing the 
gene of interest cloned in frame. The recombinant strain was grown overnight in 10 
mL of LB plus ampicillin (100 µg/L), chloramphenicol (100 µg/L) and glucose (0.4 % 
v/v). The 10 mL culture was then seeded into 2YT (2 x yeast/tryptone) broth containing 
anti-biotics and glucose. CobB was grown at 28 °C for 24 hours no induction with 
IPTG. CobQ was grown at 37 °C till an OD600 of 1.2 was reached. Protein production 
 94 
was induced using 0.4 mM IPTG and the bevelled flasks were left shaking at 160 rpm 
overnight at 19 °C. The cells were then collected the following day by centrifugation 
at 8,765 x g for 20 min at 4 °C. The pellet was then re-suspended in 30 mL of Ni Buffer 
A (20 mM Tris-HCl pH 8.0,150 mM NaCl, 20 mM imidazole, and frozen at -20 °C. 
2.2.8 Production of selenomethionine (Se-Met) labelled protein 
Brucella CobB was transformed using KRX_pET14b-cobB cells and plated onto LB 
agar plates which were left overnight at 37 °C. A single cell was incubated with 10 mL 
of LB plus 0.4% glucose (v/v) and 100 µg/L of ampicillin and incubated at 37 °C for 8 
hr until an OD600 of 0.2. 
The above starter culture was then added to 2 L of LB plus ampicillin and glucose and 
grew overnight at 37 °C . The overnight culture was spun down and resuspended in 
induction media. Cells were incubated for 1 hr and then induced using 0.2 % 
Rhamnose for 24 hr at 25 °C. 
Induction media: 100 mL of M9 salt x 10, 9 mL CaCl2, 2mL MgCl2, 100mL trace 
elements, 10% glycerol (v/v), 1 mL thiamine, 1 mL ampicillin and 125 mg/L of SeMet. 
After 24 hours the sample was centrifuged at 1,252 x g for 20 min, pellet was 
resuspended in Ni Buffer A (20 mM Tris pH 8.00, 500 mM NaCl, 2 mM MgCl2 and 20 
mM imidazole), the same method as native protein. 
2.2.9 Lysis of cells by sonication 
Harvested cells were lysed by sonication using a Sonics Vibracell Ultrasonic VCX 150 
processor (VWR), with an out watt of between 20 and 30 in 30 sec bursts with 20 sec 
break repeated 5 times. The sonicated cells were centrifuged at 8,765 x g for 20 min, 
at 4 °C to remove the cell debris. 
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2.3 Biochemical methods 
2.3.1 Protein purification by immobilised metal ion affinity 
chromatography 
The His6-tag sequence of the fused protein has affinity for transition metals such as 
Co2+, Ni2+, Zn2+ and Fe3+. Chelating SepharoseTM Fast resin loaded with Zn2+ 
selectively retains proteins with exposed histidine, which will form a complex with the 
resin enabling purification of the protein of interest. The protein can then be eluted by 
washing with an imidazole gradient. 
Protein was purified at room temperature using an Acta P-920 FPLC system 
(Amersham Biosciences). The pre-packed column was washed with 5 column 
volumes of water, and equilibrated using Ni2+ buffer A. 
The lysate was clarified by centrifugation at 8,765 x g for 20 min, and run through a 
Ni2+ NTA column, protein was eluted using an imidazole gradient (Ni buffer B: 20 mM 
Tris-HCl pH 8.0, 150 mM NaCl and 1 M imidazole), CobB elutes at around 300 mM 
imidazole. 
2.3.2 Buffer exchange 
Purified protein was desalted on a pre-packed disposable Sephadex G25 column 
(PD-10, bed volume 8.3 mL; GE Healthcare). The column was equilibrated with 3 
column volumes of MonoQ buffer A (desired exchange buffer), 2.5 mL of protein 
solution was applied to the column, and the protein was then washed through with 3.5 
mL of buffer A. 
2.3.3 Ion exchange chromatography 
Ion exchange was performed using an Äkta P-920 FPLC system (Amersham 
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Biosciences). MonoQ column was washed in buffer and then equilibrated using 20 
mM Tris-HCl pH 8.0, 150 mM NaCl2 and 2 mM MgCl. The sample was loaded to the 
equilibrated column and then removed from the column using a salt gradient (buffer 
B: 20 mM Tris-HCl pH 8.0, 1 M Nacl2 and 2 mM MgCl. 
2.3.4 Gel filtration 
An Äkta FPLC chromatography system was used for gel filtration purification. A 
Superdex™ 200 HiLoadTM 16/600 column (Sigma/Aldrich) was pre-equilibrated with 
2 column volumes of buffer A (20 mM Tris-HCl, 150 mM NaCl2 and 2 mM MgCl). 
Concentrated purified protein (1 mL) was loaded onto the column. The protein was 
eluted at a flow rate of 0.5 mL/min into 1 mL fractions with buffer A. Fractions were 
analysed by SDS-PAGE and the purest fractions pulled. The column was recovered 
with 1 column volume of buffer A and stored in water. 
2.3.5 Production and purification of HBA and HBAD 
HBA and HBAD was produced using a strain containing all of the enzymes necessary 
to produce the substrate (HBA) and product (HBAD) (Glycerol stock of strain supplied 
by Evelyne Deery). A scraping of cells from the glycerol stock was incubated in 10 mL 
of 2YTNN (see 2.1.2) media for 4 hrs, this was then added to 1 L of the same media.  
The protein media was incubated for 6 hrs, then induced using IPTG (0.4 mM), after 
induction the flask was moved to a 28 °C incubator for 24 hrs. The following day the 
lysate was centrifuged (8,765 x g for 20 min) and the pellet re-suspended in 10 mL of 
water and 30 mL methanol (v/v). The mixture was then placed in a water bath at 60 
°C for 20 min, after 20 min the sample was again centrifuged to remove the denatured 
protein. The supernatant contained the substrate and product HBA and HBAD. 
DEAE-Sepharose column (diethylaminoethyl) (Sigma-Aldrich) was equilibrated with 
10 mL of 20 mM Tris-HCL pH 7.5, the HBA/HBAD sample was applied, a small 
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amount of HBAH was in the sample which did not bind the column (this sample was 
not used). HBAD was still bound, and was washed from column with 20 mM Tris-HCL 
pH 7.5 and  200 mM NaCl2. 
LiChroprep RP18 column (20-40 µM), beads activated with hexane and then washed 
with ethanol 3 times. A small amount of activated resin was poured into the column, 
and washed with 3 column volumes of acetonitrile. Column was then equilibrated with 
5 column volumes of water. HBAD (pH to 4.5 with acetic acid) sample was applied to 
column and a further wash of 3 column volumes. Samples were separated using 5%, 
10%, 20% and 30% methanol. 
2.3.6 Preparation of crosslinkers DMS, DMP and DFDNB  
Each of the crosslinkers were resuspended in water to a concentration of 100 µM 
(stock solution). Using a PD10 column the enzymes were exchanged into phosphate 
buffer saline (PBS). The concentration of CobB and CobH were adjusted to a 
concentration of 0.7 mg/mL. HBA was added to a final concentration of 100 mg/mL to 
the dilute CobH. CobB and CobH/HBA were combined and 50 )L of the crosslinker 
was added to the dilute complex. The complex was then left rotating at room 
temperature for 2 hr. To stop the reaction the buffer was changed using a PD10 
column back into the original 20 mM Tris/HCl buffer, pH 8.0, containing 150 mM 
NaCl2. 
2.3.7 A280 protein concentration estimation 
Protein concentration was estimated using a nanolitre spectrophotometer. The OD280 
was recorded and the concentration estimated from the calculated extinction 
coefficient for the protein using the following equation. The absorbance and the 
extinction coefficient were derived from ProtoParam on the ExPASy server.  
A280 = Concentration x Extinction coefficient x Path length  
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To convert to mg mL: 
Protein concentration (mg/mL) = Molecular mass x Concentration. 
2.3.8 Polyacrylamide gel electrophoresis 
2.3.8.1 SDS-PAGE precast gels 
Pre-cast polyacrylamide gels NuPAGE Novex 4-12 % Bis-Tris Gels (1.0 mm thick, 12 
or 15 well) were used to check protein purity after purification.  
Sample buffer (5x) containing 2-mercaptoethanol was added to samples and heated 
at 95 °C for 10 mins before loading. The gels were run in MOPS buffer (50 mL of 
NuPAGE/MOPS running buffer (20x) (Life Technologies) mixed with 950 mL dH2O) 
at 200 V for 45 mins. The gels were then incubated in Coomassie blue staining 
solution (1 g Coomassie brilliant blue dissolved in 1 L of: 50 % (v/v) methanol, 10 % 
(v/v) glacial acetic acid, 40 % (v/v) dH2O). The gels were then transferred to a de-
staining solution (7% (v/v) glacial acetic acid, 25 % (v/v) methanol, 68 % (v/v) dH2O) 
2-3 times to reveal the protein bands. 
2.3.8.2 SDS-PAGE 
The composition of the gel, buffers and stain were previously described in Section 
2.1.3.1.4.  
Polyacrylamide gels were run according to Laemmli (Laemmli 1970).  The sample 
was denatured by 1:1 addition of protein and SDS sample buffer and boiling for 5 min. 
Between 10 to 20 µL denatured sample was loaded into each well and 7 µL of 
molecular mass marker was run on each gel to estimate the relative molecular mass 
of the protein of interest. Electrophoresis was performed at a constant voltage of 200 
V using an Atto Dual Mini Slab AE6450 electrophoresis apparatus and an Atto Mini 
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Power electrophoresis power supply Sj1082, both obtained from GRI Ltd. The gel was 
stained using Coomassie blue stain (2 hours) and de-stained by washing in water.  
2.3.8.3 Native PAGE  
A standard 12.5% (v/v) acrylamide gel was run as described in Section 2.3.5.1. 
Instead of staining with coomassie blue, the gel was fixed and stained using the 
following protocol. The acrylamide gel was washed in 200 mL 12.5% (v/v) TCA for 30 
min and then for a further 20 min in dH2O. Bands were developed using staining 
solution and appeared within 5 to 10 minutes. 
2.3.9 Anaerobic techniques 
Anaerobic work was carried out under nitrogen using an anaerobic chamber (glove 
box), containing less than 4 ppm oxygen. Liquids such as water and buffers stocks 
were degassed under argon prior transfer into the glove box. Chemicals were taken 
into the glove box as powders and were made up with degassed water once inside.  
2.3.10 UV/visible spectrophotometry 
All UV/visible spectra were recorded on a Varian Cary 50 Bio UV/visible 
spectrophotometer over a range of 300 -700 nm. 
Intrinsic and extrinsic fluorescence were used to measure the kinetics of the reactions.  
2.3.11 HPLC-MS 
Mass spectroscopic data were obtained on an Agilent 1100 liquid chromatography 
(LC) system connected to a Agilent 1100 LC/MSD Trap, using electro-spray ionization 
technique in the positive mode. Spectra were monitored by DAD-UV detection. 
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2.4 Biophysical analysis 
2.4.1 Fluorescence-emission spectra  
Fluorescence spectrophotometry of the binding of substrate to the enzyme was 
performed in 20 mM Tris pH 8.0 and 150 mM NaCl, at room temperature, using a 
Perkin-Elmer LS-50 fluorometer. The excitation was fixed at 280 nm (recorded from 
300-650) and 330 nm (recorded from 360-650), and the excitation slits were fixed at 
2.5 nm each. Two samples of CobB (1 µM) was mixed with HBA (10 µM) and the 
emission spectra was collected with and without AMPPNP (5 mM) present.  
2.4.2 Stopped Flow experiments 
Stopped-flow is a method employed to allow the measurement of fast reaction kinetics 
on very short time scales (Toseland and Geeves 2014). The stopped-flow 
spectrometer used throughout this thesis was a SF-61 DX2 manufactured by HiTech 
Scientific which was capable of double mixing but only used for single mixing. The 
stopped-flow contains two 700 μL sample syringes driven by air-pressure from an 
external air pressure pump (concentration can vary depending on sample). Both 
syringes were triggered simultaneously pushing the reactants into an observation cell 
which is in the optical light path of a high intensity light source. The light source used 
for these experiments was a Xenon-Mercury lamp. The fluorescence of the sample 
was detected via a photomultiplier placed at a right-angle to the incoming light. When 
the samples reached the observation cell they were mixed in a 1:1 ratio resulting in 
the concentration of both reactants being halved. As the solution leaves the 
observation cell it fills the empty stop syringe which forces the syringe to hit a back-
stop which immediately ceases the flow. The samples syringes are temperature 
controlled by an external water bath.  
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Intrinsic fluorescence originates from naturally fluorescent groups like certain amino 
acids within a protein such as tryptophan or tyrosine (Eccleston, Martin and Schilstra 
2008). Tryptophan/tyrosine fluorescence is very commonly used as it can respond to 
changes in the local environment. In the case of the CobB there are a number of 
tyrosine residue located around the hydrogenobyrinic acid (HBA) binding site. This 
can be observed by an decrease in fluorescence when HBA binds, The tyrosine 
molecule was excited at a wavelength of 295 nm with the emission signal detected 
above 320 nm via a WG320 cut- off filter.  
Extrinsic fluorescence derives from an external fluorophore being attached to a ligand 
of interest. In this study HBA, HBAM and HBAD with CobB, was excited at a 
wavelength of 360 nm and the emission detected above 450 nm. 
2.4.3 Thermal shift assay 
CobB in 20 mM Tris pH 8.00, 300 mM NaCl and 2 mM MgCl at a concentration of 5 
µM was run with and without substrates. The assay was run on a Bio-Rad qPCR 
machine (real time PCR), 45 µL of enzyme and enzymes with substrates, was added 
to a 96 well plate. To each sample 1 µL (final concentration 5 mM) of a 5,000 times 
concentrated SYPRO Orange dye was added to the samples. This assay uses a 
temperature gradient to determine stability of the complex, as the temperature 
increases the protein starts to unfold, SYPRO orange will then bind to the hydrophobic 
core of the protein emitting a fluorescence signal (Santos et al. 2012). 
2.5 MicroScale Thermophoresis (MST)  
2.5.1 His6-tag MST protocol 
To 73.5 µL of protein (10 µM) in PBS buffer (concentration of 200 mM) 1.5 µL of 
concentrated dye solution (RED-tris-NTA) was added. This dye binds to the histidine 
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tag of the protein giving a fluorescence signal enabling any changes in the molecule 
when binding to be observed. A further 25 µL of PBS was added to the sample (100 
µL), and the sample was incubated at room temperature for 30 min. After incubation 
the mixture was centrifuged at 15,000 x g at 4 °C for 10 min. 
2.5.2 MST assay   
MicroScale Thermophoresis (MST) is a method commonly used for the 
characterisation of intermolecular reactions. The instrument used was a Monolith 
NT.115. This instrument has a number of advantages over other technologies, mainly 
only very small amounts of protein are required to give accurate readings. For this 
assay a Tris-NTA with an oligohistidine tag was used, this gives a high fluorescence 
signal and an optimal signal to noise ratio in MST. The RED-tris-NTA binds to the 
histidine tag of one of the samples and enables the binding reaction to be monitored 
(Bartoschik et al. 2018). 
In total 16 eppendorf samples are labelled 1 to 16, in sample 1: 20 µL of the ligand 
solution is added. To the remaining 15 samples: 10 µL of PBS is added to each 
eppendorph. Serial dilutions are then employed, taking 10 µL from sample 1 and 
mixing with sample 2, removing 10 µL from sample 2 and mixing with sample 3 this 
is continued until all of the 16 samples have protein. The labelled samples are then 
loaded into glass capillaries using capillary action. Overview of the procedure is 




Figure 2.1 Monolith NT-115. Showing instrument Monolith NT-115, detection method and 
example of results. Results show a typical graph of two proteins binding to a ligand. Green is 
sample 1 and red is sample 2. The table shows the conditions used in the experiment and the 





2.6 Crystallisation and X-ray crystallography 
2.6.1 Initial Crystallisation using hanging drop vapour 
diffusion method 
The hanging drop vapour diffusion method was used for the screening of the proteins 
of interest (Figure 2.2). As previously described protein was purified using Ni2+ 
chromatography, de-salting column and ion exchange chromatography. Protein was 
then run on an SDS PAGE gel to determine the purity of the protein. Fractions of the 
purified protein were then collected. The protein was then tested for stability over a 
range on concentrations and temperature for storing, protein was found to be stable 
at low concentration and stored at -20 °C, aliquots of 1 mL were frozen at this 
temperature The protein for crystallisation (1 mL) was then concentrated to a final 
concentration of 4 mg/mL using an Amicon Ultra-15 centrifugal filter unit (Merck 
Millipore) with a molecular weight of 10,000 Da. 
Initial screening was carried out using Molecular Dimensions screen 1 and 2 (total of 
96 conditions), the trays were set up using greased 24 well plates, and 18 inch round 
siliconised cover slips (Hampton Research).  
A 100 µL sample of the Molecular Dimension screen 1 ad 2 was placed in each well 
(total of 96 wells), and a protein sample of 2 µL was placed on each glass cover slip, 
1µL from the well solution was then placed over the top of the protein drop. The cover 
slip was then inverted over the well solution, the grease seal on the top of the well 
plates enabled the sealing of the wells. The pates were then placed at both 4 °C and 




Figure 2.2. Vapour Diffusion in the hanging drop. Showing vapour diffusion crystallisation 
drop and phase diagram. 
2.6.2 Heavy atom soaks 
As there was no previous structure molecular replacement could not be used to solve 
the structure, so to solve the phase problem heavy atom derivatives of the structure 
was required. Native protein was selected and soaked in a range of heavy atom 
derivatives (Table 2.7). The crystals were soaked for a period ranging from 15 min to 
24 hrs, determined by the stability of the crystals. Crystals were then frozen and 
archived for diffraction purposes. 
2.6.3 SeMet crystals 
SeMet labelled CobB was expressed and purified as already described (2.2.8). A 
crystallisation tray was prepared using the same conditions as the unlabelled CobB 
(0.2 M ammonium acetate, 0.1 M Na citrate, pH 5.6, 30% PEG 4K). This produced 
crystals similar to the native crystals. The first crystal appeared four days after set up, 
but took about a week to be of a size for x-ray diffraction.  
 
Crystallisation of CobB
Vapour diffusion in hanging drop
Initial crystallisation trials were set up using Molecular Dimensions screen 1 and 2.
Optimisation produced crystals which were good enough to send to the synchrotron.
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2.6.4 Archiving and storage of crystals 
The most commonly used cryoprotectants include glycerol, ethylene glycol, PEG 400 
and propylene glycol. A good cryoprotectant will provide protection and prevent 
damage caused by freezing and at the same time will not hinder the diffraction 
potential of the crystal (McFerrin and Snell 2002). Crystals were removed from the 
protein drop using a Hampton Cryo-Loop, the loop was slowly passed through a cryo-
protectant solution. The cryo-protectant solution was 5 µL of well solution and 5 µL of 
a 50 % glycerol (v/v) solution (final concentration 25 % glycerol v/v). This seemed to 
give a glacial freeze and did not destroy the crystals. The crystals were then flash 
frozen in liquid nitrogen and stored until required for data collection. 
2.6.5 X-ray diffraction 
Crystals were mounted onto a goniometer where a constant cold stream of nitrogen 
gas at 100 K was applied, this was to keep the crystal vitrified. The data was 
processed using MOSFLM (Leslie 2006) and reduced using SCALA (Evans 2006). 
Processing refers to the indexing of the diffraction pattern and the integration of the 
intensities, image by image. Reduction is the process whereby reflections, are 
measured twice in order to obtain crystallographically equivalent reflections. These 
reflections are merged together to form the unique data set. At this stage the 
intensities are converted to structure factor amplitudes.  
The SeMet crystals, native crystals, ADP bound, CobB with mutation at position 
C327A and CobB/ATP/HBA were collected on beamline I03 at the DIAMOND Light 
Source (Oxfordshire). CobB/HBA crystals and CobB/HBA/AMPPNP crystals were 
collected at beamline Proxima 2 (Soleil, France). 
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2.6.6 Refinement and model building   
Successive cycles of refinement and model building were carried out using REFMAC 
(refinement package which includes refinement against anomalous data set this 
program is supported by the CCP4 data suite)  (Vagin et al. 2004) and COOT 
(molecular graphics model building program supported by CCP4 data suite) (Emsley 
and Cowtan 2004) to improve the agreement of the model and experimentally derived 
structure factor amplitudes. Agreement was measured as the Rfactor and along with 
this value Rfree was also calculated as a control, using the 5 % of reflections 
consistently left out of the refinement. After refinement the resultant electron density 
map was examined to see if there are any parts of the structure that could be improved 
manually using COOT (Emsley and Cowtan 2004). The Rfree and Rfactor indicate 
the quality of the refined data. Pymol was used to draw structure figures throughout 








Biochemical and structural analysis of 





The production of adenosylcobalamin involves a highly complex intricate biological 
pathway comprising more than 30 enzymes-mediated steps. In order to gain insight 
into the mechanism into how cobalamin is produced, researchers have tried to study 
each of the individual enzymes to determine their role in the formation of this valuable 
molecule (Raux, Lanois and Levillayer 1996). 
There are two distinct routes for the production of cobalamin, which are referred to as 
the aerobic and the anaerobic pathways (Figure 3.1). These two pathways diverge at 
the level of precorrin-2 and then re-converge after the synthesis of adenosylcobyric 
acid. Overall, the biosynthesis of cobalamin involves methylations, macrocyclic ring 
contraction, a decarboxylation, amidations, cobalt insertion, adenosylation and the 
construction and attachment of a lower nucleotide loop (Warren et al. 2002).  
 
Figure 3.1: Aerobic and anaerobic pathway of the production of cobalamin. Diagram 
shows where the aerobic and anaerobic pathways diverge, after the production of precorrin-













































The differences between the two pathways are in the requirement for molecular 
oxygen and the timing of cobalt insertion. For the anaerobic pathway cobalt insertion 
takes place early on whereas the aerobic pathway requires molecular oxygen and 
involves the late insertion of cobalt (Battersby 1994; Raux 1996; Scott 2003).  
In this chapter the structure of cobyrinic acid a, c-diamide synthase, CobB, from 
Brucella melitensis is described. This enzyme is involved in the aerobic pathway and 
amidates hydrogenobyrinic acid (HBA) to give firstly hydrogenobyrinic acid c-
monoamide (HBAM) and then hydrogenobyrinic acid a,c-diamide (HBAD) 
(Debussche et al. 1990). The homologous enzyme in the anaerobic pathway is called 
CbiA, which amidates cobyrinic acid to cobyrinic acid a,c-diamide. The enzymes 
require Gln/ATP/Mg2+ together with their corrin substrates to mediate the reaction 
(Fresquet, Williams and Raushel 2004). In both the aerobic and anaerobic pathways 
there are a total of six amidation steps, which are carried out by two separate enzymes 
called CobB and CobQ (Galperin and Grishin 2000). CobB from P. denitrificans has 
been shown to catalyse the amidation of the C2 and C7 carboxylates of 
hydrogenobyrinic acid (Figure 3.2). This enzyme will also use cobyrinic acid as a 
substrate, although the affinity for cobyrinic acid is significantly weaker (a Km of 160 
µM versus 0.41 µM for hydrogenobyrinic acid) (Fresquet, Williams and Raushel 







Figure 3.2: Amidation of HBA to HBAD. Diagram shows the amidation of firstly the C7 
position on the ring to form HBAM, and then the amidation of C2 to form the product HBAD. 
In order for this reaction to proceed ATP, Mg2+ and Gln are required.  
In the aerobic pathway cobalt insertion occurs at hydrogenobyrinic acid a,c-diamide 
in a reaction catalysed by the cobalt chelatase. The chelatase is a three component 
system composed of CobN, S and T and generates cob(II)yrinic a,c-diamide (Blanche 
1993). It is at this point that the aerobic and anaerobic pathways re-converge. The 
cobalt is then reduced to cob(I)yrinic a, c-diamide and adenosylated.  
CobQ (CbiP), the second amidase in the pathway, amidates adenosylcobyrinic acid 
a,c-diamide at positions b, d, e and g, on the tetrapyrrole ring to yield 
adenosylcobyrinic acid. The fifth carboxyl at the side chain f in the corrin ring is 
amidated using (R) – 1 amino-2-propanol in the aerobic pathway (Debuscche et al. 
1990; Warren et al 2002). 
In order to provide molecular detail on the mechanism of CobB the B. melitensis 
enzyme was produced recombinantly in E. coli. B. melitensis is a Gram negative 
coccobacillus bacterium from the Brucellaceae family, which is heterotrophic and can 
carry out either aerobic or anaerobic respiration. B. melitensis has all the necessary 
genes required for the aerobic biogenesis of B12. 
























































3.2.1 Expression and purification of His tagged Brucella 
melitensis CobB 
E. coli strain BL-21 (DE3) pLysS was transformed with pET14b carrying the cobB 
gene (Dr. Evelyne Deery), which allowed for the production of recombinant N-
terminus His6-tagged CobB. The cells were grown in 2YT broth supplemented with 
ampicillin and chloramphenicol overnight at 18 °C. (described in Section 2.2.7). After 
harvesting by centrifugation the cell pellet was resuspended in Tris-HCl buffer, pH 
8.0, containing 500 mM NaCl and 20 mM imidazole. The cells were then lysed by 
sonication and centrifuged for a second time to remove the cell debris.  
His tagged native CobB was purified using a Ni chelate column (Figure 3.3) followed 
by ion exchange chromatography. From 1 L of culture ~10 mg of protein was 
reproducibly produced. The purified CobB was run on a 12% SDS PAGE gel and 
appeared as a single band of 47 kDa, which is in close agreement to the expected 
molecular mass of 47.02 kDa (Figure 3.4). 
The protein was observed to be highly soluble and could be concentrated to 20 
mg/mL. However, the stability of the protein over time was problematic as it tended to 
precipitate at concentrations of greater than 2 mg/mL when stored at -20 ˚C. By 
lowering the salt concentration and keeping the concentration of the enzyme below 1 
mg/mL this problem was overcome. The enzyme could be stored for periods of up to 




Figure 3.3: Chromatogram of Ni column showing elution of CobB. The large peak was 
collected in fractions A11 to A13, whilst the smaller peak was collected in fractions A15 and 








Figure 3.4: 12 % SDS-PAGE of fractions from CobB purification from IMAC. Lane 1 
contains the protein ladder of known molecular masses as shown. Lanes 2, 3 and 4 contain 
samples taken from peak 1 from the chromatogram in Fig 3.3 and correspond to fractions A11- 
A13 (Fig 3.3). Lanes 5 and 6 contain samples from peak 2 from chromatogram in Fig 3.3 and 
correspond to peaks A15 and B15 (Fig 3.3). CobB was found to elute in peak 2, eluting at a 
concentration of ~250 mM imidazole. Over expressed CobB was not run on gel. 
Protein fractions corresponding to lanes 5 and 6 on the SDS gel were pooled and the 
enzyme was run through a PD10 column to remove the imidazole (PD10 buffer, 
20mM Tris/HCl, pH8.0, containing 150 mM NaCl and 2 mM MgCl). The protein was 
then applied to a MonoQ ion exchange column. The fractions from peak one were run 
on an SDS-PAGE gel (Figure 3.5).  
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Figure 3.5: 12 % SDS gel of B. melitensis CobB showing fractions collected during 
purification. Lane 1: contains protein markers of known molecular mass, as shown. Lanes 2 
& 3 contain the flow through from the MonoQ column.  Lanes 4-7 contain the peak fractions 
from the chromatogram. Higher molecular weight band could be a proteolytic fragment. 
3.2.1 Production and purification of HBA and HBAD 
Hydrogenobyrinic acid (HBA) is the corrin substrate for CobB, amidating the 
carboxylate on the a and c side chains of the macrocycle resulting in the production 
of hydrogenobyrinic acid a, c-diamide (Debuscche et al. 1990). To investigate the 
structure and function of CobB, ready access to the corrin substrate and product is 
required. Both of these compounds have to be isolated from a genetically engineered 
strain of E. coli. A strain containing all the necessary enzymes to produce both 
substrate and product was obtained from Dr. Evelyne Deery, University of Kent. The 
recombinant E. coli strain contains cobA-cobI-cobG-cobJ-cobM-cobF-cobK-cobL-
cobH-cobB, which encodes for all the enzymes required to convert uro’gen (III) into 
HBAD, although it also accumulates HBA too. The strain was grown in 2YTNN broth 
and expression of HBA and HBAD is described in Section 2.3.5. After overnight 
expression the mixture was spun at 13148 x g  and the pellet resuspended in 30 mL 
of ethanol. The supernatant was then boiled for 30 minutes to denature the protein, 
and spun again at 18,000 rpm to remove the debris. The samples were then vacuum 
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dried to remove ethanol and frozen at -20 °C until required. In order to separate HBA 
from HBAD, the sample was run on a DEAE column.  The first to elute from the anion 
exchange column was HBAD in 100 mM NaCl, followed by HBAD in 300 mM NaCl 
(Figure 3.6). Further purification of each sample was carried out using a reverse 
phase column (RP18), where pure material was removed from the column in 30 % 
(v/v) methanol.  
  
  
Figure 3.6: Samples of HBA and HBAD eluted from a DEAE column. HBAD (labelled wash 
3 and 4) eluted from the column by washing with 100 mM NaCl. HBA, in the tube marked wash 
5, was removed from the column with 300 mM NaCl. 
The purified samples of HBA and HBAD were then run on a 20 % polyacrylamide gel 
to determine their purity (Figure 3.7). As shown in Fig 3.7, the purified material run as 
single fluorescent bands when viewed under UV light. 




Figure 3.7: 20 % polyacrylamide gel. Standards of HBA and HBAD are shown in lanes 1 
and 7, respectively, and were supplied by Dr. Evelyne Deery. The purified HBA and HBAD 
samples are in lanes 3 and 5, respectively, from the gel HBA and HBAD look to be pure 
running at the same rate as the standards. 
3.2.3: UV/visible spectra of substrate and product 
A UV/visible spectrum of each sample was recorded over the range of 300 nM to 700 
nM. It is not possible to determine the difference between HBA and HBAD using this 
method but it does give information on the purity of the samples. HBA and HBAD have 
distinct absorbance maxima at 330 nm, 495 nm and 522 nm. With an extinction co-
efficient of 20,000 M-1 cm-1 for the peak at 330 nm and 50,000 M-1 cm-1 for peaks 495 
and 522 (Figure 3.8), it was determined that the purified batches contained ~300 µg/L 
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Figure 3.8: UV/visible spectrum of HBAD. HBAD has typical absorption maxima at 329 
nm, 498 nm and 524 nm as shown in the spectrum. 
3.2.4: Chromatography-mass spec analysis (LC-MS) 
In order to verify that there was HBA and HBAD in each of the samples and to 
determine the purity of the samples they were analysed by LC-MS (Dr. Andrew 
Lawrence, University of Kent). LC-MS revealed the presence of one major compound 
that had a mass of 881.426 g/mol for HBA and 879.465 g/mol for HBAD (Figure 3.9). 
These results were very similar to the published mass for each compound 880.989 














Figure 3.9: LC-MS analysis of HBA and HBAD. The spectra of (a) HBA shows a molecular 
mass of 881.4 Da and (b) HBAD shows a molecular mass of 879.5 Da, which is consistent 
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3.4: Thermal stability measurement of B.melitensis CobB 
In crystallisation experiments it is important to have a stable homogenous protein. 
One way to investigate the stability of the protein is to use a thermal shift assay. This 
assay is a technique that enables the determination of the stability of the protein under 
a range of conditions by, for example, monitoring the change in fluorescence of the 
binding of a dye over a temperature range. This techniques allows for an investigation 
into the suitability of buffers, binding partners or additives (Santos et al. 2012). For 
CobB this assay was performed in order to determine if the binding of substrates or 
cofactors increased the stability of CobB.  
A number of samples were run with and without substrates and product, and the 
interaction monitored. The samples were run over a temperature gradient from 25 °C 
to 80 °C, at which point the protein starts to unfold and the dye (sypro orange) binds 















Figure 3.10: Melting curves of B. melitensis CobB. Curves showing change in relative 
fluorescence of either CobB alone or with substrates against temperature. (a) CobB only 
(black), CobB/ATP (pink), CobB/Gln/ATP (green), CobB/Gln (yellow), CobB/ATP/Gln/HBA 






























































Table 3.1: Thermal melting temperature for B. melitensis CobB. CobB only has a thermal 
melting temperature of 47°C. The presence of ATP increases the binding stability of 
CobB/ATP by 14.2°C, CobB/Gln/ATP stabilisation of 14.4 °C, Brucella/Gln no change, 




CobB only 47 °C 0 °C 
CobB/ATP 61.2 °C 14.2 °C 
CobB/Gln/ATP 61.4 °C 14.4 °C 
CobB/Gln 47 °C 0 °C 
CobB/Gln/ATP/HBA 59 °C 12 °C 
CobB/HBAD 48 °C 1 °C 
B. melitensis CobB, in the absence of any substrates, has a Tm value of 47 °C. The 
addition of ATP to CobB results in an increase of 14 °C, this is a significant change in 
the stability of this enzyme. This indicates that when CobB binds ATP the active site 
of the enzyme is stabilised in the presence of ATP. The addition of Gln or HBAD does 
not change the thermal melting temperature this suggests they may not be binding or 
if they do their presence does not induce stabolisation in the active site. The thermal 
melting temperature when all cofactors are present is 59 °C this is 2 °C lower than 




3.5: Crystallisation of Brucella CobB 
His-tagged B. melitensis CobB was purified by metal affinity chromatography and ion 
exchange chromatography. The purified protein was run through a PD10 column to 
remove the excess salt from the ion exchange buffer. CobB was concentrated to 4 
mg/mL and 24 well crystallisation trays were set up using the Molecular Dimension 
crystal screens 1 and 2. The method used was vapour diffusion with hanging drops, 
with a 2:1 ratio of protein to well solution. Initial screening conditions (0.2 M 
ammonium acetate, 0.1 M sodium citrate, pH 6.5, and 30% PEG 4K) produced 
crystals, of less than 1 micron (Figure 3.11). 
(a)                                                                           (b)      
                           
Figure 3.11: Initial crystals of B. melitensis CobB. Crystals (a) grown from 0.2 M ammonia 
acetate, 0.1 M Na citrate, pH 5.6, 30% PEG 4K and (b) crystals grown from 0.1 M Na citrate, 
pH 5.6, PEG 4K, 20% propanol. 
In order to improve the quality and size of the crystals screening around the initial 
conditions by changing factors such as the pH, protein concentration and precipitant 
concentration. However, as these initial experiments did not improve the crystal 
quality, the use of an additive screen was also tried. An additive screen contains a 
number of small molecule compounds that are believed to stabilise proteins and 
improve morphology or diffraction. In this case the Molecular Dimensions Morpheus® 
Additive screen was used (Chapter 2). This library is comprised of 96 conditions 
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containing low molecular weight components that were found in many solved 
structures. Other components of the screen include compounds that are known to 
alter protein stability and solubility, such as heavy metals, polyamines, 
monosaccharides and amino acids. 
From this approach crystals of CobB were obtained in a screen that contained 
rubidium as an additive (Figure 3.12). 
 
Figure 3.12: B. melitensis CobB crystals. (a) Crystals were grown from 0.2 M ammonium 
acetate, 0.1 M Na citrate, pH 5.6, 30% PEG 4K, with a 2:1 protein to well ratio plus 0.5 µL of 
rubidium. (b) Crystals were also obtained in a well containing 0.2 M ammonium sulphate,  0.1 
M MES, pH 6.5, 30% PEG 5K and MME. 
The crystals were sent to the Diamond Light Source (DLS), Oxford for data collection. 
The crystals diffracted to 1.9 Å, with a space group of P1 and cell dimensions of 55.39 
Å, 57.12 Å and 74.23 Å and a = 82.61, b = 68.75 and g = 72.94. As there were no 
previous structures in the Protein Data Bank with sufficient sequence homology to 
CobB, experimental phasing approaches were investigated. Two approaches were 
initially employed to obtain the necessary X-ray diffraction data to solve the crystal 
structure; isomorphous replacement (using heavy atom derivatives) and single 
wavelength anomalous dispersion (SAD), using selenomethionine (Se-met) labelled 
protein. As there are 15 methionine residues in CobB, the selenomethionine route 
(a) (b)
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would produce enough phasing power to enable structure determination if heavy atom 
route failed. 
3.5.1: Heavy atom derivatives 
As there is no data set available for CobB in the protein data bank CobB native 
crystals were grown from 0.2 M ammonium acetate, 0.1 M sodium citrate, pH 5.6, 30 
% PEG 4K, with a 2:1 protein to well ratio plus 0.5 µL of rubidium. These crystals 
were soaked in solution containing 1 mM to 60 mM of a range of heavy atoms, over 
a time scale ranging from 15 minutes to 24 hours (Table 3.2). Most of the crystals 
survived the soak, even at high concentrations of the heavy atom. The crystals were 
then cryoprotected using 20 % v/v glycerol and flash frozen in liquid nitrogen. These 
crystals were taken to the DLS for data collection. Data was collected on all of the 









Table 3.2: CobB crystals soaked with heavy atom derivatives: Table shows the 
range of heavy atoms used, how long the crystals were soaked for and how the 
crystals diffracted at the synchrotron.  
Heavy atom Soak time Diffraction analysis 
Mercury chloride 
 
5 minute soak Data collected to 2 Å no 
heavy atom present 
Mercury chloride 1 week soak Crystal isomorphous no data 
set collected 
Mercury nitrate  5 minute soak Data collected to 3 Å no 
heavy atom bound 
Potassium 
tetrachloplatanate 
5 minute soak Data collected to 2.5 Å no 





Data collected to 2.6 Å no 
heavy atom bound 
Potassium 
tetrachloplatanate 




Data collected to 2 Å no 
heavy atom bound 






3.6: Production of selenomethionine enriched B. melitensis 
CobB 
Another method used for solving the phase problem is incorporation of selenium 
methionine in the protein of interest, this is a common method used in crystallography. 
It was the work of Cowie and Cohen in 1957, that demonstrated that E. coli during 
synthesis had the ability to incorporate selenium instead of sulphur during 
biosynthesis (Cowtan 2006). The production of SeMet labelled protein involves 
growing a methionine-auxotrophic strain of E. coli in LB which was supplemented with 
amino acids and SeMet (Zhoo, Hartnett and Slater 2007). 
In order to produce Se-met enriched CobB for crystallisation, the plasmid encoding 
the protein was transformed into E. coli KRX cells and plated onto LB agar plates. 
The following day a single colony was picked and incubated with 10 mL of LB broth 
plus 0.4 % glucose and 100 µg/L of ampicillin and incubated at 37 °C for 8 hours. This 
starter culture was added to 2 L of LB plus ampicillin and glucose and grown overnight 
at 37 °C. After centrifugation the pellet was resuspended in induction media, 
incubated for 1 hour and then induced using 0.2 % rhamnose for 24 hours at 25 °C.  
The T7 RNA polymerase gene in the KRX strain is under the control of the rhaPBAD 
promoter and is positively activated by rhamnose and catabolically repressed by 
glucose (Zhoo, Hartnett and Slater 2007). 
The protein was purified by use of nickel affinity resin and anion exchange 
chromatography, and the protein purity was verified by SDS PAGE gel (Figure 3.13).  
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Figure 3.13: 12 % SDS-PAGE gel. Lane 1 contains protein the markers of known molecular 
mass. Lane 2 contains a sample of the flow through from the column, lanes 3, 4 and 5 
represent impurities. Lanes 6, 7 and 8 contain the purified Se-met enriched CobB.  
Se-met enriched CobB was crystallised using the same condition as the native protein 
(0.2 M ammonium acetate, 0.1M sodium citrate, pH 5.6, 30% PEG 4K, with a 2:1 
protein to well ratio plus 0.5 µL of rubidium. The crystals were then cryoprotected 
using 25 % v/v ethylene glycol and flash frozen for data collection.  
Electrospray mass spectrometry was used to estimate the level of incorporation of 
Se-met into CobB (Figures 3.14 and 3.15). The sample proved to be difficult to work 
with but by mixing in a 1:3 ratio of 8 M urea and EDTA to a final concentration of 1 
mg/mL, the level could be calculated (Kevin Howland, University of Kent). 
The presence of Se-met in the protein results in an increased mass of 46.89 Da per 
residue in comparison to methionine. By comparing the mass of the native protein 
with that of the labelled the incorporation efficiency can be determined. 
 
% incorporation = 100 x (MWlabelled_experiment – MWunlabelled_experiment) 
       (MWlabelled_theoretical - MWunlabelled_theoretical) 
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1           2           3          4          5         6         7          8
1. Molecular marker 5. A10 MonoQ
2. Flow through 6. A13 MonoQ
3. A9 MonoQ 7. A14 MonoQ









His-CobB from the MS trace has a molecular mass of 49066.30 Da whilst the Se-met 
enriched material has a mass of 49768.9 Da. The theoretical molecular mass for 
unlabelled CobB is 48498.69 Da whilst the theoretical mass of the Se-met protein is 
49202.04. By using the above equation it was determined that a high level of 
incorporation (>90 %) had been achieved. 
 
 
Figure 3.14: LC-MS trace of native CobB. The trace shows a molecular mass of 49066.30 




Figure 3.15. LC-MS trace of Se-met enriched CobB. The trace shows the molecular mass 
of Se-met enriched CobB as 49768.9 Da. 
3.6.1 Purification and crystallisation of Se-met CobB  
Se-met enriched CobB (Chapter 2) was produced and purified for crystallisation using 
a combination of metal affinity and ion exchange chromatography. The purified protein 
was run through a PD10 column to remove the excess salt from the ion exchange 
buffer. Se-met enriched CobB was concentrated to 4 mg/mL and a crystal tray was 





Figure 3.16: Se-met labelled CobB crystals. Picture showing crystals of Se-met enriched 
CobB. Although twinned these crystals were of a suitable size and quality for X-ray diffraction 
data collection. 
Crystals were flash frozen in liquid nitrogen using 25 % (v/v) ethylene glycol and sent 
to DLS. Data sets were collected using single-wavelength anomalous diffraction 
(SAD) at the K-absorption edge of selenium. These crystals diffracted to 1.7 Å 
resolution with two molecules of CobB in the asymmetric unit. 
3.7 Crystallographic data collection and refinement 
Both native and Se-met crystal data were collected on beam line I03 at the DLS, in 
collaboration of Prof. Dave Brown (University of Kent).  Se-met data was collected to 
1.7 Å, which allowed phasing using SAD (single anomalous diffraction) This method 
is favoured as only one crystal is required to obtain all of the necessary data. 
Fortunately, the native and the Se-met structures belonged to the same space group 
P1, with a Matthews coefficient of 2 molecules of the dimer in the asymmetric unit. 
SHELX was used to find the initial Se-met sites, this program was designed by George 
Sheldrick (Cowtan 2006). The anomalous data from this experiment was then fed into 
this program, enabling the electron density for the CobB structure to be calculated. 
Bucaneer is a software program that is used for automatic model building (Cowtan 
2006) this program was used to trace the initial backbone of the protein. 
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The initial model was built and refined against the data from the Se-met crystals, 
however, the native data, which diffracted to higher resolution, was used to refine the 
first structure of CobB. The resolution of these two data sets are similar but the overall 
quality of the native data is better. 
The native structure was built with molecular replacement of the Se-met model using 
Refmac for sequential refinement of the data and manually rebuilt using COOT 
(Emsley  2004).  
3.7.1: Structure of Brucella melitensis CobB 
The structure of CobB confirms that the enzyme is a homodimer with each subunit 
composed of two globular #/! domains. The crystal has two molecules of CobB in 
the asymmetric unit (AU). Each subunit consists of an N-terminal and C-terminal 
domain joined by a linker region. The crystals were grown without removing the 
histidine tag but this feature is not present in the final structure (Figure 3.17 and 3.18). 
Figure 3.17: Crystal structure of B. melitensis CobB. Cartoon diagram of CobB showing 
molecule A (green) with ADP (red) in the active site and molecule B (cyan) with ADP (red) and 
phosphate (blue) also present. 
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(a)                                                                  (b) 
 
 
Figure 3.18: Structure of B. melitensis CobB. Molecule B alone shows evidence of ATP 
turnover, as it has a free phosphate and Mg in the active site, whereas molecule A has only 
ADP. 
From sequence analysis the structure of CobB is said to be related to a family of 
ATPases which are involved in the regulation of cell division in bacteria and archaea. 
The paper by Michael Galperin and Nick Grishin (Galperin and Grishin 2000), used 
the crystal structure of Dethiobiotin synthetase (DTBS) to look at the likely mechanism 













Figure 3.19: Cartoon representation of the overlaid structure of CobB and 
dethiobiotin synthetase: (a) shows the N-terminal binding site with HBA bound to CobB 
(cyan) and  dethiobiotin synthetase (blue). ATP binding site (pale blue). (b) shows a 
representation of the dimer of CobB binding HBA (cyan), overlaid with the dethiobiotin 
synthetase monomer domain (blue).   
Figure 3.19 shows the importance of the formation of the dimer in the binding of HBA. 





from the other monomer. Due to this fact dethiobiotin synthetase. Is not a truly represent 
CobB binding to HBA.  
The N-terminal domain of CobB is composed of 8 alpha helices and 6 parallel beta 
sheets. Amino acids 184-198 are missing from the crystal structure, most likely due 
to this region being unstructured and flexible. The N-terminal contains a typical ATP 
binding domain (Walker et al. 1982), composed of Gly12, Ser13, Gly14, Lys15 and 
Thr16. This constitutes a Walker A motif (P loop) which is a typical ATP binding 
domain present in all ATPase family of proteins, the lysine side chain in this family of 
proteins is essential for binding ATP. The lysine residue forms a hydrogen bond with 
the oxygen atoms of the phosphate groups within ATP, thereby creating proximity and 
orientation for ATP in the binding site. This is also a short loop (Walkers motif) fold 
over the ATP binding site, and is preceded by a beta strand (b1) and followed by an 
alpha helix (a1) in the crystal structure (Figure 3.20). 
The C-terminal domain of CobB contains 4 alpha helices and 15 beta sheets. Three 
of the helices sit on the surface of the protein (#1, #2	and	#3)	where a4 is buried in 
the active site. The 15 beta sheets form a beta barrel type structure with 10 parallel 
(β1, β2, β3, β4, β5, β7, β9, β11,	β12 and β15) (β6, β8,	β10,	β13 and β14) and 5 anti-




Figure 3.20: Ribbon diagram of CobB with labelled N- and C-terminal domains. The N- 
and C-domains of CobB are highlighted, showing alpha helices (orange and mustard) and 
beta sheets (purple) joined by a long flexible loop (yellow). Missing loop region on N-terminal 
184 to 196 and N and C terminal 228 to 232, this region looks to be flexible.  
The C-terminal domain, known as the GATase domain binds Gln and converts it to 
ammonia, this domain has a conserved cysteine and histidine residues (Cys327 and 
His427 in the B.melitensis CobB) but lacks the typical Glu residue seen in other class 
1 Gln amidotransferases (Raushel, Thoden and Holden 2003; Raushel, Thoden and 
Holden 1999; Holden, Thoden and Raushel 1998; Galperin and Grishin 2000). The 
nucleophile of this catalytic triad is generally located in a very sharp turn of the protein 
backbone structure, called the nucleophilic elbow, and is identified by the consensus 
sequence GXSXG and the oxyanion hole formed by the residues next to the catalytic 
cysteine (Figure 3.21) (Leisico et al. 2018). In the CobB structure this group of 
residues is GEC327GG.  
 
 
Missing loop N-terminal 184-198






































Figure 3.21: C-terminal domain of CobB. showing nucleophile elbow (identified by 
consensus structure GXCXG) and oxyanion hole. The conserved residues are 
















Nucleophilic elbow – sharp turn on protein backbone structure identified by concensus
structure GXCXG 
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Table 3.3 Summary of crystallographic data and refinement statistics for Se-
met CobB. RMSD – root mean squared deviation. 
Data collection  Refinement  
Source DIAMOND I03 Resolution 1.73 
Wavelength 0.97971 No. reflections 84604 (6260) 
Oscillation range 0.1 Rwork / Rfree 0.159/0.183 
Space group P1 No. atoms  
Number of frames  7200 Beam Intensity 50m 5% 
transmission 
Molecules/a.s.u 2 Protein 5260 
Cell dimensions 




Cell dimensions  




Resolution (Å) 43.53 – 1.71 




Rmerge 0.158 (1.602) Protein  32.32 
I / sI 8.7 (1.0) Ligand (s) 37.55 
CC 1/2 0.992 (0.656) Water 496 





Total number of unique 79307  Bond length (Å) 0.013 
Completeness (%) 9.3 (8.1) Bond length (°) 1.493 









Table 3.4 Summary of crystallographic data and refinement statistics for CobB. 
RMSD – root mean squared deviation. 
Data collection  Refinement  
Source DIAMOND I03 Resolution 1.5 
Wavelength 0.9763 No. reflections 37322 
(2740) 
Oscillation range 0.1 Rwork / Rfree 0.184/0.234 
Space group P2 No. atoms  
Number of frames 360 Beam Intensity 50m 5% 
transmission 
Molecules/a.s.u 2 Protein 5282 
Cell dimensions 




Cell dimensions  




Resolution (Å) 55.00 – 1.47 




Rmerge 0.087 (0.853) Protein 59.91 
I /  I 6.2 (1.5) Ligand (s) 95.19/69.93 
CC 1/2 0.925 (0.581) Water 53.10 
Total number of 
observations 
44270 (22848) R.m.s 
deviations 
 
Total number of unique 134120 (8283) Bond length (Å) 0.013 
Completeness (%) 95.1 (74.6) Bond length (°) 1.572 









3.7.2: Crystal structure of CobB co-crystallised with HBA and 
HBA/AMPPNP 
In order to determine the structure of CobB bound with HBA, 1 mL of HBA (200 µM) 
was added to 3.5 mL of CobB (0.8 mg/mL). The complex was diluted and 
concentrated 3 times with Tris-HCl buffer, pH 8.0, (3 X 15 mL) using a 30 kDa cut 
off centricon. This process enables unbound substrate to be removed from the 
enzyme. Removal of unbound substrate or small molecular weight aggregates can 
aid in crystallisation.  
Crystallisation trays were set up at a protein concentration of 4 mg/mL and Molecular 
Dimension screens 1 and 2 were prepared, with two drops on each cover slip. Drop 
one contained CobB with HBA only whilst the second drop contained HBA and 
AMPPNP, AMPPNP is a non-hydrolysable form of ATP, so its presence will not result 
in the turnover of substrate (HBA) to product (HBAD). A structure of AMPPNP bound 
would enable information to be obtained about the binding of ATP in N-terminal 
binding site.  Crystals appeared after 2 days with condition 0.1 M Na cacodylate, pH 
6.5, Mg acetate and PEG 8K for the CobB/HBA drop whilst crystals of the CobB/ 
HBA/AMPPNP complex were observed in  0.01 M Fe(II)Cl,  0.5 M ammonium 
sulphate and 0.1 M sodium citrate, pH 5.6.  
The crystals were archived and stored in liquid nitrogen using the same protocol as 
described previously. The crystals were sent to SOLEIL, France, for data collection, 
on beamline Proxima 2. The HBA bound crystals diffracted to 2 Å resolution with a, 
space group P1 and cell dimensions of 56.05 Å, 57.77 Å, 75.40 Å, # = 82.48, ! = 
68.58 and 7  = 73.24 with 2 molecules in the AU (Figure 3.21, Table 3.4).  
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The HBA/AMPPNP structures diffracted to 2 Å,	with a space group P21 and cell 
dimensions of 55.62 Å, 186.47 Å, 89.39 Å,  # = 90,  ! = 90.22, 7  = 90, with 2 molecules 
in the AU. 
 
 
Figure 3.22: Crystal structure of B. melitensis CobB/HBA. Cartoon structure of the CobB 
dimer showing HBA (stick) bound in both subunits. The phosphate (blue) and magnesium 
(yellow) ions are also shown.  
A comparison of the apo structure to the HBA bound structure indicates that no major 
conformational change has taken place with the binding of HBA to CobB. In the 
CobB/HBA structure each monomer of the dimer has a HBA molecule bound (Fig 
3.22). The molecule is positioned with C2 and C7 of the ring facing into the active site 
and the other 5 carboxylates facing towards the C-terminal. There is also evidence of 
the presence of phosphate in both molecule A and molecule B and magnesium in 
molecule A. As magnesium is present in the purification buffers this was not 
surprising. However, the presence of phosphate was unexpected as there is no free 
phosphate present in the buffers or the crystallisation condition. The phosphate is 
located in close proximity to C7, and aligned in a way that it indicated the site was 
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primed for amidation.  Addition of AMPPNP did not alter the structure of CobB in any 
way from that of the HBA-only structure.  The presence of AMPPNP confirmed that 
C7 was amidated before C2 as the phosphate from the AMPPNP directly faces the 
corrin substrate (Figure 3.22, Table 3.5). 
The CobB active site contained a number of residues that are observed to be 
conserved from protein sequence alignments, including Gly39, Pro40, Asp41, Tyr42, 




3.23: B. melitensis CobB/AMPPNP/HBA. Ribbon diagram highlighting the binding of HBA 




Figure 3.24: Active site of CobB showing the binding of ATP and HBA. The figure shows 
how helices 5 and 6 of the opposite monomer are involved in binding of HBA to the active site. 
This shows how dimer formation is necessary for HBA binding.  
From the crystal structures the alpha 5 and alpha 6 helices in the N-terminus of each 
monomer contribute to the binding of HBA. This explains why dimer formation is 













Table 3.5 Summary of crystallographic data and refinement statistics for 
CobB/HBA. RMSD – root mean squared deviation. 
Data collection  Refinement  
Source SOLEIL Proxima2 Resolution 1.83 
Wavelength 0.98397 No. reflections 69149 
(5134) 
Oscillation range 0.1 Rwork / Rfree 0.183/0.220 
Space group P1 No. atoms  
Number of frames 360 Beam Intensity 50m 5% 
transmission 
Molecules/a.s.u 2 Protein 5260 
Cell dimensions 




Cell dimensions  









Rmerge 0.076 (1.168) Protein 39.44 
I / sI 9.7 (1.0) Ligand (s) 47.94/46.74 
CC 1/2 0.9654 (0.463) Water 43.81 





Total number of unique  Bond length (Å) 0.016 
Completeness (%) 98.0 (98.4) Bond length (°) 1.770 









Table 3.6 Summary of crystallographic data and refinement statistics for 
CobB/HBA/AMPPNP. RMSD – root mean squared deviation. 
 
Data collection  Refinement  
Source SOLEIL Proxima2 Resolution 2.01 
Wavelength 0.98397 No. reflections 53212 
(3925) 
Oscillation range 0.1 Rwork / Rfree 0.195/0.237 
Space group P21 No. atoms  
Number of frames 600 Beam Intensity  
Molecules/a.s.u 4 Protein 5260 
Cell dimensions 




Cell dimensions  
#, !, 7 (°) 
90, 90.22, 90 Water 335 






Rmerge 0.222 (1.158) Protein 48.58 
I / sI 5.3 (1.4) Ligand (s) 81.17/60.84 
CC 1/2 0.972 (0.393) Water 48.6 
Total number of 
observations 
152516 (15305) R.m.s 
deviations 
 
Total number of unique 44751 (4589) Bond length (Å) 0.013 
Completeness (%) 97 (95.6) Bond length (°) 1.523 








3.7.3 Structure of C327A CobB 
The essential catalytic residues within the C-terminal domain of CobB include C327 
and H427, In order to determine the importance of these residues in the B. melitensis 
CobB two variants of the enzyme were cloned with mutations at these position C327A 
and position H427A. The same protocol as previously used for CobB expression and 
purification was employed. The C327A variant expressed and behaved well producing 
10 mg/L of enzyme. However, the H427A variant yielded very little enzyme and was 
not used in crystallisation trials. Initial crystal trials were set up using protein from the 
C327A variant. The protein produced crystals, including crystals grown in the 
presence of either Gln or with HBA/ATP/Mg2+/Gln. Unfortunately, the crystals 
obtained with Gln did not show the presence of this substrate molecule in the crystal 
structure. However, the crystals grown with HBA/ATP/Mg2+/Gln gave data to 1.6 Å. 
There was no turnover of HBA to HBAD, which confirms that the cysteine residue is 













Table 3.7 Summary of crystallographic data and refinement statistics for CobB 
mutated. RMSD – root mean squared deviation.  
 
Data collection  Refinement  
Source Diamond I03 
Mx16207-13 
Resolution 1.6 
Wavelength 0.91587 No. reflections 106816 
Oscillation range 0.1 Rwork / Rfree 0.23/0.267 
Space group P1 No. atoms  
Number of frames 360 Beam Intensity 50m 5% 
transmission 
Molecules/a.s.u 2 Protein 6720 
Cell dimensions 
a, b, c (Å) 
55.7 57.9 74.6 Ligand/ion 137 
Cell dimensions  
#, !, 7 (°) 
82.88 68.99 73.04 Water 291 





Rmerge 0.0453 (0.4376) Protein 16.77 
I / sI 6.63 (1.07) Ligand (s) 53.85 
CC 1/2 0.9971 (0.5290) Water 29.99 





Total number of unique 7600 Bond length (Å) 0.020 
Completeness (%) 95.46 Bond length (°) 1.985 








3.7.4: Crystal structure of B. melitensis with HBAM 
(hydrogenobyrinic acid c-monoamide) 
CobB is a multi-functional enzyme that amidates firstly at the C7 position of HBA and 
then the C2 position to give the product HBAD. The mono-amidated intermediate is 
HBAM. Attempts were made to obtain crystals of CobB with HBAM bound. To achieve 
this 1 mL of 200 µM HBAM (supplied by Joe Baker, University of Kent) and 5 mM 
AMPPMP were added to 3.5 mL of 0.8 mg/mL CobB. The complex was diluted 3 times 
in Tris-HCl buffer, pH 8.0, (3 x 15 ml) using a 30 kDa cut off centricon, a process 
which helps to remove any unbound substrate from the enzyme. 
Crystallisation trials were initiated with Molecular Dimension screens 1 and 2 at a 
protein concentration of 4 mg/mL. Small crystals appeared in a number of the drops 
but were not of a high enough quality required for X-ray diffraction. Optimisation of 
the most promising condition (1.8 M ammonium sulphate) produced slightly larger 
crystals (Figure 3.25). The crystals grew with ammonium sulphate as precipitant and 
took about 4 days to grow to a size suitable for X-ray diffraction. The golden colour of 
the crystals suggested that HBAM had bound to the active site of CobB. The crystals 
were cryogenically frozen using 25 % (v/v) ethylene glycol and were found 
subsequently to diffract to high resolution. 
The crystals diffracted to 1.5 Å resolution, with a space group of P1 and, cell 
dimensions of 55.9 Å x 58.04 Å x 75.156 Å, # =		82.190, , ! = 68.61 and	7  = 73.11 
with 2 molecules in the AU (Table 3.8) 
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Figure 3.25: Crystals of CobB grown in the presence of HBAM. The picture shows a 
number of orange-coloured clumped crystals together with some orange-coloured spheres. 
The HBAM crystal structure showed that, in comparison to HBA, the HBAM had 
rotated 90° in relation to the previously obtained position of HBA, consistent with it 
being in a conformation that allows C2 to be amidated (Figure 3.26). The question 
arises as to how this reaction takes place in the enzyme, it is possible that the enzyme 
simply rotates in the active site, allowing C2 to be in the position for amidation. 
Another possibility is that the molecule leaves the active site, rotates and then returns 
in the correct orientation.  
 
Figure 3.26: Active site of CobB bound to HBA and HBAM. (a) The carboxylate at C7 is 
positioned close to AMPPNP. There is also a magnesium ion (green) that sits between the 
AMPPNP and the HBA. (b) The structure with HBAM reveals the macrocycle has rotated so 
that C2 is now in the correct orientation for amidation. 




HBA structure 1 HBAM structure 2
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Table 3.8  Summary of crystallographic data and refinement statistics for 
CobB/HBAM. RMSD – root mean squared deviation. 
Data collection  Refinement  
Source Diamond I03 
 
Resolution 1.53 
Wavelength 0.91587 No. reflections  
Oscillation range 0.1 Rwork / Rfree 0.20/0.23 
Space group P2 No. atoms  
Number of frames 360 Beam Intensity 50m 5% 
transmission 
Molecules/a.s.u 2 Protein 6275 
Cell dimensions 
a, b, c (Å) 
55.9 58.04 75.156 Ligand/ion 136 
Cell dimensions  









Rmerge 0.0462 (0.4668) Protein 6253 
I / sI 6.85 (1.01) Ligand (s) 41.86 
CC 1/2 0.995 (0.5844) Water 43.15 





Total number of unique 30421 Bond length (Å) 0.0318 
Completeness (%) 93.84 (80.89) Bond length (°) 1.5 




3.7.5 Structure of an incomplete HBAD phosphorylated 
Intermediate 
From the previous structures it seems likely that ATP binds CobB first followed by 
HBA, prior to the generation of a phosphorylated intermediate (Figure 3.27). Ammonia 
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is transported from the C-terminal active site via a molecular tunnel to the ATP/HBA 
binding site (Huang, Holden and Raushel 2001) (Raushel, Thoden and Holden 2003) 
where the phosphorylated carboxylate intermediate is then amidated by ammonia at 
the C7 position. This is followed by a second amidation step at C2 resulting in the 
product HBAD.  
Figure 3.27: CobB stepwise conversion of HBA into HBAD. CobB binds HBA in the 
presence of ATP, Mg2+ and Gln. This activates the enzyme for turnover of HBA to producing 
firstly HBAM and then HBAD the product. Diagram showing the phosphorylated intermediates 
formed at each stage of the transformation of HBA into HBAD. 
Crystal trays were set up in the presence of CobB/HBA/ATP/Mg2+/Gln in the hope of 
obtaining CobB bound to its product HBAD. A number of small crystals appeared after 
a couple of days. The crystals were archived for data collection at the DLS using the 
same cryo conditions employed for all of the crystals. Although these crystals were 
small and looked to be twinned, they did diffract to a high resolution. Diffraction data 
was collected to 1.59 Å with cell dimensions of 55.76 Å  x 55.76 Å  x 58.09 Å, a = 
Hydrogenobyrinic acid Hydrogenobyrinic acid c-monoamide Hydrogenobyrinic acid a,c-diamide



























































































82.260, b = 68.650 and g = 72.920 with 2 molecules in the AU (Table 3.9). The 
structure was solved by molecular replacement. Surprisingly the structure showed a 
phosphorylated intermediate (Figure 3.28) with the phosphate attached to the 
carboxylic acid of the acetic acid side chain on C2. This was obvious from the electron 
density where the C2 position is clearly extended (Figure 3.29). Within the enzyme 
structure the C2 position of the corrin is in closer proximity to the resultant ADP 
molecule. 
 
Figure 3.28: Trace of CobB with the phosphorylated intermediate of HBAMP. Ball and 
stick showing the backbone of CobB binding HBAMP (C2) binding in the active site close to a 
molecule of ADP (does not show side chains).  
Although there is no evidence of a conformational change, when the structure of 
HBAM is overlaid with the position of the phosphorylated intermediate some distortion 
of the corrin ring appears to have taken place. On closer inspection it looks like that 






Figure 3.29: Electron density map of CobB monoamide structure overlaid with CobB 
diamide phosphate intermediate. CobB/monoamide structure (green) shows C2 positioned 
for amidation,  and CobB phosphorylated intermediate (yellow) picture shows C2 which is 
phosphorylated.  The residues around the active site (green) for HBAM and HBAM-




Figure 3.30: HBAM and HBAMP overlaid. Close up of the individual carboxylates C2, C7, 
C8, C13, C17 and C18 showing distortion in the ring. The phosphorylated intermediate is 








Table 3.9 Summary of crystallographic data and refinement statistics for 
CobB/HBAM phosphorylated intermediate. RMSD – root mean squared 
deviation. 
Data collection  Refinement  
Source Diamond I03 
 
Resolution 1.59 
Wavelength 0.91587 No. reflections 102986 
Oscillation range 0.1 Rwork / Rfree 0.20/0.24 
Space group P1 No. atoms  
Number of frames  Beam Intensity  
Molecules/a.s.u 2 Protein 6309 
Cell dimensions 




Cell dimensions  




Resolution (Å) 69.61-1.59 Average B 
factors 
 
Rmerge 0.0761 (0.7554) Protein 24.3 
I / sI 9.78 (1.00) Ligand (s) 35.44 
CC 1/2 0.9756 (0.4501) Water 31.2410 





Total number of unique 45000 Bond length (Å) 0.018 
Completeness (%) 96.4 (95.00) Bond length (°) 1.990 









3.7.6: Crystal structure of CobB/HBAD 
In order to try and obtain a crystal structure with HBAD bound, crystal trays were 
prepared using CobB/HBAD and ADP. From the initial screen tiny crystals were 
obtained, although the crystals appeared to be badly twinned. Nonetheless, these 
crystals were sent to the DLS for data collection. The crystals diffracted to 2.5 Å with 
a space group P1 and cell dimensions of 56.05 Å, 57.77 Å, 75.4 Å, a = 82.26 b = 
68.65, g = 72.92. with 2 molecules in the AU.  
The structure was solved by molecular replacement. HBAD was docked into the 
active site but the orientation of the molecule did not fit with the density. On closer 
inspection, the molecule in the active site appeared to be HBA with the C7 carboxylate 
where the C2 should be. The reason for this is unclear and further investigation would 











The B. melitensis CobB is the first amidase of the vitamin B12 pathway to have its 
structure determined at high resolution. Initial heavy atom soaks with this enzyme 
were unsuccessful, however, Se-met crystals of the B. melitensis CobB were obtained 
which enabled determination of the first structure of this enzyme. The structure was 
partially solved with these crystals whilst molecular replacement was used to 
complete the structure. The initial crystal diffracted to 1.7 Å resolution and was solved 
using single anomalous diffraction (SAD). The crystals grew in bunches (Figure 3.18) 
but once separated the crystals diffracted to high resolution.  
All of the crystal structures of CobB show that the protein is composed of two globular 
domains: An N-terminal amidotransferase domain that binds ATP, Mg2+ and HBA and 
a C-terminal domain that binds Gln. These domains are connected by a long flexible 
region. For this reaction to go to completion, ATP, Gln and Mg2+ must be present to 
allow the formation of the product (HBAD). In the initial structure of CobB no ATP was 
added to the enzyme prior to crystallisation. However, the structure of the enzyme 
revealed the presence of ADP in one of the monomers whilst the other monomer 
contained ADP and a free phosphate. The presence of ADP reflects that it must be 
carried by the enzyme during the purification process. 
From the structural information ATP binds in the N-terminal binding site, Mg2+ 
activates the ATP (Ko, Hong and Pedersen 1999) ATP is then hydrolysed to ADP, the 
free phosphate forms a phosphorylated carboxylate at positions C7 on the HBA 
macrocycle, ready for amidation. 
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The GAT domain is divided into two subfamilies, which are termed type I and II. CobB 
resembles the class 1 of GAT domain enzymes although it lacks the third residue 
(Glu) in the catalytic triad associated with this family of enzymes (Cys, His and Glu).  
The oxyanion hole in the class 1 type enzymes is believed to stabilise the negative 
charge on the oxygen atom on the tetrahedral intermediate that results from attack of 
the cysteine residue on Gln (Trotta et al. 1974). 
The crystal structure of B. melitensis CobB shows that the active sites of the a and b 
subunits are	17.7 Å apart (Figure 3.31). For the two domains in the catalytic sites to 
come together would require a major conformational change.  However, no such 
major conformational change is observed in any of the CobB crystal structures.  
 
Figure 3.31: Distance between the two distinct actives sites in CobB. The distance 
between the conserved cysteine (Cys327 in C-terminal domain) and the phosphorylated 
intermediate in the N-terminal domain is highlighted as a dotted line 1 reveals a largely 
hydrophobic area surrounding the Gln binding site, which is similar to other enzymes 
containing molecular tunnels (Miles, Rhee and Davies. 1999).  It is therefore plausible that B. 
melitensis CobB also uses substrate channelling to transport ammonia from the GATase 
domain to the amidotransferase domain by a molecular tunnel. 
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This suggests that CobB uses substrate channelling in order to transport ammonia 
from the C-terminal domain to the N-terminal domain. A research article by Lucas 
Pravda et al analysed the active site of 4,306 enzymes, which all had channels of 
greater than 15 Å long. They showed that 64 % of enzymes contained two or more 
long channels. On the whole, the channel tends to have more aromatic residues such 
as His, Trp, Tyr and Cys. CobB has a tunnel of 17.7 Å long, and the channel has Tyr, 
Pro, His and Asp the length of the tunnel (Pravda et al. 2014). 
  
Figure  3.32: Channel frequency of amino acids. Enhancement of frequencies of individual 
amino acids in channels indicates which amino acids are more likely to occur in the channel 
walls than anywhere else in the protein structure. Hydrophobic aliphatic residues are shown 
in grey, aromatic amino acids in magenta, polar residues in green, negatively charged in red, 
positively charged in blue and cysteine in yellow (Pravda et al. 2014). 
Site directed mutagenesis of the CobB to generate a Cys327Ala variant allowed an 
investigation into the role played by this amino acid for activation. This structure was 
solved in the presence of HBA/ATP/Mg2+/Gln. If the variant was active it would result 
in the production of HBAD when supplied with HBA, ATP and Gln. As this did not 
happen it confirmed that the Cys327 is essential for enzyme activity. 
The class 1 Triad family of GAT enzymes normally contain a conserved His-Cys-Glu 
motif in their active site. However, although CobB is considered part of this family it 
does not have the conserved Glu. Nonetheless, there is a conserved Glu in the CobB 
family of proteins, which given its position within the active site, suggests that this 
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alternative Glu likely forms the third member of this Triad family (Figure 3.33). 
 
 
Figure 3.33: Amino acid sequence alignment of CobB proteins. Q91471 (Pseudomonas 
aeruginosa), P63836 (Mycobacterium bovis), Q8UBQ8 (Agrobacterium fabrum), 
Q8YHU1(Brucella melitensis) and 068108 (Rhodobacter capsulatus). Conserved Glu residue 
















Stopped Flow analysis of binding of 





The X-ray crystal structures discussed in Chapter 3 of the B. melitensis CobB 
represent the first molecular description of this enzyme. These structures have helped 
in understanding the mechanism underpinning the amidation process of this enzyme. 
CobB is a multifunctional enzyme that employs two distinct active sites to catalyse 
firstly the deamidation of Gln and then secondly the amidation of HBA. Moreover, it 
repeats the same amidation chemistry at two sites on the corrin substrate, initially at 
position C7 where HBA is amidated to HBAM and subsequently at C2 to produce 
HBAD (Fresquet, Williams and Raushel 2004).  
Debussche et al looked at CobB from Pseudomonas denitrificans and determined the 
catalytic properties and substrate specificity of this enzyme using steady state kinetic 
analysis. By this approach they determined Km values of CobB for HBA (0.41 µM), 
HBAM (Km = 0.21 µM), Gln (Km = 20.3 µM) and ATP (Km = 30.2 µM) (Debussche et 
al. 1990).  
Cobyrinic acid a, c-diamide synthetase from Salmonella typhimurium (CbiA) is the 
equivalent enzyme to CobB from the anaerobic pathway. Fresquet et al determined 
the kinetic data for this enzyme (Fresquet, Williams and Raushel 2004). CobB and 
CbiA share a reasonable degree of identity (40%) and perform the same amidations 
albeit on slightly different corrin substrates. For CbiA, the activity of the C-terminal 







CbiA was able to hydrolyse Gln (Km = 49 µM) in the absence of cobyrinic acid or ATP, 
which suggests there is no crosstalk between the two domains. However, V. Fresquet 
et al 2004 noted that when ATP or glutamic acid was added there was an enhanced 
rate of Gln hydrolysis. This was enabled by a two-fold lowering of the Km for Gln in the 
presence of ATP (Km = 2.5 µM) and a 20 x fold decrease with glutamic acid present 
(Km = 25 µM) (Fresquet, Williams and Raushel 2004).  
However, the decrease in the Km for Gln is substantially larger (200-fold) when both 
ATP and cobyrinic acid (Km = 0.2 µM) are present in solution. They surmised that the 
reduction in the Km for Gln must originate from conformational changes in the binding 
site for Gln that are allosterically induced by the binding of substrates to the 
synthetase domain (Fresquet, Williams and Raushel 2004). 
Fresquet et al also went on to hypothesise that the conformational change could be 
induced by the formation of a phosphorylated intermediate of cobyrinic acid, before 
amidation to cobyrinic acid c-monoamide. The X-ray crystal structure of B. melitensis 
CobB is a dimer and shows both monomers occupied by a phosphorylated 
intermediate of hydrogenobyrinic acid c-monoamide after amidation (see Chapter 3). 
Interestingly, when the structures of the HBAM-bound enzyme and the form 
containing a phosphorylated intermediate are superimposed, there appears to be a 
slight distortion of the substrate, resulting in change in conformation of the propionic 
acid attached to the C13 position (Figure 4.1). However, there did not seem to be any 
conformational change in the enzyme itself.  
Gln binds at a separate site in the C-terminal domain, whereas HBA/ATP binds in the 
N-terminal domain. As there is no X-ray crystal structure of Gln bound at the C-






Figure 4.1: Overlay of substrates HBA, HBAM and HBAD when bound to CobB. (a) 
Shows all three substrates overlaid, where the side chain attached to C-13 on the corrin ring 
has a different conformational. (b) The binding of HBAM and HBAD show that the side chain 
attached to C-13 has undergone a conformational change with a slight movement in the side 
chain attached to C-14.  
In order to obtain kinetic information that would complement the structural data, 
stopped flow analysis was undertaken (Toseland and Geeves 2014). This method is 
mostly commonly employed for transient type reactions where the reaction occurs at 
a very fast rate. It can be coupled with fluorimeters and spectrophotometers to look 
at changes in the fluorescence or the absorbance of a protein on binding of a 
substrate. Fluorescence signals can be attributed to the protein if it contains 
tryptophan or tyrosine residues as they are known to have inherent fluorescence 
properties (Rehms and Callis 1993). However, if the substrate also has strong 
absorbance or fluorescence properties, then these can also be measured. 
Overlay of , and incomplete 




From the crystal structure of CobB it can be seen that there are a number of tyrosine 
residues in the HBA binding site. In addition to the aromatic residues at the binding 
site, the substrate, HBA, also has a conjugated $ system, which gives it fluorescence 
properties. With this in mind it was envisioned that fluorescence emission 
spectroscopy and stopped flow analysis could be performed to monitor binding to the 
protein. This would provide kinetic data for this reaction, and complement the recently 
determined structural information. Using stopped-flow spectroscopy to look at the 
individual steps of this reaction could give valuable information on reaction rates, 
identifying rate limiting steps and substrate and product binding (Woalder Xiwe et ali 
Zheng, Cong Bi, Zhao Li, Maria Podariu 2017) (Toseland and Geeves 2014). 
In order to identify the optimal reporter system to monitor binding, fluorescence 
emission spectra were run. This involved two separate experiments, firstly looking at 
the intrinsic properties of the protein and secondly looking at the emission spectra for 
he substrate.  Once optimum conditions were identified stopped flow analysis of the 
B. melitensis CobB was performed in order to gain insight into the reaction catalysed 










4.2.1 Fluorescence-emission spectra measuring protein 
fluorescence 
The basis of stopped flow analysis relies on significant changes in absorbance or 
fluorescence emission when the enzyme and substrate interact. Therefore, it is 
important to know the optimum wavelength to be monitored during the reaction.  
It was predicted that as the ATP/substrate binding site of CobB has a number of 
tyrosine residues (Y257, Y295, Y366 and Y388) present it may be possible to 
measure the binding affinity of HBA using the protein’s intrinsic fluorescence 
(Eccleston, Martin and Schilstra 2008). This was investigated by monitoring the 
fluorescence-emission spectra from 300 nm to 700 nm after excitation of the protein 
at a wavelength of 280 nm. CobB, by itself, has fluorescence emission peaks at 350 
nm and another at 650 nm. HBA by itself shows no fluorescence when excited at the 
same wavelength. When CobB (1 µM) was mixed with a sample of HBA (10 µM) and 
was excited at 280 nm the fluorescence emission spectra showed a reduction in the 
peak at 330 nm together with a new emission peak at 540 nm and 600 nm. This 
confirmed that when CobB binds HBA there is a significant change in the fluorescence 
emission spectrum reflecting the binding of the corrin substrate. These results 







Figure 4.2: Measurement of protein fluorescence emission of CobB binding HBA. 
Excitation at 280 nm shows CobB by itself (dark blue) has a large peak at 350 nm and small 
peak at 650 nm, whereas excitation at 280 nm of CobB with HBA (pink) sees a reduction in 
the size of the peak at 350 nm and new peaks at 540 nm and 600 nm (intrinsic protein 
fluorescence). Excitation at 330 nm of CobB alone (orange) shows no peak. Excitation at 330 
nm of HBA alone (green) shows peaks at 540 nm and 600 nm, whilst  excitation of CobB with 
HBA (pale blue) at 330 nm shows an increase in the size of the peaks at 540 nm and 600 nm 
(corrin fluorescence).  
4.2.2: Fluorescence-emission spectra measuring substrate 
fluorescence 
Changes in the emission spectrum of the corrin substrates and product were also 
monitored on binding to CobB. In this case the florescence emission spectra were 
recorded over a range of 360 nm to 700 nm after excitation at 330 nm. When CobB 
(1 µM) was mixed with HBA (10 µM) and was excited at 330 nm the fluorescence 
emission spectrum showed peaks at 400 nm, 550 nm and 600 nm. The same 
conditions were used to measure the fluorescence spectrum for CobB binding HBAM. 
This gave the same spectrum as CobB binding HBA. However, again keeping 
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conditions constant, CobB in the presence of HBAD showed an increase in the peak 
size at 540 nm and 600 nm, with a new emission peak at 440 nm (Figure 4.3).  
 
Figure 4.3: Fluorescence from HBA, HBAM and HBAD binding to CobB. Samples were 
excited with a wavelength of 330 nm. CobB/HBA peaks (dark blue) are observed at 400 nm, 
540 nm and 600 nm, CobB/HBAM peaks (red) are observed at 400, 540 nm and 600 nm and 
HBAD peaks (green) are observed at 440 nm, 540 nm and 600 nm. 
4.2.3: Stopped-Flow analysis using substrate fluorescence  
4.2.3.1 Stopped flow experimental parameters 
The fluorescence emission spectra gave a clear indication of binding using both the 
intrinsic protein fluorescence and substrate fluorescence. Although either approach 
could have been used it was decided to use the substrate fluorescence for monitoring 
its binding to CobB.   
Stopped flow was performed with CobB (1 µM) in one of the two syringes on the 
stopped flow apparatus. The other syringe contained HBA, and the concentration was 
increased for each data collection from 1 µM to 5 µM. At the start of the experiment 
CobB HBAD CobB HBA CobB HBAM
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each syringe injects 100 µL of sample into the cell where the two samples are mixed. 
The stop flow syringe enables data to be collected instantaneously, and usually about 
six samples are run at a single concentration. The average from these runs is used 
to give the final data for each concentration of ligand. This experiment was used to 
measure the fluorescence change from HBA on binding CobB by exciting at 330 nm.   
4.2.3.2 Stopped-Flow analysis of CobB binding HBA 
Stopped-flow fluorescence spectroscopy was used to determine the dissociation 
constant (Kd) associated with the binding of CobB to HBA. This experiment was 
carried out using a constant concentration of CobB (1 µM) and varying the 
concentration of HBA (between 1 µM and 10 µM). Excitation was carried out at 330 
nm and fluorescence emission was measured at 450 nm. The reaction was then 
monitored by recording fluorescence emission changes resulting from the substrate 
binding to the enzyme (Figure 4.5).  
 
Figure 4.4: Stopped-flow trace. An example trace of the fluorescence change upon 
1 μM HBA binding to 1 μM CobB. The trace shows the biphasic nature of the binding 
of HBA to CobB. 
 
Fast phase: k+1 !M-1 s−#
Slow phase: k+1’ !M-1 s-1



















Figure 4.4 shows a trace taken from the stopped-flow experiment highlighting the 
binding of HBA to CobB. The binding of HBA to CobB shows a two phase reaction, 
an initial fast rate followed by a slower rate. The initial fast (burst) phase is termed R1 
and is complete after 0.05 seconds. The second phase is termed R2, and lasts 
approximately one second. There are several possible explanations for this biphasic 
binding. As a homodimer, the enzyme has two active sites that bind HBA and it could 
be that R1 represents fast binding to one site and that R2 represents the binding of 
HBA to the second site. This would require that the binding of HBA to the first site 
leads to a change in the conformation of the second site so that it binds at a slower 
rate. Alternatively, the different rates could reflect an initial fast binding phase followed 
by a slower change in the conformation of the protein that affects the binding of HBA. 
It is more likely that the bi-phasic binding mode reflects the former rather than the 
latter. 
The process of reversible binding is described in the equations in Scheme 1.  
 
For reversible association reactions a plot of the observed rate (kobs) versus 
concentration of protein will be a straight line. As the observed rate of reaction is a 
combination of both the forward and reverse reactions, kobs = k+1[CobB] + k-1, when 
[CobB] is zero then kobs will equal k-1. Hence the y-intercept gives a value for k-1.  




Kd = k-/k+ = [CobB] [L]/[CobB.L]
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For the interaction between CobB and HBA the initial rate data from Figure 4.4 can 
be determined by the use of non-linear regression to generate the kobs at different 
CobB concentrations. The observed rates of either R1 or R2 can then be plotted 
against the concentration of CobB, which generate straight line graphs demonstrating 
that the observed rate constants are a linear function of CobB concentration. The 
gradient of these plots, as shown in Figure 4.5, represents k+1 whilst the y intercept 











      
                       
 
Figure 4.5: Dependence of kobs versus [HBA]. Calculation of rate constants k+1 (line 
gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBA (1-10 µM) and constant concentration of CobB (1 µM) a) the initial 
phase of reaction (R1), with calculated k+1 = 5.76 µM-1 s-1, k-1 = 3 s-1 and Kd1 = 0.52 µM and b) 
the second phase of reaction (R2) with k+1’ = 0.65 µM-1 s-1, k-1’ = 1.61	s-1 and Kd2 = 2.48 µM. 
Values are averages of 3 biological repeats (from three different HBA preparations) ± SEM. 
By knowing the values of k+1 and k-1 it is possible to determine Kd (Scheme 1). Thus, from 
Figure 4.5 it is possible to say that HBA binds to CobB relatively tightly with a Kd1 = 0.52 )M 
with a rate constant of 5.76 µM-1 s-1. This is 9 fold faster than the second step of the reaction 
(R2), which has an association rate of 0.65 µM-1 s-1 and a Kd2 of 2.48 )M.  
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4.2.3.3 Effects of ATP on the binding of HBA to CobB  
Figures 4.4 and 4.5 demonstrated that it was possible to determine the Kd for values 
for the binding of HBA to CobB in the absence of any other substrates. However, we 
wanted to know if the presence of the other substrates had an effect on either the 
rates of association or the Kd values. Therefore, the binding of HBA to CobB was 
repeated in the presence of the other substrates, the first of which was ATP. In this 
case the kobs was monitored at a fixed concentration of CobB and ATP but with 
variable [HBA] (1 µM to 5 µM). The addition of ATP to the CobB/HBA sample did not 
appear to change the Kd1 value, but did slow the rate at which HBA binds to CobB 
(R1) by 3 fold (k+1 = 5.76 µM-1 s-1 value without ATP and k+1 = 1.78 µM-1 s-1 with ATP) 
(Figure 4.6). This suggests that, most likely, ATP binds first to CobB, inducing a slight 
change in the conformation of the active site. This could hinder the binding of HBA, 





   
 
Figure 4.6: Dependence of kobs versus [HBA] and ATP. Calculation of rate constants 
k+1(line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBA (1 µM – 5 µM )/ATP (5 mM) and constant concentration of CobB (1 
µM).  a) the initial phase of reaction (R1), with calculated k+1 = 1.78 µM-1 s-1, k-1 = 0.92 s-1 and 
Kd1 = 0.52 µM and b) the second phase of reaction (R2) with k+1’ = 0.12 µM-1 s-1, k-1’ = 0.27 s-
1 and Kd2 = 2.23 µM. Values are averages of 3 biological repeats (from three different HBA 
preparations) ± SEM.  
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4.2.3.4 Effects of Gln on the binding of HBA to CobB  
To determine the effects of Gln on the kinetics of HBA binding to CobB, the stopped-
flow assay was repeated as in the previous experiments. Gln was added to CobB at 
a concentration of 5 mM and the concentration of the enzyme was kept constant (1 














Figure 4.7: Dependence of kobs versus [HBA] in the presence of Gln. Calculation of rate 
constants k+1 and k-1 from stopped-flow measurements of kobs at different concentrations of 
HBA (1 µM 5 µM) in the presence of CobB (1 µM )/Gln (5 mM) for a) the initial phase of reaction 
(R1) with CobB, with calculated k+1= 1.22 µM-1 s-1, k-1 = 0.46 s-1 and Kd1= 0.38 µM and b) the 
second phase of reaction (R2) with CobB, with k+1’ = 0.10 µM-1 s-1, k-1’ = 0.2	s-1 and Kd2 = 2 µM. 
Values are averages of 3 biological repeats (from three different HBA preparations) ± SEM. 
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The results show that the addition of Gln slightly increases the affinity of HBA binding 
to CobB (Kd1 = 0.38 µM with and 0.52 µM without). The second phase Kd2 was very 
similar to Kd2 without Gln (2.00 µM and 2.48 µM respectively). The results are 
summarized in Table 4.1.  
4.2.3.5 Effects of ATP and Gln on the binding of HBA to CobB 
To complete the data set, the binding of HBA with CobB was investigated in the 
presence of ATP and Gln. This was accomplished by keeping a fixed concentration 
of CobB, ATP and Gln and varying the concentration of HBA. The results of this are 










Figure 4.8: Dependence of kobs versus [HBA] in the presence of Gln and ATP. Calculation 
of rate constants k+1 and k-1 from stopped-flow measurements of kobs at different 
concentrations of HBA (1	µM – 5 µM) in the presence of Gln (5 mM) and ATP (5 mM) for a) 
the initial phase of reaction (R1) with CobB (1 µM), with calculated k+1 = 0.62 µM-1 s-1, k-1 = 
1.36	s-1 and Kd1 = 2.12 and b) the second phase of reaction (R2) with CobB, with k+1’ = 0.05 
µM-1 s-1, k-1’ = 0.28 s-1 and Kd2 = 5.83 µM. Values are averages of 3 biological repeats (from 
three different HBA preparations) ± SEM.  
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The largest change in the rate of binding and the affinity of HBA to CobB was the 
addition of both ATP and Gln. The reaction, in the presence of both Gln and ATP, had 
a lower affinity of binding (Kd = 2.14 µM) and a much slower reaction rate of both k+1 
and k+2’, which was approximately 10 fold slower (k+1 = 0.62 µM-1 s-1 and k+1’ = 0.05 
s1) than binding of HBA alone. The results are summarized in Table 4.1.  
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Table 4.1 Rate and binding constants of HBA, HBA/ATP, 
HBA/Gln and HBA/ATP/Gln binding CobB. 
 
 4.2.3.6 Stopped-Flow analysis of CobB binding HBAM 
Stopped-flow was used to monitor the binding of HBAM to CobB. The parameters of 
the experiment were the same as used in the binding of HBA, where the concentration 
of HBA was varied between 1 µM to 5 µM with a fixed concentration of CobB (1 
µM).As with the binding of HBA to CobB, the binding of HBAM was also found to be 
biphasic (Figure 4.9).  
 
Figure 4.9: An example trace of the fluorescence change upon 1 μM HBAM binding to 1 
μM CobB. The trace shows the biphasic nature of the binding of HBAM to CobB. 
 




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBA 0.998 0.52 2.48 5.76 3.00 0.65 1.60
HBA/ATP 0.959 0.52 2.23 1.78 0.90 0.12 0.27
HBA/Gln 0.832 0.38 2.00 1.22 0.46 0.10 0.20
HBA/ATP/Gln 0.967 2.14 5.83 0.62 1.36 0.05 0.28




k+1 !M-1 s−# k-1 s-
1
k+1’ !M-1 s-1 k-1’ s-1
HBAM 0.929 3.88 20.70 0.99 3.80 0.03 0.56
HBAM/ATP 0.819 4.01 4.22 0.35 1.42 0.05 0.21
HBAM/Gln 0.809 0.53 5.86 1.50 0.80 0.07 0.41
HBAM/ATP/Gln 0.985 5.13 5.80 0.32 1.64 0.04 0.23




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBAD 0.934 0.94 13.20 0.87 0.81 0.03 0.44
HBAD/ATP 0.813 0.17 ------- 2.51 0.41 ------ ------
HBAD/Gln 0.972 0.04 1.65 1.80 0.06 0.15 0.24
HBAD/ATP/Gln 0.709 2.00 3.00 1.25 2.31 0.09 0.24


















Slow phase: k+1’ !M-1 s-1




Figure 4.10: Dependence of kobs versus [HBAM]. For R1, the rate constants k+1 and k-1 were 
determined from the line gradient and y intercept. (a)  Shows the initial phase of reaction (R1), 
with calculated k+1 = 0.99 µM-1 s-1, k-1 = 3.85 µM-1 s-1 and Kd1 = 3.88 whilst (b) shows the second 
phase of reaction (R2) with k+1’ = 0.03 µM-1 s-1, k-1’ = 0.56 s-1 and Kd2 = 21 µM. Values are 
averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
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A comparison of kobs for both the fast (R1) and slow (R2) binding of HBAM with CobB 
revealed a linear relationship with the concentration of HBAM, as shown in Figure 
4.10. From these data it was determined for the R1 reaction that HBAM binds with a 
Kd of 3.89 µM with a rate constant of 0.99 µM-1 s-1. In contrast, for the second binding 
event (R2) HBAM binds with a higher Kd2 of 20.7 µM and a slower rate constant of 
0.03 µM-1 s-1 (Table 4.2). 
4.2.3.7 Effect of ATP on the binding of HBAM to CobB 
The stopped-flow experiment was repeated in the presence of the other substrates 
(ATP, Gln and then both ATP with Gln) to determine the effects of these substrates 
would have on HBAM binding CobB. In the presence of a fixed concentration of ATP 
and CobB the kobs was monitored against variable HBAM concentrations (Figure 
4.11). For the binding of the first HBAM molecule (R1) the presence of ATP did not 
appear to change the Kd value, but did slow the rate at which HBAM binds to CobB 
by nearly 3 fold (k+1  = 0.99 µM-1 s-1 value without ATP and k+1 = 0.35 µM-1 s-1 with ATP, 
respectively) (Figure 4.10, Figure 4.11, Table 4.2). For the second binding event, R2, 
there was a significant, five-fold, drop in the Kd2 from 20.7 to 4.2 µM (Table 4.2). 
However, the data generated for the R2 binding is of variable quality (Figure 4.11) 
and the R2 value is low.   





Figure 4.11: Dependence of kobs versus [HBAM] and ATP. Calculation of rate constants k+1 
(line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of [HBAM] and constant concentration of CobB/ATP for a) the initial phase of 
reaction (R1), with calculated k+1 = 0.35 µM-1 s-1, k-1 = 1.42 s-1 and Kd1 = 4 µM and b) the second 
phase of reaction (R2) with k+1’ = 0.21 µM-1 s-1, k-1’ = 0.05 s-1 and Kd2 = 4.22 µM. These values 
have very high errors and the data is poor, so the accuracy of these results is questionable. 
Values are averages of 3 biological repeats (from three different HBA preparations) ± SEM.. 
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4.2.3.8 Effect of Gln on the binding of HBAM to CobB 
To determine if Gln has any effect on the binding of HBAM to CobB, the stopped-flow 
assay was repeated but in the presence of a fixed concentration of Gln. Gln was 
added to CobB at a concentration of 5 mM and the concentration of CobB was kept 
constant (1 µM) and HBAM was varied between 1 µM and 5 µM. The results are 














Figure 4.12: Dependence of kobs versus [HBAM] and Gln. Calculation of rate constants k+1 
(line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBAM and constant concentration of CobB/Gln for a) the initial phase of 
reaction (R1), with calculated k+1 = 1.51 µM-1 s1, k-1 = 0.74 s-1 and Kd1 = 0.49 and b) the second 
phase of reaction (R2) with k+1’ = 0.14 µM-1 s-1, k-1’ = 0.22 s-1 and Kd2 = 1.5 µM. Values are 
averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
 
For the R1 binding event, the effect of Gln was significant (Figure 4.12). The Kd1 
reduced to 0.49 μM, which is nearly an order of magnitude lower than that observed 
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in the absence of Gln. In particular, the rate describing the dissociation of the CobB-
HBAM complex, k-1, was much slower (Table 4.2). For the second binding event, R2, 
there was also a reduction in the Kd2 although in this case the reaction was linked with 
a faster association (k+1’) of the CobB-HBAM complex 
4.2.3.9 Effect of ATP and Gln on the binding of HBAM to CobB 
To complete the data set, the binding of HBAM with CobB was investigated in the 
presence of both ATP and Gln. This was accomplished by keeping a fixed 
concentration of CobB, ATP (5mM) and Gln (5 mM) and varying the concentration of 














Figure 4.13: Dependence of kobs versus [HBAM], ATP and Gln. For R1 the rate constants 
k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBAM and constant concentration of CobB/ATP/Gln for a) the initial phase 
of reaction (R1), with calculated k+1 = 0.32 µM-1 s-1, k-1 = 1.64 s-1 and Kd1 = 5.13 and b) the 
second phase of reaction (R2) with k+1’ = 0.04 µM-1 s-1, k-1’ = 0.23 s-1 and Kd2’  = 5.8 µM. Values 
are averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
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= 5.80 !M ±4
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When all the substrates (HBAM, ATP and Gln) are present the binding of CobB to 
HBAM mirrors the binding that is observed in the presence of ATP alone. Thus, for 
both R1 and R2, the reduction that was observed in the presence of Gln is lost when 
both Gln and ATP are present (Table 4.2). 
Table 4.2: Reaction rates and binding constants of amidation reaction of HBAM, 
HBAM/ATP, HBAM/Gln and HBAM/ATP/Gln/ binding to CobB 
 
R2 is an indication of the accuracy of the data, the closer this value is to 1 the more 
accurate the data is considered to be. With CobB/HBAM/ATP and HBAM/Gln having 
R2 values of 0.819 and 0.809 respectively the validity of these results is questionable. 
4.2.3.10 Binding of HBAD to CobB 
HBAD is the final product of the enzymatic reaction of CobB, which is generated after 
amidation of both the C2 and the C7 side chains of HBA. HBAD was produced and 
purified from a recombinant strain of E. coli as described in Chapter 2. The binding of 
HBAD to HBAD was investigated in the same way as the binding of HBA and HBAM. 
Stopped-flow was again used to determine the binding of HBAD to CobB, where CobB 
was maintained at 1 µM whilst the concentration of HBAD was varied between 1 µM 
and 5 µM (Figure 4.14). 




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBA 0.998 0.52 2.48 5.76 3.00 0.65 1.60
HBA/ATP 0.959 0.52 2.23 1.78 0.90 0.12 0.27
HBA/Gln 0.832 0.38 2.00 1.22 0.46 0.10 0.20
HBA/ATP/Gln 0.967 2.14 5.83 0.62 1.36 0.05 0.28




k+1 !M-1 s−# k-1 s-
1
k+1’ !M-1 s-1 k-1’ s-1
HBAM 0.929 3.88 20.70 0.99 3.80 0.03 0.56
HBAM/ATP 0.819 4.01 4.22 0.35 1.42 0.05 0.21
HBAM/Gln 0.809 0.53 5.86 1.50 0.80 0.07 0.41
HBAM/ATP/Gln 0.985 5.13 5.80 0.32 1.64 0.04 0.23




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBAD 0.934 0.94 13.20 0.87 0.81 0.03 0.44
HBAD/ATP 0.813 0.17 ------- 2.51 0.41 ------ ------
HBAD/Gln 0.972 0.04 1.65 1.80 0.06 0.15 0.24




Figure 4.14: Dependence of kobs versus [HBAD]. Dependence of kobs versus [HBAD]. For 
R1 the rate constants k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements 
of kobs at different concentrations of HBAD and constant concentration of CobB for a) the initial 
phase of reaction (R1), with calculated k+1 = 0.87 µM-1 s-1, k-1 = 0.18 s-1 and Kd1 = 0.94 and b) 
the second phase of reaction (R2) with k+1’ = 0.03 µM-1 s-1, k-1’ = 0.4	s-1 and Kd2 = 13.2 µM, this 
data is poor and is not considered to be accurate. Values are averages of 3 biological repeats 
(from three different HBA preparations) ± SEM.  































= 0.94 !M ±0.808
Kd2 = 0.443/0.032
= 13.20 !M ±15.5
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= 0.94 !M ±0.808
Kd2 = 0.443/0.032
= 13.20 !M ±15.5
(a)                                                                               (b)
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From Figure 4.14 it can be seen that for the first binding event (R1) that HBAD binds 
CobB with a Kd1 of 0.94 μM whilst the second binding event (R2) has a Kd2 of 13.2 µM 
indicating that the second HBAD molecule binds much less tightly (Figure 4.14 and 
Table 4.3). However, the binding rates for the formation of the CobB2-HBAD and 
CobB2-HBAD2 complexes are relatively slow, with k+1 = 0.87 µM-1 s-1 and k+1’ = 0.03 
s-1 respectively (Figure 4.14 and Table 4.3).  
4.2.3.11 Binding of HBAD to CobB in the presence of ATP 
Stopped-flow was used to monitor the binding of HBAD to CobB in the presence of 
ATP. The parameters of the assay were as described previously, with CobB fixed at 
1 µM, ATP at 5 mM and with variable concentrations of HBAD between 1 µM and 5 
µM (Figure 4.15). 
 
Figure 4.15: Dependence of kobs versus [HBAD] and ATP. Dependence of kobs versus 
[HBAD]. For R1 the rate constants k+1 (line gradient) and k-1 (y intercept) from stopped-flow 
measurements of kobs at different concentrations of HBAD and constant concentration of 
CobB/ATP for a) the initial phase of reaction (R1), with calculated k+1 = 1.77 µM-1 s-1, k-1 = 1.32 
s-1 and Kd1 = 0.75 µM. This data is poor and not considered to be accurate. Values are 
averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
Kd1 = 1.318/1.766
= 0.75 !M ±1.92















In the presence of a fixed concentration of ATP and CobB the kobs was monitored 
against variable HBAD concentrations (Figure 4.18). For the binding of the first HBAD 
molecule (R1) the presence of ATP changed the affinity of HBAD only, binding CobB 
by almost 6 fold tighter in the presence of ATP (Kd = 0.17 and 0.94 respectively), 
however, slowed the rate at which HBAD binds to CobB by nearly 3 fold (k+1 = 0.87 
µM-1 s-1 value without ATP and k+1 = 2.4 µM-1 s-1 with ATP, respectively) (Figure 4.14, 
Figure 4.15, Table 4.3).  
4.2.3.12 Binding of HBAD to CobB in the presence of Gln 
To determine if Gln has any effect on the binding of HBAD to CobB, the stopped-flow 
assay was repeated in the presence of a fixed concentration of Gln. Gln was added 
to CobB at a concentration of 5 mM and the concentration of CobB was kept constant 
(1 µM) and HBAD was varied between 1 µM and 5 µM. The results are shown in 









Figure 4.16: Dependence of kobs versus [HBAD] and Gln. For R1 the rate constants k+1 (line 
gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBAD and constant concentration of CobB/Gln for a) the initial phase of 
reaction (R1), with calculated k+1 = 1.80 µM-1 s-1, k-1 = 0.06 s-1 and Kd1 = 0.04 and b) the second 
phase of reaction (R2) with k+1’ = 0.15 µM-1 s-1, k-1’ = 0.24 s-1 and Kd2 = 1.65 µM. Values are 


















= 0.04 !M ±0.01
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= 0.04 !M ±0.12
Kd2 = 0.241/0.146
= 1.65 !M ±1
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(a)                                                                                     (b)
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Figure 4.16 shows that in the presence of a fixed concentration of Gln and CobB 
where the Kobs was monitored against variable HBAD concentrations, that Gln has a 
striking effect on the binding of HBAD to CobB (Figure 4.16). For the binding of the 
first HBAD molecule (R1) the presence of Gln changed the affinity of HBAD by 27 fold 
compared to that of CobB binding HBAD only, and 5 fold CobB-ATP (Kd1 = 0.04, Kd1 
= 0.94 and Kd1 = 0.17 respectively) (Table 4.3).  
4.2.3.13 Binding of HBAD to CobB in the presence of Gln and 
ATP 
To complete the data set, the binding of HBAD with CobB was investigated in the 
presence of ATP and Gln. This was accomplished by keeping a fixed concentration 
of CobB (1 µM), ATP (5 mM) and Gln (5 mM) and varying the concentration of HBAD. 












Figure 4.17: Dependence of kobs versus [HBAD], ATP and Gln. For R1 the rate constants 
k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBAD and constant concentration of CobB/ATP/Gln for a) the initial phase 
of reaction (R1), with calculated k+1 = 1.25 µM-1 s-1; k-1 = 2.37 s-1 and Kd1 = 2 µM and b) the 
second phase of reaction (R2) with k+1’ = 0.09 µM-1 s-1; k-1’ = 0.24 s-1 and Kd2 = 3 µM. Values 
are averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
 
 


































Kd1 =  2.371/1.248
= 2!M ±1
Kd2 = 0.242/0.095 
= 3!M ±2.8
(a)                                                                                (b)


































Kd1 =  2.371/1.248
= 2!M ±1
Kd2 = 0.242/0.095 
= 3!M ±2.8
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When all the substrates (HBAD, ATP and Gln) are present the binding affinity of CobB 
for HBAD is decreased by 2 fold (Kd1 = 2.0 and Kd1 = 0.94 respectively). Thus, for both 
R1 and R2, reduction that was observed in the presence of Gln is lost when both Gln 
and ATP are present. The first order rate constants however, are very similar to HBAD 
binding CobB/Gln and CobB/ATP/Gln (k+1 = 1.80 µM-1 s-1 and k+1 = 1.25 µM-1 s-1 
respectively) (Table 4.3). Whereas, the rate describing the dissociation of the CobB-
HBAD in the presence of Gln was 38 fold slower than that of CobB-HBAD in the 
presence of ATP and Gln (k-1 = 0.06 s
-1 and k-1 = 2.37 s
-1 respectively) (Table 4.3).   
Table 4.3 Reaction rates and binding constants of CobB binding to HBAD in the 
presence and absence of cofactors ATP and Gln. 
 
To conclude the results show that CobB binds HBA/ATP/Mg2+/Gln with a Kd  = 2 µM, 
HBAM/ ATP/Mg2+/Gln Kd  = 5 µM and  HBAD/ ATP/Mg
2+/Gln Kd  =  2 µM. These results 
are a representation of the enzyme being active, as all of the necessary cofactors are 
present. For HBA and HBAM do not bind CobB to high affinity as HBA will be turned 
over to HBAD you would not expect tight binding as the product has to tunover quickly 
for the production of more product. The fact that HBAM binds 2.5 fold weeker could 
represent the theory that once amidated at possition C7 the molecule leaves the 
active site and rebinds at possition C2. The Kd value obtained for HBAD/ 
ATP/Mg2+/Gln binding, can be considered speculative as the R2 value is 0.709, for an 
accurate result the R2 value should be close to 1.  
 




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBA 0.998 0.52 2.48 5.76 3.00 0.65 1.60
HBA/ATP 0.959 0.52 2.23 1.78 0.90 0.12 0.27
HBA/Gln 0.832 0.38 2.00 1.22 0.46 0.10 0.20
HBA/ATP/Gln 0.967 2.14 5.83 0.62 1.36 0.05 0.28




k+1 !M-1 s−# k-1 s-
1
k+1’ !M-1 s-1 k-1’ s-1
HBAM 0.929 3.88 20.70 0.99 3.80 0.03 0.56
HBAM/ATP 0.819 4.01 4.22 0.35 1.42 0.05 0.21
HBAM/Gln 0.809 0.53 5.86 1.50 0.80 0.07 0.41
HBAM/ATP/Gl 0.985 5.13 5.80 0.32 1.64 0.04 0.23




k+1 !M-1 s−# k-1 s-1 k+1’ !M-1 s-1 k-1’ s-1
HBAD 0.934 0.94 13.20 0.87 0.81 0.03 0.44
HBAD/ATP 0.813 0.17 ------- 2.51 0.41 ------ ------
HBAD/Gln 0.972 0.04 1.65 1.80 0.06 0.15 0.24
HBAD/ATP/Gln 0.709 2.00 3.00 1.25 2.31 0.09 0.24
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4.3 Discussion 
In this chapter stopped-flow was used to measure the binding of CobB with its corrin 
substrates and product in the presence and absence of co-substrates ATP and Gln. 
The binding profile indicate that CobB and HBA interact in a two phase process. The 
first 0.05 seconds signifies the fast phase of the reaction representing the initial 
formation of a CobB-HBA (monomer A) complex. The second binding phase is much 
slower and is presumed to represent monomer B. The crystal structures of CobB looks 
to confirm this as there is differences between the active site in each monomer. When 
there is no substrate in the active site, Arg177 in the unstructured region moves away 
from the HBA binding site of the opposite monomer and the other residues looks to 
fold round the ATP binding site of their own monomer. However, when HBA is present 
in the active site, Arg177 from the opposite monomer (B) interacts with the side chain 
attached to C18 of the corrin ring present in monomer A, whilst the other residues 
from Ala180 to Leu183 in monomer B flip away from the ATP binding site. This scissor 
like mechanism explains the difference in affinity and binding rate between the two 
monomers.  
The Kd of HBA binding in the first phase is 0.52 µM, whilst in the second phase it is 
2.48 µM. CobB seems to exhibit negative cooperativity, in that binding of a substrate 
molecule to one active site decreases the affinity of the enzyme for the second 
substrate molecule. The negative cooperativity of substrate binding suggests that the 
enzyme follows a sequential model in which binding of substrate to one monomer 
induces a change in the other monomer. The X-ray crystal structure of CobB binding 
HBA looks to confirm this theory. On examination of the two monomers (A and B), 
residues V171 to G184 show weak electron density. This suggests that the region is 
disordered, on examination of the B-factors (Mura 2014) between the two monomers 
we see a difference in the stability of each. Monomer A with HBA bound looks to be 
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slightly more stable than monomer B which is empty (Figure 4.18).   
(a)                                                  (b)                           
 
Figure 4.18: Crystal structure of monomer A and B for B. melitensis CobB/HBA (B-
factors). Structure shows B-factors (corresponding to flexible regions), where blue represents 
low flexibility and red indicates high flexibility. (a) Monomer A appears slightly less flexible than 
(b) monomer B. Image created using B-factor Putty in PyMol. 
In the crystal structure the unstructured region (Phe176 to Leu183) from each 
monomer is involved in substrate binding to the opposite monomer. One of the main 
contributors to binding in this unstructured region is Arg177 (Figure 4.19).  When HBA 
binds to monomer A the unstructured loop region containing Arg177 of monomer B 
binds to HBA in the active site of monomer A. This pools the unstructured loop further 
away from the HBA binding site (monomer B) shortening the distance between 
Leu183 to the Gly198 (6.8 Å) in monomer A, and increasing the distance in these two 
residues from the other monomer (11.4 Å) (Figure 4.20). This changes the active site 
of the second monomer, which could account for the different binding affinity and 




(a)                                                        (b) 
 
Figure 4.19: Monomer A binding ADP and Monomer B binding ADP plus free phosphate. 
(a) Monomer A showing the unstructured region of B (yellow) that spans the ATP binding site. 
Leu183 has flipped outwards away from the ADP binding site. Arg177 is positioned into the 
HBA binding site. (b) Monomer B showing where the unstructured region of A (blue) spans the 
ATP binding site. Ser182 and Leu183 look to be interacting with ADP, whilst Arg177 is shown 
in two positions and appears to flip between the two states.  
(a)                                                                  (b) 
 
Figure 4.20: B. melitensis CobB binding HBA structure. (a) Unstructured region (yellow) 
of monomer A (with beta sheet) showing the distance 6.8 Å to alpha helix. (b) Unstructured 
region of monomer B (no beta sheet) showing distance 11.4 Å to alpha helix. 
When ATP binds CobB the affinity for HBA binding remains the same as when no 
ATP is present (Kd = 0.52 µM with ATP and Kd = 0.52 µM without). However, the rate 
of the binding of the two reaction was three fold slower when ATP was present. This 









Unstructured region binding helix
monomer A.  Arg177 binding HBA 
in monomer B
Unstructured region binding helix
monomer B.  Arg177 binding HBA 
in monomer A
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unstructured region (Phe176 to Leu183) of the CobB. As already stated, the crystal 
structure shows that on binding ATP Arg177 flips into the HBA binding site (Figure 
4.19). When binding ATP, part of the loop is pulled closer to the ATP binding site, thus 
moving the other part further away from HBA binding site. Overall, this may have the 
effect of restricting the binding of HBA to the second monomer.   
When Gln, but not ATP, is present, the Kd = 0.38 µM and with ATP/Gln Kd = 2.14 µM 
this is not surprising as in the presence of all the cofactors HBA will be turned over to 
HBAD the product which is expected to not bind as tightly (see Table 4.1).  The rate 
of the reaction is two-fold slower when all the cofactors are present which suggests 
that Gln influences the rate of binding, suggesting that cooperation between the two 
binding sites. This could infer that Gln binds first and that this binding is relayed to the 
HBA active site, perhaps causing a slight conformational change that obstructs the 
binding of HBA. However, Fresquet et al surmised that the reduction in the Km for Gln 
must originate from conformational changes in the binding site for Gln, which are 
allosterically transmitted by the binding of substrates to the synthetase domain 
(Fresquet, Williams and Raushel 2004). This would only be correct if HBA bound first. 
The stopped flow analysis does infer that there is some sort of communication 
between the two domains. 
The binding of HBAM to CobB is a lot weaker than HBA, and occurs at a much slower 
rate (11 fold slower) in the fast phase of the reaction. HBAM, once formed, most likely 
leaves the active site and rebinds to position itself in an orientation that allows 
amidation at the second position, producing the final product (HBAD). It would be 
unusual for the enzyme to want to bind tightly and hold onto to a partially amidated 
product, therefore, it is expected that binding to CobB should be weaker.  
As with HBA binding to CobB in the presence of ATP, there is very little difference in 
the fast phase (R1) of HBAM binding to CobB/ATP, (Kd = 4.01 µM with ATP and Kd = 
 199 
3.88 µM without). However, for the slower phase R2, the Kd2 has 5 fold weaker affinity 
for HBAM/ATP binding (Kd2 = 4.22 µM with ATP and Kd2 = 20.6 µM without). 
Another issue that could affect the binding affinity and rate of the reaction of HBAM 
with or without cofactors is the formation of the phosphorylated intermediate. From 
the X-ray crystal structure of HBAM with a phosphorylated intermediate at the C2 
position there is a clear difference between the two monomers. Arg177 of monomer 
B has moved away from the HBAM active site (13.6 Å), whereas monomer A is still 
very much in the HBAM binding site (4.1 Å). In the monomer A structure the 
unstructured region looks to be more stable than monomer B (Figure 4.21).   
 
 
Figure 4.21: Crystal structure of monomer A and B of B. melitensis CobB binding 
HBAMP (B-factors). Structure shows B-factors (corresponding to flexible regions), where 
blue represents low flexibility and red indicates high flexibility.  (a) monomer A to be slightly 
more stable than monomer B when binding HBAM as a phosphorylated intermediate. Figure 
was generated using B-factor Putty in PyMol.  
In the presence of Gln but not ATP, HBAD binding to CobB shows a 2 fold increase 
in the rate of reaction, compared to HBAD on its own. It is possible this is caused by 
a conformational change in the enzyme that is not observed in the crystal structure. 
(a) (b)
 200 
There is no crystal structure of CobB with Gln or products of this partial reaction 
(ammonia or Gln). However, the mechanism for this part of the reaction has been 
previously well established. 
The production of HBAD is the final step in the enzyme reaction. In the presence of 
ATP and Gln it would normally be expected for the product HBAD to leave the active 
site at a faster rate than that of HBA and HBAM. However, HBAD/ATP/Gln (Kd1 = 2 
μM) has the same binding affinity as that of HBA/ATP/Gln (K1d = 2.14 μM).This slow 
release reflects the general tight binding of products to the B12 biosynthetic enzymes, 
where evidence suggest the enzymes operate a form of substrate channelling. 
Indeed, the  rate for the dissociation of the CobB.HBAD complex is significantly slower 
than that for either the CobB.HBA or CobB.HBAM complexes. 
To summarise, in the presence of ATP, HBA binds tightly (0.52 µM) to CobB at 
monomer A, a binding that induces a conformational change in monomer B. ATP 
binds monomer B at a slower rate than binding of monomer A, by what looks to be a 
scissor type mechanism, as one monomer opens up after binding ATP the other 
monomer becomes more closed (see Figure 4.19). In Figure 4.19, Arg177 looks to be 
in two positions with one pointing into the ADP binding site and the other flipping 
outwards to bind in the HBA binding site. From the crystal structures it could be 
assumed that monomer B is preparing to bind HBA. At this point monomer A has most 
likely bound at the C7 position on the corrin ring and has started the process of 
amidation, by forming a phosphorylated intermediate. This intermediate is then 
amidated to produce HBAM.  
The crystal structure of CobB binding HBAM shows the unstructured region in 
monomer A to be more structured with the formation of a beta sheet, whilst in 
monomer B this region remains unstructured. Another difference between the two 
monomers is that Arg177 no longer binds to the corrin ring, but has flipped back 
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allowing the active site to open up. In monomer B, however, Arg177 still remains 
bound (Figure 4.22).  
 
Figure 4.22: HBAM binding CobB. Monomer A shows Arg177 (blue) moving away from the 
active site, whereas in monomer B Arg177 (yellow) interacts with the side chain attached to 
C13 on the corrin ring. 
Once amidated at position C7, HBAM then leaves the active site, repositioning itself 
for amidation of the side chain attached to C2. HBAM binding to CobB /ATP has a 
similar affinity for binding as HBAM alone. After amidation of the C2 position the final 
product is achieved (HBAD). From the stopped-flow assay and the X-ray crystal 
structures, it seems that this scissor type mechanism may be the method in which 













Evidence for an interaction between 
Brucella melitensis CobB and CobH to 








CobH and CobB are two enzymes involved in sequential steps in the cobalamin 
pathway. CobH is the enzyme that mediates the migration of a methyl group from 
position C11 to C12 on the corrin ring system of its substrate, precorrin-8x, resulting 
in the production of product hydrogenobyrinic acid (HBA) (Thibaut et al. 1992; 
Blanche et al. 1992; Shipman et al. 2001).  
 
 
Figure 5.1: CobH binding its substrate precorrin-8 to produce product HBA. Precorrin-
8 binds CobH where the nitrogen of pyrrole ring C is protonated, this triggers a suprafacial 
[1,5]-sigmatropic rearrangement; the methyl group then passes from C-11 to C-12 in a single 
concerted step, with the double bonds in the ring shifting position, to give the product precorrin 
8. 
The next enzyme in the pathway is catalysed by CobB, which is involved in the 
amidation of the carboxylic acid side chains attached to C2 and C7 of HBA on the 
corrin ring (Debuscche et al. 1990). CobH is known to bind its product (HBA) very 
tightly and hence the question arises as to how this product is released so that it can 


















































determine the mechanism by which HBA is transferred from CobH to the active site 
of CobB for the amidation reactions to take place.  
The crystal structure of Rhodobacter capsulatus CobH shows that its product HBA is 
encapsulated within the active site of the enzyme (Figure 5.2). CobH forms a 
homodimer and contains two active sites, which are composed of amino acid residues 





Figure 5.2: Cartoon representation of R. capsulatus CobH. The diagram shows the 
presence of two molecules of HBA encapsulated within the active site of the homodimeric 







Figure 5.3: Cartoon representation of R. capsulatus CobH. The diagram shows HBA 
binding the monomer, where ring A and B of the corrin substrate are positioned near the 
opening of the active site. 
In the crystal structure rings A and B of HBA are positioned near the opening of the 
active site and are exposed to solvent, whereas rings C and D are encapsulated more 
deeply within the cavity, with many of the hydrophobic residues making hydrogen 
bonds with the macrocycle (Figure 5.3) (Deery et al. 2012). The complex between 
HBA and CobH suggests that free movement of HBA from this pocket would be 
hindered. This infers that a conformational change in the enzyme is required in order 
to release the product. Weak density is observed for residues 79-102 of the CobH 
structure, residues that contribute to a flexible C-terminal loop region, which may 
swing open to allow the free movement of HBA (Shipman et al. 2001). 
The kinetic parameters for the P. denitrificans CobH reveal that the enzyme has a 
high affinity and low turnover for its product HBA. This means that HBA binds very 
tightly to CobH and is very slow to leave the active site. This was determined by 
measuring the kcat (which is the number of substrate molecules converted to product 





h-1. The Vmax for the reaction is 230 nmol h
-1 mg-1. It was concluded from this research 
that HBA competitively inhibits CobH (Thibaut et al. 1992). 
Due to the tight binding and the build-up of HBA in the active site of CobH, it is not 
clear how this molecule is released from the active site and transferred to the next 
enzyme in the pathway (CobB). One possibility is that CobH and CobB interact, 
whereby CobB encourages CobH to release its product directly into the active site of 
CobB. This would represent a form of direct metabolite transfer. In order to determine 
the mechanism by which CobH and CobB communicate with each other, structural 
and biophysical analyses were employed. For the purposes of this study the B. 
melitensis CobB and CobH were used since interactions between sequential 
enzymes in a pathway are more likely to be conserved between enzymes from the 
same species.  
5.2 Results 
5.2.1 Expression and purification of His6- tagged B.melitensis 
CobH 
E. coli strain BL-21 (DE3) pLysS was transformed with pET14b carrying the B. 
melitensis cobH gene, provided by Dr. Evelyne Deery, which allowed for the 
production of recombinant N-terminus His6-tagged CobH. The cells were grown in 
2YT broth supplemented with ampicillin and chloramphenicol overnight at 37 °C, as 
described in Chapter 2.4. After harvesting the bacteria by centrifugation the cell pellet 
was resuspended in Tris-HCl buffer, pH 8.0, containing 500 mM NaCl and 20 mM 
imidazole. The cells were then lysed by sonication and centrifuged for a second time 
to remove the cell debris.  
His6-tagged native CobH was purified using a Ni-chelate column followed by ion 
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exchange chromatography. From 1L of culture ~20 mg of protein was reproducibly 
purified. The protein ran as a single band, with a molecular mass of 24 kDa, which is 
in close agreement to the gene predicted molecular mass (Figure 5.4). 
 
Figure 5.4: 12.5% SDS PAGE gel of purified B. melitensis CobH. Sample of CobH from 
Ni+ affinity column. Lane 1 contains protein markers of known molecular mass, as shown. 
Lane 2 is empty. Lane 3 contains purified B. melitensis CobH (24 kDa).  
 
5.2.2 Expression and purification of His6-tagged B. melitensis 
CobB 
E. coli strain BL-21 (DE3) pLysS was transformed with a pET14b plasmid carrying the 
B. melitensis cobB gene, which allowed for the production of recombinant N-terminus 
His6-tagged CobB. The cells were again grown in 2YT broth supplemented with 
ampicillin and chloramphenicol overnight at 18 °C, as described in Section 2.2.7. After 
harvesting a 1 L culture by centrifugation the cell pellet was resuspended in Tris-HCl 
24th July 2018 Thrombin cleavage of CobH
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buffer, pH 8.0, containing 500 mM NaCl and 20 mM imidazole. The cells were then 
lysed by sonication and centrifuged for a second time to remove the cell debris. His6 
tagged native CobB was purified using a Ni-chelate column followed by ion exchange 
chromatography. From a 1 L culture ~10 mg of protein was reproducibly produced. 
The purified CobB was run on a SDS gel, which migrated as a single band, as 
previously reported in Chapter 3 (see Figure 3.6).  
5.2.3 Co-crystallisation of CobH/HBA with CobB/HBA 
In order to determine if CobH and CobB form a complex co-crystallisation of the two 
proteins was attempted. HBA was added stochiometrically to each of the proteins 
(100 µM) and then the two proteins were mixed in an equi-molar ratio. The sample 
was left at room temperature for one hour before being concentrated using a 30 kDa 
cut off centricon. The complex was diluted into 20 mM Tris-HCl buffer, pH 8.0, 
containing 150 mM NaCl, and repeatedly concentrated and diluted in buffer  in order 
to help remove any unbound HBA. The final concentration for crystallisation was 4 
mg/mL.  Molecular Dimensions crystal screens 1 and 2 were used for crystallisation 
with a protein to well ratio of 2:1 by using the hanging drop vapour diffusion method. 
Initial screening produced a number of crystals of a quality suitable for initial X-ray 
diffraction (Figure 5.5). 
Crystals were flash frozen in liquid nitrogen using 2 µL of well solution with 2 µL of 
50% v/v ethylene glycol (cryo-protectant). X-ray data were collected on four of the 
crystals at the DIAMOND Synchrotron Radiation Centre. These structures were 
solved using molecular replacement. 
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 (a)                             (b)                           (c)                                 (d) 
 
Figure 5.5: Crystals of CobH/CobB were grown from Molecular Dimensions screen 1 
and 2: (a) 10 % PEG 1K (v/v) +10 % PEG 8K (v/v), crystals 2: 0.2 M magnesium acetate, 0.1 
M cacodylate pH 6.5 and 30% PEG 8K v/v,(b) 0.2 M lithium sulphate, 0.1 M Tris-HCl pH 8.5 
and 30% PEG 8K, (c): 0.2 M ammonium sulphate, 0.1 M sodium cacodylate pH 6.5, 30%(v/v) 
PEG 8K (d) 30% (v/v) ethylene glycol. 
 
The CobH/HBA/CobB crystallisation trials produced 4 crystals that were subject to X-
ray diffraction. Unfortunately, the data revealed that these crystals contained only 
CobH, with no density for CobB in any of the structures.  
The three published X-ray crystal structures of P. denitrificans (HBA bound), R. 
capsulatus (HBA bound) and B. melitensis all have similar structures. However, the 
in-house structure of B. melitensis, although similar to the published structures, has 
HBA bound in only one molecule of the dimer (Figure 5.6).  This crystal diffracted to 
2 Å resolution, with a space group P21 21 2, and cell dimensions of 68.282 Å, 126.51 
Å, 51.177 Å, a = 90, b = 90 and g = 90 with 2 molecules in the AU. The sequence of 
B. melitensis, P. denitrificans, R. capsulatus CobH are highly conserved, so it is 
expected that the crystal structures will be very similar (Figure 5.7). 
 
 
Attempts at crystallisation of CobB/CobH
• Expressed and purified CobH
• Crystallisation of CobB/CobH number of hits
• Crystals went to synchrotron
• To Date there are now 4 different crystal forms
• All diffracted to high resolution best to 1.3A
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Figure 5.6: X-ray crystal structure of Brucella melitensis CobH. Ribbon diagram of CobH, 
with one molecule of HBA bound in one of the monomers. Conserved residues in red, and 
HBA in green. 
 
Figure 5.7: Sequence alignment of the B. melitensis (A0A2X1C), P. denitrificans P21638, 









5.3. Model to hypothesise interaction between CobH and 
CobB 
Under steady state conditions CobH shows a high affinity for its product HBA (Kd = 
0.91 µM and a Ki = 0.7 µM respectively) (Thibaut et al. 1992), slightly higher than that 
of its substrate, which was evident by the inhibitory effect of HBA (Shipman et al. 
2001). Therefore, the mechanism by which CobH releases its product to CobB, the 
next enzyme in the pathway, is of importance. The crystal structure of CobH shows a 
globular protein, whereas the structure of CobB is more elongated (Figure 5.8 and 
5.9). The general shape of these two enzymes indicates that it may be possible for 
them to form a complex, resulting in the transfer of HBA from CobH to CobB. With 
this in mind, a model of CobH binding to CobB was produced. Although the fit of CobH 
into CobB from the model looks to be tight, it is conceivable that there is a 
conformational change on binding. Both enzymes have flexible regions, Arg78 to 
Arg103 in CobH and Arg226 to Asn243 in CobB which could allow for the 
conformational change required. Until the structure of the complex is determined the 
nature of how these two proteins interact will remain conjecture.  
 
Figure 5.8: R. capsulatus CobH. Flexible region spanning Arg78 to Arg103 (red), CobH 
(purple) with HBA bound in each site (green). 
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Figure 5.9: Hypothetical docking of CobB binding with CobH. Cartoon representation of 
CobH (purple and gold), which at the widest point of the enzyme has a width of 52.4 Å, together 
with CobB (green), which has an opening of 43.4 Å for binding of CobH. Complex shows CobH 
(purple) binding CobB (green) where HBA (blue and yellow) are present in both enzymes. 
Flexible regions in both enzyme could allow for an improved fit upon conformational change 
(Dave Brown). 
There is, however, no experimental evidence for the formation of a complex between 
CobH and CobB, or the transfer of HBA directly from one enzyme to the other. In 
order to obtain experimental data to support this hypothesis stopped-flow was 
employed as a technique to monitor the binding of CobH and CobB. In order to do 
stopped-flow analysis it is first important to determine if there are any significant 
changes in either the absorbance or fluorescence spectra of these proteins when they 
come together. Such changes would be expected to occur, for instance, if CobH 









5.4 Fluorescence-emission spectra measuring substrate 
fluorescence 
5.4.1 Measurement of fluorescence emission spectra for 
CobH/HBA and CobB/HBA.  
To monitor changes associated with the transfer of HBA from CobH to CobB, 
fluorescence emission spectra of CobH/HBA and CobB/HBA were initially recorded 
before a study was made of any reaction between CobH/HBA and CobB. The 
florescence emission spectra were recorded over 360 nm to 700 nm after excitation 
at 330 nm. It was found that the fluorescence associated with HBA when bound to 
CobB ( (lmax = 410 nm) is quite distinct to that observed when HBA is bound to CobH 
(lmax = 450 nm) (Figure 5.10). Therefore, the transfer of HBA from CobH to CobB can 




Figure 5.10: Fluorometer showing binding of CobB/HBA, CobH/HBA and 
CobB/CobH/HBA. Excitation at 330 nm shows CobB/HBA has a large peak at 410 nm and 
small peaks at 555 nm and 625 nm. CobH/HBA has a unique peak at 450 nm and two small 
peaks at 550 nm and 635 nm. CobH/HBA peak moves from 450 nm to 410 nm in the presence 
of CobB.   
5.5: Stopped-Flow analysis using substrate fluorescence  
5.5.1 Effect of CobH on the binding of HBA to CobB 
In order to obtain kinetic data on the mechanism by which HBA is transferred from 
CobH to CobB, stopped-flow fluorescence spectroscopy was employed. In this 
stopped-flow experiment the concentration of CobH and CobB (1 µM) was kept 
constant and the concentration of HBA was varied (1 )M to 5 )M). Excitation was 
performed at 330 nm to measure fluorescence emission from HBA binding CobB. A 
GG455 filter was used to remove scattered light from the excitation. 
Stopped flow was performed with the CobB mixture in one of the two syringes on the 
stopped flow apparatus (Eccleston et al 2008). The other syringe contained CobH 
mixed with the HBA whose concentration was varied from 1 µM to 5 µM. At the start 
of the experiment each syringe injects 100 µL of sample into the cell where the two 




CobB and CobH binding HBA spec. Exc. 330
INT
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instantaneously, and usually about six samples are run at a single concentration. The 
average from these runs is used to give the final data for each concentration of ligand. 
The reaction was followed by monitoring the fluorescence emission at 410 nm from 
HBA on binding to CobB after excitation at 330 nm.   
5.5.2 Stopped-Flow analysis of CobB/ATP/Gln plus 
CobH/HBA/ATP/Gln where HBA is varied 
In order to determine the dissociation constant (Kd) associated with the binding of 
HBA to CobB stopped-flow fluorescence spectroscopy was used. An example of the 
fluorescence change is shown in Figure 5.10. This experiment was carried out using 
a constant concentration of CobB (1 µM) and CobH (1 µM). Both of the enzymes were 
initially mixed with 5 mM ATP and 10 mM Gln. HBA was mixed with CobH only and 
the concentration of the substrate was varied between 1 µM and 5 µM (HBA). 
Excitation was carried out at 330nm and fluorescence emission was measured at 410 
nm. The reaction was then monitored by recording fluorescence emission changes 
resulting from the substrate binding to the enzyme (Figure 5.12). 
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Figure 5.11: An example trace of the fluorescence change upon 1 μM HBA binding to 1 
μM CobB. Trace shows a biphasic reaction with a fast and slow phase, with HBA binding 
monomer A and then monomer B of CobB. Where kobs = 3.3 s
-1 
with fluorescence increase 
= 4 %. 
As already shown in Chapter 4.2.2.2 the binding of HBA to CobB shows a biphasic 
reaction. This is also the case when the binding of HBA to CobB is followed in the 





Fast phase: k+1 !M-1 s−#
Slow phase: k+1’ !M-1 s-1




















Figure 5.12: Dependence of kobs versus [HBA], ATP and Gln. Calculation of rate constants 
k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of HBA and constant concentration of CobB/ATP/Gln/Mg+ and 
CobH/ATP/Gln/Mg+ for a) the initial phase of reaction (R1), with calculated k+1 = 1.4 µM-1 s-1, 
k-1 = 2.9 s-1 and Kd1 = 2 µM. Values are averages of 3 biological repeats (from three different 
HBA preparations) ± SEM.  
For the interaction between CobB and HBA the initial rate data from Figure 5.12 can 
be determined by the use of non-linear regression to generate the kobs at different 
HBA concentrations. The gradient of these plots, as shown in Figure 5.12, represents 
k+1 whilst the y intercept represents k-1. The data indicate that the binding of HBA to 
CobB (Kd = 2 µM) is relatively weak, with a rate constant of k+1 = 1.4 µM-1 s-1. Data for 





= 2 !M ±#. %&














CobB/ATP/Gln/MgCl + CobH/HBA/ATP/Glu  R1
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5.5.3 Effect of ATP and Gln on the transfer of HBA from 
CobH.HBA to CobB  
In order to determine if ATP and Gln have an effect on the binding of HBA to CobB in 
the presence of CobH, the experimental parameters of the stopped flow assay were 
adjusted, where ATP and Gln were removed from both enzymes. The experiment was 
run keeping CobB and CobH constant (1 µM), and again varying the concentration of 











Figure 5.13: Dependence of kobs versus [HBA] CobB and CobH constant. Calculation of 
rate constants k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements of 
kobs at different concentrations of HBA and constant concentration of CobB and CobH for a) 
the initial phase of reaction (R1), with calculated k+1 = 1.49 µM-1 s-1, k-1 = 1.47 s-1 and Kd1 = 1 
µM and b) the second phase of reaction (R2) with k+1’ = 0.09 µM-1 s-1, k-1’ = 0.28 s-1 and Kd2 = 
3.17 µM. 
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Kd = 0.285/0.091
= 3.17!M ±1.395
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The removal of ATP and Gln from the stopped-flow had very little effect on the initial 
binding of HBA to CobB (R1). The reaction was found to have a Kd1 = 1 µM with a 
rate of k+1 1.49 µM-1 s-1. The affinity of substrate binding was much weaker (~3 fold) 
Kd2 = 3.2 )M (Table 5.1). Values are averages of 3 biological repeats (from three 
different HBA preparations) ± SEM.  
5.5.4 Effects of removing ATP and Gln from CobB keeping 
CobH/ATP/Gln/Mg/ HBA varied 
To look at the effects of having ATP and Gln with CobH only, the stopped flow assay 
was run again. ATP (5 mM) and Gln (10 mM) were added to CobH/HBA, where the 
HBA concentration was varied. The concentration of CobB and CobH were kept 
constant (1 mM) and the concentration of HBA was varied from 1 )M to 5 )M (Figure 









Figure 5.14: Dependence of kobs versus [HBA] CobB and CobH/ATP/Gln. Calculation of 
rate constants k+1 (line gradient) and k-1 (y intercept) from stopped-flow measurements of kobs 
at different concentrations of HBA and constant concentration of CobB and CobH/ATP/Gln for 
a) the initial phase of reaction (R1), with calculated k+1 = 0.67 µM-1 s-1, k-1 = 0.45 s-1 and Kd1 = 
0.67 µM and b) the second phase of reaction (R2) with k+1’ = 0.08 µM-1 s-1, k-1’ = 0.13 s-1 and 
Kd2 = 2 µM. Values are averages of 3 biological repeats (from three different HBA preparations) 
± SEM.  
Kd = 0.45/0.67
= 0.67 !M ±0.264
Kd = 0.1316/0.077  
= 2 !M ±1.205
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When ATP/Gln are present with CobH only, HBA binds CobB relatively tightly with a 
Kd1 of 0.67 µM but the rate is 3 fold slower than with HBA present only, and 2 fold 
slower (R1 and R2) than HBA/ATP/Gln present in both enzymes (Table 5.1). 
Table 5.1: Rate and binding constants of HBA binding CobB where HBA 
concentration has been varied:  
 
From the above table, R2 is a statistical measure of the fit of the linear regression line, 
where a value as close to 1 signifies a good fit for the data collected. The weakest 
binding (Kd = 2 µM) value is the binding of HBA to CobB when all cofactors are 
present. This reaction showed two phases although the data for the second phase 
was of very poor quality and was not determined. 
These values are very similar to CobB/HBA/ATP/Gln in Chapter 4, Table 4.1, where 
the Kd is very similar (Kd = 2 µM). However, the rate of the reaction (k+1 = 0.62 µM-1 s-
1) was two-fold slower. Again comparing the binding and rate of reaction with 
CobB/HBA only (Chapter 4, Table 4.1) to CobB only with CobH/HBA/Gln the Kd looks 
to be two-fold weaker, and R1 the rate of the fast reaction eight-fold slower. 
Strangely, in the absence of ATP and Gln, CobB appears to have a greater affinity for 
HBA in the presence of CobH. CobB with CobH/HBA shows HBA binds CobB two-
R2 Kd  !M
R1
k+1 !M-1 s−# k-1 s-1 Kd  !M
R2




0.981 2.00 1.4 2.9 ----------- ------------ --------
CobB/Mg +
CobH/Mg/HBA varied




0.957 0.672 0.67 0.45 2 0.077 0.13
Brucella CobB Vs HBA varied/CobH
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fold tighter than when CobH/HBA has all the cofactors present. Not only does the 
absence of cofactors increase the binding affinity it also increases the rate of the 
reaction, which is nine-fold faster (5.70 µM-1 s-1 and 0.62 µM-1 s-1).  
5.5.5 Effects of varying the concentration of CobB and keeping 
CobH.HBA constant 
To look at the effects of having excess CobB in the transfer of HBA from CobH to 
CobB, CobB was varied from 1 µM to 5 µM. The ratio of CobH and HBA was 1:1 and 
kept at a concentration of 1 µM (Figure 5.15). Fluorescence was monitored at 410 nm 
after excitation at 330 nm with a GG455 filter. 
 
 
Figure 5.15: Dependence of kobs versus [CobB]. Calculation of rate constants k+1 (line 
gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of CobB and a constant concentration of CobH/HBA. This is a single phase 
reaction with calculated k+1 = 3.2 µM-1 s-1, k-1 = 2 s-1 and Kd  = 0.62 µM. (Table 5.2). Values are 
averages of 3 biological repeats (from three different HBA preparations) ± SEM.  
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All the stopped flow data to date had shown a bi-phasic reaction. Initially there is a 
fast reaction which signified binding of HBA to the N-terminal active site of one of the 
monomers and then a much slower rate of binding to the second monomer. However, 
when excess CobB is present there is a single phase reaction consistent with the 
transfer of a single HBA to the CobB dimer. The single reaction, equivalent to R1, had 
a Kd of 0.62 µM, and a relatively fast phase of k+1 = 3.2 µM-1 s-1 and a k-1 = 2 s-1. As 
both k+1 and k-1 are relatively fast reactions (3.2 µM-1 s-1 and 2 s-1 respectively) it 
suggests preferential binding to one monomer. 
5.5.6 Effects of varying the concentration of CobB and keeping 
CobH.HBA constant with the addition of ATP and Gln 
 To determine if having ATP and Gln mixed in with the CobH and HBA would change 
the binding of HBA to CobB, the assay was adjusted by the addition of ATP (5 µM) 
and Gln (10 µM) to the CobH/HBA mix. The concentration of CobB (1 µM to 5 µM) 
was again varied (Figure 5.16). The fluorescence was monitored at 410 nm after 




Figure 5.16: Dependence of kobs versus [CobB] constant concentration of CobH/HBA 
1:1 ATP/Gln/Mg. Calculation of rate constants k+1 (line gradient) and k-1 (y intercept) from 
stopped-flow measurements of kobs at different concentrations of CobB and constant 
concentration of CobH/HBA 1:1 ATP/Gln/Mg. The rates were calculated as k+1 = 0.74 µM-1 s-
1, k-1 = 0.14 s-1 and Kd = 0.189 µM. Values are averages of 3 biological repeats (from three 
different HBA preparations) ± SEM.  
Again the results indicate a single phase reaction (Figure 5.16). However, the addition 
of ATP and Gln changed the affinity with which HBA binds to CobB three-fold. This 
tighter binding results from a 4 fold decrease in k+1 and a 14 fold decrease in k-1 (0.74 
µM-1 s-1 and 0.14 s-1 respectively) (Table 5.2). 
  

















CobB varied V CobH/HBA 1:1/ATP/Gln
Kd = 0.14/0.74
= 0.19 ±0.21 
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Table 5.2: Rate and binding constants of HBA binding CobB 
where CobB concentration has been varied 
 
The presence of ATP and Gln in the above reaction increase the affinity of HBA 
binding to CobB, which results in a slower association and dissociation rate. 
5.5.7 Effects of varying the concentration of CobH/HBA 1:1 and 
keeping CobB constant  
A third assay was run this time varying the concentration of CobH and HBA (1:1) 
keeping CobB constant. The experimental parameters varied were carried out firstly 
using a constant concentration of CobB (1 )M), and varying the concentration of 
CobH and HBA (1 µM, 2 )M, 3 )M, 4 )M and 5 )M) (Figure 5.17). Fluorescence 
emission at 410 nm was monitored after excitation at 330 nm with a GG455 filter.  
 
CobB Vs CobH varied
R2 Kd  !M
R1
k+1 !M-1 s−# k-1 s-1
CobB/Mg Vs CobH/HBA 1:1 varied 100sec 0.804 2.00 0.137 0.266
CobB/Mg Vs CobH/varied/HBA 1$M 0.791 2.00 0.134 0.272
R2 Kd  !M
R1
k+1 !M-1 s−# k-1 s-1
CobB varied/Mg Vs 
CobH/Mg/HBA
0.914 0.625 3.2 2
CobB varied/Mg Vs 
CobH/ATP/Mg/Gln
0.940 0.4 0.714 0.286
Brucella CobB varied Vs CobH
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Figure 5.17: Dependence of kobs versus [CobH/HBA]. Calculation of rate constants k+1 (line 
gradient) and k-1 (y intercept) from stopped-flow measurements of kobs at different 
concentrations of CobH/HBA with a constant concentration of CobB.  The calculated rates 
were k+1 = 0.14 µM-1 s-1, k-1 = 0.25 s-1 with a Kd1 = 2 µM (Table 5.3). Values are averages of 3 
biological repeats (from three different HBA preparations) ± SEM.  
5.5.8 Effects of varying the concentration of CobH in presence 
of constant HBA and CobB  
Stopped flow was run by varying the concentration of CobH and keeping the 
concentration of CobB at 1 µM. CobH concentration was varied at 1 µM, 2 )M, 3 µM, 
4 )M and 5 )M and to each sample 1 )M of HBA was added (Figure 5.18). The 
fluorescence emission was recorded at 410 nm with excitation at 330 nm with a 
GG455 filter.  
 
 



















Figure 5.18: Dependence of kobs versus [CobH] constant concentration of CobB, 
HBA/ATP/Gln/Mg. Calculation of rate constants k+1 (line gradient) and k-1 (y intercept) from 
stopped-flow measurements of kobs at different concentrations of CobH and constant 
concentration of CobB, HBA/ATP/Gln/Mg. The reaction rates were k+1 = 0.15 µM-1 s-1,  k-1 = 
0.26 s-1 with a Kd  = 2 µM. Values are averages of 3 biological repeats (from three different 
CobH preparations) ± SEM.  
In this assay CobH is in excess but HBA is constant at the same level as CobB. As 
the HBA level does not exceed the concentration of CobB this binding event is also 
observed to be a single phase reaction. However, what is interesting here is that the 
increasing concentration of CobH results in an increase in kobs, indicating that CobH 
appears to help promote the binding of HBA to CobB (Table 5.3). 
Table 5.3: Rate and binding constants of HBA binding CobB 
where CobH and HBA concentration has been varied 
 













CobB v CobH varied HBA 1 !M
Kd = 0.26/0.15
= 2 "M±1.5
R2 Kd  !M
R1
k+1 !M-1 s−# k-1 s-1
CobB/Mg Vs CobH/HBA 1:1 varied 
100sec
0.833 2.00 0.14 0.25
CobB/Mg Vs CobH/varied/HBA 1$M 0.832 2.00 0.15 0.26
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5.6 Crosslinking of CobB and CobH 
To understand protein-protein interactions at an atomic level X-ray crystallography 
and NMR spectroscopy are the most common methods employed (Acuner 
Ozbabacan et al. 2011). However, capturing these interactions in order to obtain 
structural information has proven difficult due to the nature of their life time in this 
complexed state. Crystallisation of the complex was unsuccessful. This was not 
unexpected due to the likely transient nature of the interactions between CobB and 
CobH. At this point two methods were considered, either engineering a fussed 
construct of CobH/CobB or trying to crosslink the two enzymes. Due to time 
restrictions it was decided to crosslink the two enzymes, to try and overcome this 
transient problem (Vishnu et al. 2013).   
Three crosslinkers were chosen that differed in the length of their spacer arm; DMS 
(dimethyl suberimidate) which has an 11 Å spacer arm, DMP (dimethyl pimelimidate) 
which has a 9.2 Å spacer arm and DFDNB (1, 5-difluoro-2, 4-dinitrobenzene) which 
has a 3.0 Å spacer arm (Figure 5.19). Both DMS and DMP have reactive imidoester 
groups at either end of the molecule whilst DFDNB contains reactive aryl halide 
groups. All three of these protein cross-linking reagents are reactive to primary 
amines at alkaline pH (pH 8-10) and form amidine derivatives. Due to the functional 
groups in proteins, primary amines are typically nucleophilic which makes them easy 





Figure 5.19: Chemical crosslinkers. Structure of the chemical crosslinking reagents used to 
link CobH and CobB. These crosslinkers react with primary amines at alkaline pH to form 
amidine derivatives. 
5.6.1 Preparation of crosslinkers DMS, DMP and DFDNB  
Each of the crosslinkers were resuspended in water to a concentration of 100 µM 
(stock solution). Using a PD10 column the enzymes were exchanged into phosphate 
buffer saline (PBS). The concentration of CobB and CobH were adjusted to a 
concentration of 0.7 mg/mL. HBA was added to a final concentration of 100 mg/mL to 
the dilute CobH. CobB and CobH/HBA were combined and 50 )L of the crosslinker 
was added to the dilute complex. The complex was then left rotating at room 
temperature for 2 hours. To stop the reaction the buffer was changed using a PD10 
column back into the original 20 mM Tris/HCl buffer, pH 8.0, containing 150 mM NaCl. 
5.6.1.1 Gel Filtration column CobH, CobB and crosslinked 
CobH.CobB 
In order to determine where the individual proteins would elute on a gel filtration 
column the proteins were run individually. CobH has a molecular mass of 24 kDa, and 
as a dimer should run at around 48 kDa. The protein was applied to a Superdex 
S20016/600 column and eluted in 20 mM Tris-HCl, pH 8.0, containing 150 mM NaCl 
and 2 mM MgCl2 (Figure 5.20). 
Description
Thermo Scientific Pierce DMS is dimethyl suberimidate, a 
membrane-permeable crosslinker that contains an amine-
reactive imidoester group at each end of an 8-atom spacer arm.
Features of dimethyl suberimidate:
• Reactive groups: imidoester (both ends)
• Reactive towards: amino groups (primary amines)
• Longest of three similar imidoester crosslinkers, which include 
DMA, DMP and DMS
• Water-soluble
• Imidoesters react with amines at alkaline pH values (pH 8-10) 
to form amidine bond
• Amidine bond retains net charge character of protein primary 
amine to which it reacts
• Reversible at high pH values
• Tool for study of quarternary structure of proteins
Description
Thermo Scientific Pierce DMP is dimethyl pimelimidate, a 
membrane-permeable crosslinker that contains an amine-
reactive imidoester group at each end of a 7-atom spacer 
arm.
Features of dimethyl pimelimidate:
• Reactive groups: imidoester (both ends)
• Reactive towards: amino groups (primary amines)
• Mid-length reagent of three similar imidoester crosslinkers, 
which include DMA, DMP and DMS
• Water-soluble
• I idoesters react with amines at alkaline pH values (pH 8-
10) to form amidine bond
• Amidine bond retains net charge character of protein 
primary ami e to which it reacts
• Reversible at high pH values
• Tool for study of quarternary structure of pro eins
Crosslinking DFDNB (1,5-difloro-2,4-dinitrobenzene)
CobB + CobH (1:1 ratio)
Add 200uL of DFDNB, leave gently shaking at room temperature for 2 hours.
Run through PD10 column into Tris buffer (stops reaction).
Run native gel
Run Gel filtration column in PBS
Description
Thermo Scientific Pierce DFDNB is 1,5-difluoro-2,4-dinitrobenzene, an aryl halide 
compound with two reactive fluorine atoms that can couple to amine-containing 
molecules, yielding stable arylamine bonds.
Features of DFDNB:
• Reactive groups: aryl halide (both ends)
• Reactive towards: amino groups (primary amines)
• Short distance crosslinker.
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Figure 5.20: CobH gel filtration and resultant SDS PAGE analysis. Gel filtration 
chromatogram is shown with large peak at 64 mL and smaller second peak at 98 mL. SDS 
PAGE, lane 1 contains protein markers of molecular masses as shown. Lanes 3 and 4 
represent samples taken from the main peak at 64 mL. The second peak did not show on an 
SDS PAGE gel. As this represents something with a molecular weight of less than 24 kDa on 
this gel it would not be visible. Second peek most likely a small contaminant. 
The large peak at 64.47 mL was analysed by SDS PAGE gel. The major protein was 
assumed to be CobH as it had a molecular mass of 26 kDa (Figure 5.19).  
5.6.1.2 CobB Gel filtration column 
CobB has a molecular mass of 47 kDa and as a dimer should run at 114 kDa. The 
protein was applied to a Superdex S200 16/600 column and eluted in buffer 
containing 20 mM Tris-HCl, pH 8.0, 150 mM NaCl and 2 mM MgCl2 (Figure 5.21). 
CobH










Figure 5.21: CobB gel filtration. Peak at 51.4 mL was run on 10% SDS PAGE gel. Lane 1: 
main peak, Lane 2: CobH, Lane 3: CobB before gel filtration. Lane 1 shows protein at a 
molecular mass of 47 kDa. This corresponds to the molecular mass expected for CobB. 
The large peak at 51.4 mL was analysed by SDS PAGE gel and the major protein 
was assumed to be CobB as it had a molecular mass of 47 kDa (Figure 5.21).  
5.6.1.3 CobH.CobB crosslinked with DMS and DMP run on gel 
filtration column 
DMS and DMP were used to crosslink CobH and CobB using the method described 
in Section 5.3.1. However, both of these crosslinkers did not appear to give any cross-
linked material. Small peaks were seen on the gel filtration chromatograph but when 










5.6.1.4 CobH.CobB crosslinked with DFDNB run on gel 
filtration column 
The third crosslinker to be used was DFDNB using the same method as described 
in Section 5.3.1. 
 
Figure 5.22: CobH.CobB crosslinked with DFDNB gel filtration. Large peak shows elution 
at 41.73 mL. Peak run initially on a native gel, shows molecular mass of around 135 kDa. 
Analysis by SDS PAGE gel, lane 1 contains protein markers of known molecular mass, as 
shown, lane 2 blank, lane 3 and 4 reveals bands at 47 kDa and 24 kDa. These bands 
correspond to the molecular mass of CobH (24 kDa) and CobB (47 kDa). 
DFDNB was incubated with a mixture of CobH and CobB and run on a gel filtration 
column (Fig 5.22). A large peak was observed at 41.73 mL, which appeared promising 
as there was also a smaller peak at 57.22 mL, which could suggest free CobB. The 
samples were run on a native gel and also a 10% SDS gel. From the native gel a 
band was observed at about 135 kDa, which is close to what would be expected for 
the complex between a CobH dimer and a CobB dimer. However, the SDS gel 
revealed two bands, one at 26 kDa and the other at 47 kDa (same molecular mass 
Cross-linked










as native CobH and CobB respectively). As DFDNB is a covalent crosslinker it would 
not be expected to see the individual enzymes on denaturing gel.  
5.7 Crystallisation of crosslinked CobH and CobB  
The crosslinked protein from the gel filtration column was, however, run in 
crystallisation trials. The protein had a concentration of 0.7 mg/mL and HBA was 
added to the dilute protein at a concentration of 100 mg/mL. The complex was then 
diluted and concentrated in a 30 kDa concentrator 3 times using 20 mM Tris-HCl 
buffer, pH 8.0, containing 150 mM NaCl and 2 mM MgCl2 and concentrated to 4 
mg/mL. 
Crystallisation trays were then prepared using Molecular Dimensions screens 1 and 
2. A 24 well plate was used and 500 )L of screen was added to each well, the drop 
ratio was 2:1. Small crystals appeared after 2 to 3 days, these crystals were less than 
1 micron in length and were badly twinned (Figure 5.23). 
 
Figure 5.23: Crystals of crosslinked CobH-CobB with HBA. Condition (a), 0.2 M 
ammonium acetate, 0.1 M sodium citrate pH 5.6 and 30% PEG 4K, condition (b) 0.2 M sodium 
acetate, 0.1 M sodium cacodylate, pH 6.5, and 30% PEG 4K. 
Crystal of CobB/CobH/HBA
 235 
The crystals were archived by freezing in liquid nitrogen and sent to DLS for data 
collection. The crystals diffracted to 2.5 Å and 2.6 Å and were predicted to have two 
molecules in the AU. Molecular replacement using the maps from both CobB and 
CobH were used to try to solve the structures. However, the data collected was of 
poor quality and it was not possible to solve the structure. Further optimisation of this 








The crystal structures of CobH, an enzyme involved in methyl rearrangement of 
precorrin 8 to HBA, have previously been solved from a number of bacterial systems 
including P. denitrificans (Shipman et al 2001), R. capsulatus (Deery et al 2012) and 
B. melitensis (Seattle Structural Genomics PBS. 3E7D not published, no HBA bound). 
CobH catalyses the methyl group migration from C11 to C12 of the corrin ring 
(Shipman et al. 2001; Deery et al. 2012).  
CobH crystallises as a homodimer with two molecules in the asymmetric unit, where 
one molecule of each forms the interphase to complete the dimer.  The structure of 
CobH shows a highly conserved region of amino acids that project into the active site 
of each monomer. These polar residues generate an extensive hydrogen bonding 
network between the side chains and the carboxylates on the corrin ring (Shipman et 
al. 2001) (Deery et al. 2012).   
In the B. melitensis structure of CobH there is one molecule of HBA bound to 
monomer A leaving monomer B empty. However, in the R. capsulatis structure with 
HBA bound both sites have HBA present. The lack of full occupancy in the B. 
melitensis structure may represent an artefact of the crystallisation process. 
An overview of the B. melitensis apo structure with the R. capuslatus CobH (two HBA 
molecules bound) structure shows that there are pronounced changes in the side 
chains within the active site when HBA is bound between the two species. In the 
bound structure Arg115 flips between two conformations where it folds into the active 
site binding to HBA and moving away from the active site in its absence (Figure 5.24 
and 5.25). Overall it looks as if most of the side chains within the active site change 





Figure 5.24: Ribbon diagram of B. melitensis CobH apo structure (green) overlaid with 
R. capsulatus CobH HBA bound (cyan). R114 from B. melitensis and R115 R. capsulatus 
show movement of this residue in the bound structure and unbound. Y12 from B. melitensis 
and R13 from R. capsulatus also show a change in conformation. 
  








Figure 5.25: Ribbon diagram of B. melitensis CobH native structure (green) overlaid 
with R. capsulatus CobH HBA bound (cyan) (2). Different view of the changes in bound and 
unbound residues. 
Due to the transient nature of the CobH.CobB reaction, crystals of the complex were 
not generated. In order to try and obtain structural data of the complex a technique 
involving crosslinking of the two enzymes was employed. Three crosslinkers were 
used varying in the length of their spacer arm. The most promising results came from 
the shortest spacer arm of 3 Å (DFDNB), however, SDS PAGE did show two separate 
bands, which corresponded to the same molecular weight as the two enzymes (CobH 
and CobB). This was not what would be expected, as DFDNB is a covalent 
crosslinker. Therefore, under denaturing conditions you should still expect to see the 
complexed protein. This sample was put into crystallisation trials, and very small 
crystals were obtained. The crystals were sent to the DLS for data collection. One 
data set was collected but the diffraction data was too low resolution, anisotropic and 
had ice rings, so no structure was obtained.  
The binding of HBA to CobB was investigated in the presence of CobH in order to 
determine whether CobH has an effect on mediating the direct metabolite transfer of 




HBA from CobH to CobB. Three separate Stopped flow experiments were used to 
investigate this reaction. Firstly varying the concentration of HBA, secondly CobB and 
thirdly CobH.  
The initial results where CobH is present and HBA is varied show a two phase reaction 
which is identical to CobB binding HBA when HBA s varied (Chapter 4). When CobB 
has ATP/Mg2+/Gln present the Kd is the same as HBA binding CobB, when no CobH 
is present (2.0 µM for both). However there is a difference in the rate of the reaction, 
with CobH present, this reaction is two-fold faster than without (CobB/ATP/Gln/Mg2+ 
+ CobH/ ATP/Gln/Mg/HBA = 1.4 )M-1 s-1 compared to CobB + ATP/Gln/Mg/HBA = 
0.62 )M-1 s-1). This suggests that the presence of CobH in this interacting with CobB 
induces a conformational change in the active site of CobB. This more open 
conformation results in a quicker rate of binding. When the reaction is carried out 
again this time with no ATP or Gln present in CobB or CobH the Kd is two-fold weaker 
(1 )M), however the rate of the reaction is almost the same (1.5 )M-1 s-1). The next 
reaction was with CobB/Mg only + CobH/ATP/Gln/Mg/HBA, the Kd for this reaction 
was 0.672 )M. CobH has Gln present, as this is not required for enzyme activity the 
free molecule of Gln may have passed from CobH to CobB, this would account for 
the slightly tighter binding affinity of HBA to CobB. In all of the previous reaction in 
Chapter 4 the binding affinity of HBA was always tighter when Gln was present with 
CobB. As there is no crystal structure with Gln bound it is inconclusive regarding the 
effects Gln has on the enzyme. 
The second experiment was carried out, this time varying the concentration of CobB 
and keeping CobH/HBA at a constant concentration (1 )M:1 )M). This resulted in a 
single phase reaction which is consistent with the transfer of a single HBA molecule 
to the CobB dimer. This is not surprising as there is an excess of CobB and a limited 
number of HBA molecules present to fully occupy the enzyme. The experiment was 
run again this time CobH/HBA (1 )M:1 )M) was in the presence of ATP/Mg/Gln. As 
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expected this was again a single phase reaction. However the addition of ATP and 
Gln change the Kd values from Kd = 0.625 )M to 0.189 )M, which is 3 fold tighter 
binding and a four-fold decrease in the rate of the reaction  (3.2 )M-1 s-1 and 0.189 
)M-1 s-1 respectively). This results are consistent with what we are seeing in all of the 
Stopped flow reactions where the presence of Gln increases the affinity for HBA 
binding CobB. The increased affinity in these two reactions could also be the fact that 
there is no turnover of HBA to HBAD as there is no ATP present in the CobB sample. 
The third assay to be run was this time varying the concentration off CobH/HBA and 
keeping the concentration of CobB constant (1 µM). This experiment was problematic 
and did not initially give usable data. The experiment was run for over 100 sec (normal 
exposure 10 sec) in order to obtain a result. A second experiment was carried out this 
time by varying CobH only and keeping CobB and HBA at a concentration of 1 µM. 
This reaction as less problematic and gave the exact same result as CobB + 
CobH/HBA (1 µM:1 µM) with Kd = 2 µM. The most interesting fact is by increasing the 
concentration of CobH results in an increase of  kobs in both reactions (0.25 s
-1 and 
0.26 s-1). This indicates that CobH appears to help promote the binding of HBA to 
CobB. 
In summary the binding of HBA to CobB is dependent upon the concentration of 
CobH. As expected, the binding of HBA to CobB is not as fast with free HBA as 
reported in Chapter 4, but as outlined in Chapter 4 the CobB.HBA complex is 
stabilised in the presence of Gln. Given the tight association of HBA with CobH, the 
fact that CobB is able to obtain HBA from the CobH.HBA complex indicates that the 
two proteins interact in a productive manner. Further work is required to investigate 










Production, purification and crystallisation 
of the CobQ enzymes from Allochromatium 








Adenosylcobyrinic acid a,c-diamide acts as the substrate for the second amidase 
enzyme in the pathway, CobQ (Debuscche et al. 1990). In a similar reaction to that 
catalysed by CobB, CobQ amidates the carboxylic acids found on side chains b, d, e 
and g. These series of four amidations transform adenosylcobyrinic acid a,c-diamide 
into adenosylcobyric acid (Figure 6.1).  
  
 
 Figure 6.1: Amidation of adenosylcobyrinic acid a, c-diamide to adenosylcobyric acid. 
Figure shows the amidation at positions b, d, e and g on the corrin ring. 
CobQ firstly amidates the carboxylate acid side chain at position e, followed by 
positions d, b and g. It is believed that on partial amidation of e the intermediate 
dissociates from the active site and re-orientates at position b, d and g sequentially 
(Fresquet, Williams and Raushel 2007). Interestingly, CobQ amidates three 
propionate side chains and one acetic acid side chain, so the enzyme displays a level 
of variability in terms of its regio-specificity. The aim of this chapter was to learn more 
about the structure of CobQ and understand how the enzyme affords its regio-
specificity given that it amidates side chains on different poles of the substrate. The 
structure would also allow a direct comparison with CobB and would thus give an 
























primary sequence in relation to CobB and CobQ (Chapter 4, Figure 4. ), both enzymes 
have a typical ATP binding site and GAT domain binding site, and belong to a family 
of proteins termed Gln dependent amidotransferses. These enzymes share typical 
features such as a Gln deaminase (GAT) domain and an ATP hydrolysing synthetase 
domain where it is attached to phosphorylated carboxyl group of the substrate that is 
to be amidated. Both enzymes have conserved residues in the N-terminal domain 
which show a walker motif (p-loop) which is typical for this family of proteins. There 
are a number of conserved residues with regard to secondary structure between the 
two enzymes see Figure 1.8 (Galperin and Grishin 2000). In this family of proteins the 
ATP binding domain shows little homology other than the motifs involved in ATP 
binding. 
The C-terminal domain classified as the GAT domain falls into two groups, both CobB 
and CobQ although not officially classified as type 1 Gln amidotransferses, homology 
wise fall into this class. This is due to the presence of a catalytic triad (C366, 425E 





6.2.1 Recombinant production of A. vinosum, B. melitensis 
and R. capsulatus CobQ 
In order to overproduce the various CobQ enzymes E. coli strain BL-21 (DE3) pLysS 
was transformed with pET14b vectors harboring the various cobQ genes (from A. 
vinosum, B. melitensis and R. capsulatus) (Dr. Evelyne Deery). The encoded gene 
products allow for the production of the various recombinant CobQs with an N-
terminal His6-tag. 
The 3 E.coli strains each harbouring a cobQ gene from a different organism (A. 
vinosum, B. melitensis and R. capsulatus) were streaked on agar plates containing 
chloramphenicol and ampicillin and grown overnight at 37 °C. A single colony was 
removed from each plate and inoculated into 3 separate 10 mL cultures of LB, 
containing antibiotics and grown overnight at 37 °C (see Chapter 2.2.7 for protocol).  
The following day the overnight cultures were transferred into 3 x 1 L flasks containing 
2YT broth with antibiotics and glucose. When the OD600 reached around 0.7 the 
cultures were induced with IPTG and left to grow for a further 3 hours. The cells were 
harvested and the pellet resuspended in 50 mL of 20 mM Tris-HCl buffer, pH 8.0, 
containing 500 mM NaCl and 20 mM imidazole, and frozen at -20 °C. When required 
the cells were lysed by sonication and centrifuged for a second time to remove the 





6.2.2 Purification of His6-tagged Allochromatium vinosum 
CobQ 
Approximately, 60 mL of supernatant from the E. coli strain overproducing the A. 
vinosum CobQ was loaded to a Ni-sepharose column. Fractions from the elution 
buffer containing 300 mM imidazole were collected (Figure 6.2). The collected 
samples were run through a PD10 column into ion exchange buffer (Buffer A: 20 mm 
Tris-HCl, pH 8.0, containing 150 mM NaCl and 2 mM MgCl2) in order to remove the 
imidazole as the protein was found to be unstable if left overnight in the elution buffer. 
The final purification step was carried out using an ion exchange column (MonoQ) 
and the protein eluted by running a gradient between buffer A and buffer B (Buffer B: 
20 mM Tris-HCl, pH 8.0, containing 1 M NaCl and 2 mM MgCl2). The purified protein 
eluted from the column in ~ 250 mM NaCl. The peak fractions were run on an SDS 
PAGE gel (Figure 6.3) and the protein fractions that contained protein were collected 






Figure 6.2: 10% SDS PAGE gel of A. vinosum CobQ from Ni column. Lane 1 contains 
protein markers of known molecular mass, as shown, Lane 2 Supernatant pre-column, 
Samples 3, 4 and 5. Peak 1 from chromatograph, Lane 6, 7, 8 and 9, 2 mL samples collected 





Figure 6.3: A. vinosum CobQ from Ion exchange column. 10% SDS PAGE gel showing 
purified CobQ, from ion exchange column. Two large bands are CobQ 
6.2.3 Purification of His6-tagged Brucella melitensis CobQ 
The recombinant E. coli cell extract containing the overproduced His6-tagged B. 
melitensis CobQ (~60 mL supernatant) was loaded onto a Ni-sepharose column. The 
protein was eluted from the column in elution buffer containing 250 mL imidazole and 
the CobQ-containing fractions were pooled (Figure 6.4). Following this the CobQ was 
run through a PD 10 column to remove imidazole and the same protocol applied as 
described in Section 6.1.2. This enzyme eluted from the ion exchange column in 350 
mM NaCl. The purified protein, determined from SDS PAGE (Figure 6.5) was 
aliquoted and stored at -20 °C.  
 






Figure 6.4: B. melitensis CobQ SDS PAGE gel from Ni column. Lane 1. contains protein 
markers of known molecular mass, as shown, Lane 2. Pre-column A. vinosum CobQ, Lane 3, 
4, 5, 6 and 7 peak 1. Lane 8, 9 and 10 peak 2. Purified B. melitensis CobQ in peak 2.  
   
Figure 6.5: B. melitensis CobQ SDS PAGE gel from ion exchange. Lane 1, contains 
protein markers of known molecular mass, as shown, Lane 2 and 3 (A12 to B13). No sample, 
Lane 4-6. CobQ in samples 4, 5 and 6.  










1        2        3       4       5       6       7       8       8         9
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6.2.4 Purification of His-tagged R. capsulatus CobQ 
A cell extract from the E. coli strain overproducing recombinant His6-tagged R. 
capsulatus CobQ was applied to a Ni-sepharose column (~60 mL of supernatant). 
The protein was found to elute from the column in elution buffer containing 300 mM 
imidazole. CobQ-containing fractions were identified by SDS-PAGE and were pooled 
(Figure 6.6).  
 
  
Figure 6.6: R. capsulatus CobQ from Ni column. (a) Chromatogram showing large protein 
peak of R. capsulatus CobQ (samples A9 to B15). These samples were collected and run on 
an SDS gel. (b) SDS PAGE gel Lane 1: contains protein markers of known molecular mass, 
as shown, Lane 2 & 3: contains flow through from the column, Lane 4: A9, A10 and A11, Lane 
5: A12, A13 and A14, Lane 6: A15, B15 and B14. Fractions from samples 4, 5 and 6 were 
collected .  
 250 
The collected fractions were run through a PD10 column and applied to an ion 
exchange column, where the protein eluted at around 300 mM NaCl (Figure 6.7). 
 
Figure 6.7: R. capsulatus CobQ from ion exchange column. Lane 1, contains protein 
markers of known molecular mass, as shown, Lane 2-6 A13 to B14. Protein was found to be 
in samples A15, B15 and B14. 
6.3 Thermostability measurement of A. vinosum CobQ 
For most CobQ enzymes, their corrin substrate is adenosylcobyrinic acid a,c-diamide, 
However, as A. vinosum is able to produce cobalt-free corrinoids it seems likely that 
the A. vinosum CobQ is able to amidate HBAD directly and must therefore be able to 
bind HBAD. In order to determine if the A. vinosum can bind HBAD, and also to 
identify the conditions under which CobQ is most stable, a thermostability assay of 
the reaction was generated. Here, the protein was subject to a temperature gradient 
from 25°C to 80°C, as the protein starts to unfold the dye (sypro orange) binds to the 
hydrophobic core of the enzyme resulting in a fluorescent signal (Santos et al. 2012). 
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A change in Tm value will give a good indication of whether there is a stabling effect 
on binding ligand, anything over 2 °C can be considered relevant. The other 
techniques that can be used to measure protein stability is Dynamic Light Scattering 
(DLS), but this method was unavailable.  
The A. vinosum CobQ sample was analyzed in this way in the presence and absence 
of substrates in order to determine if HBAD-binding had a monitorable effect on the 





Figure 6.8: Melting temperatures for A. vinosum CobQ. (a) CobQ only (purple), 


























































Table 6.1 Showing change in melting temperatures for A. vinosum CobQ. 
Enzyme Tm (Temperature melt) ∆Tm 
A. vinosum CobQ only 47 °C 0°C 
A. vinosum CobQ with 
ATP/Gln/HBAD 
51 °C 4°C 
A. vinosum CobQ/HBAH 47 °C 0°C 
A. vinosum CobQ/ATP 51 °C 4°C 
 
From the thermofluor results there is a clear 4 °C increase in the thermal stability of 
CobQ when it binds ATP and HBAD/ATP/Mg2+. This indicates that CobQ from A. 
vinosum has increased stability in the presence of ATP. 
6.4 MicroScale Thermophoresis (MST) 
6.4.1 MST analysis of A. vinosum binding HBAD 
To look more closely at binding of the A. vinosum CobQ with HBAD a MicroScale 
Thermophoresis (MST) assay was employed. This is a method commonly used for 
the characterisation of intermolecular reactions. It has a number of advantages over 
other technologies, including the use of very small amounts of protein to give accurate 
readings. For this assay a Tris-NTA (Tris-nitrilotriacetic acid) with an oligohistidine tag 
(Figure 6.9)  was used to bind the His-tag of CobQ. This gives a high fluorescence 
signal and an optimal signal to noise ratio in microscale thermophoresis (MST). The 
RED-tris-NTA was found to be the optimal dye conjugate, this molecule has a high 
affinity towards histidine tags. Red-tris-NTA has emission in the red region of the 
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spectrum, and enables reliable measurements of complex biological matrices. By 
binding to the histidine tag of CobQ the binding reaction can then be monitored 
(Jerabek-Willemsen et al. 2014; Bartoschik et al. 2018). 
 
Figure 6.9: Labelling of protein with fluorescent dye. (A) Structure of Ni-NTA showing 
linker with bound fluorophore, typical fluorophores used in MST, NT647 (red), NT547 (green) 
and Orgeon green 488 (blue). (B) Schematic representation of the conjugate (Dye-Ni-NTA), 
which has Ni(II) ions enabling site specific labelling of the his-tagged protein (Bartoschik et al. 
2018).  
His-tagged A. vinosum CobQ was first labelled with the fluorescent dye (Red-Ni-NTA)  
using the protocol in Chapter 2 (2.5.1). The unlabelled molecule (HBAD) was then 
added to the enzyme. In total 16 eppendorf samples were labelled 1 to 16, in sample 
1: 20 µL of the ligand solution is added. To the remaining 15 samples,10 µL of PBS 
was added. Serial dilutions are then employed, taking 10 µL from sample 1 and mixing 
with sample 2, removing 10 µL from sample 2 and mixing with sample 3 this is 
continued until all of the 16 samples have protein (protocol 2.5.2). The labelled 
samples are then loaded into glass capillaries using capillary action. Overview of the 
procedure is shown in Figure 2.1 
Sixteen glass capillaries were loaded with increasing concentrations of labelled 
enzyme, these samples are used for analysis. (see protocol 2.5.2).  The samples were 
run a number of times but did not give usable data.  This indicates that A. vinosum 
CobQ from this sample did not bind HBAD.  
Red-Ni-NTA Fluorophores Dye-Tris-NTA bound to histidine tagged protein
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6.5 Crystallisation of CobQ from A. vinosum, B. melitensis and 
R. capsulatus  
The Molecular Dimensions screens 1 and 2 were used for initial screening of CobQ 
from A. vinosum, B. melitensis and R. capsulatus in crystallisation trials. Each of the 
three proteins was concentrated to 4 mg/mL in the presence of AMPPNP (5 uM) using 
purified protein. The protein to precipitant concentration was 2:1 (2 µL of protein and 
1 µL of well solution). The crystal trays were monitored on a day to day basis.  
6.5.1 Crystals of A. vinosum CobQ 
After two days of screening, very fine needles were observed in a condition containing 
1.6 M magnesium sulphate and 0.1 M MES, pH 6.5, for the A. vinosum CobQ (Figure 
6.10). By optimisation of the magnesium sulphate  concentration a usable crystal was 
obtained (Figure 6.10). This crystal was archived using well solution and 25% 
ethylene glycol and flash frozen in liquid nitrogen. The crystal was sent to the DLS but 










(a)                                                                             (b) 
 
Figure 6.10: Crystals of A. vinosum CobQ. (a) Initial crystals appeared after two days, 
grown from 1.6 M magnesium sulphate and 0.1 M MES, pH 6.5 (very fine needles). (b) 
Optimisation of the above condition gave single crystals. This crystal was of a quality required 
for X-ray diffraction. 
6.5.2 Crystallisation of CobQ from R. capsulatus 
Crystallisation of the R. capsulatus CobQ was investigated using Molecular 
Dimensions screens 1 and 2 and from this a number of hits were identified. All of the 
hits in wells containing phosphate were found to be salt, however, in the presence of 
AMPPNP one condition containing 0.2 M magnesium formate with trans 4-hydroxyl-
L-proline as an additive yielded a diffraction quality crystal (Figure 6.11). This crystal 





Figure 6.11: R. capuslatus crystals. Crystals were grown using 0.2 M Mg formate with trans 
4-hydroxyl-L-proline as an additive. Crystals took three days to grow and were sent to the DLS 
for data collection.    
This crystal diffracted to 4.5 Å, with a space group of P61 and cell dimensions of 
174.12 Å. 174.12 Å 146.14 Å, a = 90.00, b = 90.00 and g = 120.00. Although the 
structure was very low resolution an attempt was made to obtain the initial phases 
using the CobB structure. This, perhaps unsurprisingly, was unsuccessful since 
structure determination by molecular replacement generally requires much higher 
quality data. The best way forward would be to obtain higher quality CobQ crystals. 
6.6 Production and purification of HBAD and HBAH 
Adenosylcobyrinic acid a, c-diamide is the natural substrate for CobQ. This enzyme 
binds its substrate and amidates the carboxylates groups of position b, d, e and g of 
the ring resulting in the product adenosylcobyric acid. Crystals of the R. capsulatus of 
CobQ were obtained that diffracted to 4.5 Å, but due to poor resolution the structure 
was not solved. In order to increase the chance of obtaining crystals that would diffract 
to higher resolution, attempts were undertaken to make both the substrate and the 
product of the CobQ reaction, adenosylcobyrinic acid a,c-diamide and 
adenosylcobyric acid respectively. The binding of these compounds good potentially 
Picture 7 C2 Drop 4 Picture 8 C3 Drop 4
Picture 11 D5 Drop 3/trans 4-hydroxyl-L-proline Picture 12 D1 Drop 1
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stabilise the enzyme and lead to crystals that would diffract to higher resolution. As 
these molecules are not commercially available they must be produced in the lab. A  
A plasmid containing all the necessary enzymes to produce both HBAD and HBAH 
was obtained from Evelyne Deery, University of Kent. The resulting strain (E. coli 
BGEC043 with (T7P)-AIG*JFLMKLH-A lvBQ-E*) was produced using 2YTNN broth 
and described in Chapter 2. After overnight production the culture was harvested by 
centrifugation and the pellet was resuspended in 30 mL of ethanol. The supernatant 
was then boiled for 30 minutes in order to denature the protein and separate the 
protein from its product and substrate (HBAD and HBAH). Centrifugation removed the 
denatured protein leaving HBA and HBAD in solution. The two compounds were 
separated using reverse phase chromatography. They were then separated on a 
DEAE column, with HBAH flowing through the column. HBAD was then removed from 
the column using an increasing concentration of NaCl, eluting in 100 mM NaCl. The 
compounds were dried and stored at -20°C until required.  
6.6.1 Cobalt insertion to HBAD and HBAH  
In order to bind these compounds to CobQ two separate samples were prepared, 
sample 1: HBAD and sample 2: HBAH were resuspended in 0.5 mM cobalt acetate 
at pH 6.0 and left at room temperature on a small shaker for up to 4 days to secure 
full insertion of the cobalt. Both reactions (HBAD and HBAH) were run of a 
spectrophotometer, and scanned from 300 nm to 700 nm (Figure 6.12) both samples 




Figure 6.12: Cobalt insertion into HBAH. Trace shows HBAH after one day, with a typical 
absorption peak at 330 nm (black). After four days absorption peak moves from 330 nm to 350 
nm (red) showing typical absorption peak at 350 nm which signifies full incorporation of cobalt. 
6.7 Overexpression and purification of BtuR for adenosylation 
In order to attach the upper ligand to cobyrinic acid a,c-diamide the expression of 
BtuR (CobR) is required, as BtuR is the enzyme involved in the attachment of the 
ligand to the enzyme (Lawrence et al. 2008b).  
E. coli strain BL-21 (DE3) pLysS was transformed with pET14b carrying the BtuR 
gene resulting in the production of recombinant N-terminus His-tagged BtuR. The 
cells were grown in 2YT broth supplemented with ampicillin and chloramphenicol for 
6 hours at 18 °C till an OD600 of 0.6 . The cells were induced with IPTG and were 
allowed to grow for a further 24 hours at 18°C (as described in Chapter 2). After 
harvesting by centrifugation the cell pellet was resuspended in Tris-HCl buffer, pH 
8.0, containing 500 mM NaCl and 20 mM imidazole. The cells were then lysed by 
sonication and centrifuged for a second time to remove the cell debris. The protein 
was purified using a Ni chelate column and no further purification was necessary. 
Cobalt insertion HBAH
HBAH 1 day 330 nm
HBAH 4 days 350 nm
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From a 1 L culture ~20 mg of protein was produced. BtuR was run on a 10 % SDS 
PAGE gel and appeared as a single band with a molecular mass of 22 kDa (Figure 
6.13), which is in close agreement to the expected molecular mass of 21.986 kDa. 
The enzyme was found stable enough to be stored for periods of up to 6 months 
without any degradation. 
 
Figure 6.13: SDS PAGE gel of BtuR. Lane 1. contains protein markers of known molecular 
mass, as shown. Sample 2-5. 3 mL fractions from Ni column. All purified  samples of BtuR 
were pulled and stored at -20 °C. 
6.8 Adenosylation of cobalt HBAD and HBAH 
As described in Chapter 2 all the components for the reaction buffer were placed in 
an anaerobic chamber for 24 hours before sample preparation, in order to make sure 
no oxygen was present in the samples. As this reaction is not only oxygen sensitive 
but also light sensitive everything was wrapped in tin foil. The cobyrinic acid a,c-
diamide and cobyric acid with cobalt inserted were also placed in the chamber. The 
reactants were mixed and incubated again in the glove box for 24 hours. After 
incubation the sample was removed from the chamber, centrifuged and run through 
a reverse phase column (RP18), to remove any unbound material. 
BtuR Enzyme
1   2    3     4     5  
24 kDa
1. Marker




The product from the adenosylation assay using a UV-visible spectrometer was 
measured recorded 300 nm to 700 nm. The characteristic peak for the cobalt inserted 
substrate 350 nm was no longer present which signified that the adenosylation had 
been successful (Figure 6.14). 
 
Figure 6.14: Adenosylation of HBAH. (a) Adensolyted sample removed from glove box, with 
characteristic yellow colour. (b) Adensolyted sample run on UV shows loss of 350 nm peak 
(see figure 6.12) indicating adensilation.  
In order to verify that there was indeed adenosylation of the sample LC-MS analysis 
was undertaken (Dr. Andrew Lawrence, University of Kent). From the results there 
looks to be fragmentation of the sample in the run but there is a peak at 1186 Da 
which is the correct molecular mass for this product (Figure 6.15). 
 
 





Figure 6.15: LC-MS analysis of adenosylated HBAH. LC-Ms shows a number of fragmented 
peaks, adensolyted HBAH peak at 1186.46 m/z.   
6.9. Co-crystallisation trials of Rhodobacter capsulitis CobQ 
with adenosylcobyrinic acid a, c-diamide  
To the purified R. capsulatus CobQ at a concentration of 4 mg/mL adenosylcobyrinic 
acid a, c-diamide (only) was added at a concentration of 100 µM. Co-crystallisation 
screens were set up using Molecular Dimension screens 1 and 2. A single tray was 
prepared using the  condition that gave the initial diffracting crystals (0.2 M 
magnesium formate with trans 4-hydroxyl-L-proline) was also set up. Crystal trays 
were checked daily, but no crystals were observed. Further work is required to obtain 































400 600 800 1000 1200 1400 m/z
200 300 400 500 600 700 Wavelength [nm]
 263 
6.10 Discussion 
There are two enzymes involved in the six amidations of the side chains on the corrin 
ring, and these are CobB and CobQ. CobB has already been discussed in Chapter 3 
and 4, whilst CobQ was the focus of this chapter. In order to increase the chances of 
obtaining structural information for CobQ, a number of CobQs from a range of bacteria 
were investigated for their suitability for crystallisation. Recombinant CobQs from A. 
vinosum, B. melitensis and R. capsulatus were expressed and purified from E. coli. 
Each of these proteins could be purified to homogeneity and behaved well when 
stored at -20 °C.  
The added difficulty in obtaining a structure of CobQ is in the fact that binding of 
substrate only takes place after cobalt insertion and adenosylation. It was however 
reported that CobQ from A. vinosum was able to amidate the carboxylates on the 
corrin ring prior to cobalt insertion. When A. vinosum was supplemented with 
dimethylbenzimidazole (the lower ligand bound to cobalamin) this resulted in a 
compound that was identical to cobalamin (Koppenhagen and Pfiffner 1971). 
In order to determine if this looked to be possible a thermofluor assay was set up. 
This assay did show an increase in stabilisation when ATP/Gln/HBAD were present, 
however, CobQ/ATP gave the same increase of 4 °C which could infer the 
stabilisation is due to the effects of ATP. In order to look more closely at this reaction 
an MST assay was run. No readable results were obtained which indicated that using 
this assay could not confirm binding.  
A number of crystallisation trials were carried out which eventually resulted in a data 
set being collected for the R. capsulatus CobQ that was grown in the presence of 
AMPPNP. However, this crystal only diffracted to very low resolution (4.5 Å). 
Unfortunately, due to the low resolution and the fact that the CobB structure has only 
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15% identity between the two sequences no structural information was obtained. 
 In order to add stability to the enzyme and hopefully increase the chance of obtaining 
crystals, attempts were made to crystallise the protein in the presence of either its 
corrin substrate or corrin product. The substrate and product, adenosylcobyrinic acid 
a,c diamide and adenosylcobyric acid had to be produced from HBAD and HBAH. 
This synthesis was successful as determined by the UV visible analysis and the mass 
spectroscopy data (see Figure 6.14 and 6.15).  
However, attempts to crystallise CobQ in the presence of either the corrin substrate 
or product were not successful. Due to the limited time in which to work with this 
complex no further trials have been attempted. However, there is still plenty of scope 
to explore the structure of CobQ in the future. Optimisation of the crystals that 























7.1 General discussion 
The knowledge and understanding of the biosynthetic pathways for cobalamin has 
come a great way since the structure of B12 was initially determined and the chemical 
synthesis of this molecule was first described (Woodward 1973.; Eschenmoser and 
Wintner 1977) (Quadros 2010). However, there are still several enzymes within the 
known biosynthetic pathways for cobalamin biogenesis that have not been fully 
characterised. A complete molecular understanding of the role played by the 
individual enzymes of the cobalamin pathway is important not only from a 
fundamental scientific standpoint, since it helps explain the molecular logic 
underpinning the process (Deery et al. 2013), but it can also be advantageous in 
exploiting the pathway to enable improved production of this essential nutrient and in 
the development of anti-vitamin molecules that interfere with B12-dependent 
processes. 
The aim of the research described in this thesis was to gain structural information on 
the enzymes that perform the amidations of the peripheral side chains of the corrin 
ring, namely CobB and CobQ. In fact, CobB proved to be the more amenable of the 
proteins to structural studies. This enzyme is responsible for amidating the a and c 
propionic acid side chains (Debuscche et al. 1990).  
The X-ray crystal structure of Brucella melitensis CobB shows that the protein exists 
as a homodimer, where each subunit is composed of two globular domains. Dimer 
formation is mediated through interactions between helices 5 and 6 from each 
monomer (Chapter 3 Figure 3.23). CobB is composed of an N-terminal domain that 
binds ATP and the corrin substrate, and a C-terminal (GATase) domain that binds Gln 
as the amido donor (Debuscche et al. 1990).  
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In the C-terminal domain Gln is hydrolysed to glutamate and ammonia. The GATase 
domain belongs to the triad family of amidotransferase domains, which normally 
contain an active site with a conserved hydrogen bonded Cys-His-Glu arrangement 
(Raushel, Thoden and Holden 1999). However, in CobB the glutamic acid is not 
conserved when CobB is aligned with GATase family members (Raushel, Thoden 
and Holden 1999). Nonetheless, there is an alternative glutamic acid in the CobB 
family of proteins that is conserved (Glu326). From the structure of CobB it is clear 
that Glu326 is able to interact with His427 and Cys 327 and generate a catalytic triad 
(Figure 7.1). The glutamic acid acts to align and polarise His 427, which then activates 
the nucleophilic Cys327 (Bairagya and Bansal 2016). The triad reduces the pKa of the 
nucleophilic cysteine which then attacks the substrate, allowing the release of 
ammonia from Gln and generating glutamic acid. Attack on the amido group of Gln 
leads to the formation of an oxyanion, which is stabilised in the oxyanion hole of CobB 
by the presence of positively charged backbone amides, all of which helps to stabilise 
the charge build up on the substrate transition state. Mechanistically, the active site 
His427 activates Cys327 for nucleophilic attack on the carboxyamide moiety of Gln 
to form a thioester intermediate, which leads to the release of ammonia (Bairagya and 
Bansal 2016).  
The released ammonia is channelled from the GATase domain to the 
aminotransferase domain located in the N-terminal region of the protein so that it can 
be used to amidate the appropriate side chain on the corrin ring (Debuscche et al. 
1990). The distance between the two domains is 17.7 Å (Chapter 3 Figure 3.30), and 




Figure 7.1 C-terminal binding site of CobB. Showing conserved histidine and cysteine, 
Glu326 conserved in CobB bacterial enzymes. 
When CobB binds the corrin substrate in the N-terminal domain there is evidence of 
two distinct binding events, one of which is fast and one that is slow. This very likely 
represents the binding of corrin substrate to monomer A and then binding of a second 
corrin substrate to monomer B. This is evident from the observed kinetic data, which 
shows the rate of binding is much faster to monomer A than to B. This mechanism 
suggests negative co-operative feedback, which may be employed to control the rate 
of the enzyme, particularly its Gln hydrolysing activity since this could deplete levels 
of Gln within the cell if left unregulated. 
CobB binds ATP in the same N-terminal active site of monomer A where the corrin 
substrate binds. The binding of ATP results in a slight change of conformation in the 
protein and decreases the rate at which HBA binds. HBA binds in an orientation that 
allows for the amidation of the C7 position on the ring to take place (Debussche et al. 
1990). The carboxylate is able to promote the displacement of the terminal phosphate 
of ATP, generating ADP and a phosphorylated carboxylic acid. Ammonia, transferred 
to the active site from the GAT domain by a molecular tunnel, then acts as a 
nucleophile to displace the phosphate from the carboxylic acid, resulting in the 




leaves the active site, rotates 90° before being re-positioned in the active site with the 
C2 propionate side chain close to the ATP binding sight, and the process is repeated 
(Figure 7.2).   
The negative cooperativity of substrate binding suggests that the enzyme follows a 
sequential model in which binding of substrate to one monomer induces a change in 
the other monomer. In the crystal structure the unstructured region (Phe176 to 
Leu183) from each monomer is involved in substrate binding to the opposite 
monomer. When there is no substrate in the active site, Arg177 in the unstructured 
region moves away from the HBA binding site of the opposite monomer and the other 
residues looks to fold round the ATP binding site of their own monomer. However, 
when HBA is present in the active site, Arg177 from the opposite monomer (B) 
interacts with the side chain attached to C18 of the corrin ring present in monomer A, 
whilst the other residues from Ala180 to Leu183 in monomer B flip away from the ATP 
binding site. This scissor like mechanism explains the difference in affinity and binding 
rate between the two monomers. When HBAM is in the active site and C2 is 
positioned in a conformation ready for amidation, the Arg177 now interacts with C13 
on the ring.
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Monomer A of CobB
Figure 7.2 Mechanism by which CobB binds HBA. The pathway shows the structure of 
CobB (only), binding Mg2+ and ATP which has been converted to ADP and free phosphate in 
the second structure. The third structure shows HBA binding CobB where the free phosphate 
and Mg2+ are visible. The next part of the reaction is the formation of a phosphorylated 
intermediate at position C7 (no crystal structure). This phosphorylated intermediate then 
undergoes amidation, and the mono amide leaves the active site rotates 90 °C and re-binds 
with the C2 position  ready to be amidated (structure shown in pathway). The next structure 
shows the phosphorylated intermediate at the C2 position. Once this is amidated the product 





CobQ, the second enzyme in the amidation process, amidates adenosylcobyrinic acid 
a, c-diamide to produce adenosylcobyric acid. As with CobB, CobQ is also a 
multifunctional enzyme, amidating four side chains on the ring (b, d, e, g) (Francis 
Blanche et al. 1991). Given the sequence similarity between CobB and CobQ it is 
highly likely that the these two enzymes will have a similar overall topology, reflecting 
the fact that they mediate a similar catalytic process albeit at different sites on the 
corrin ring. A crystal of CobQ was obtained, which diffracted to 4.5 Å resolution but 
unfortunately the structure could not be solved due to the poor resolution.  
Obtaining a crystal structure of CobB enabled a closer look at the possible interaction 
that CobH may have with CobB since these two protein catalyse consecutive steps 
in the pathway. The crystal structures of CobH (Shipman et al. 2001) and CobB are 
such that it is plausible to suggest that an interaction may take place that enables 
CobH to release its product to CobB (Figure 5.9). CobH is known to binds its product, 
HBA, very tightly and it has been speculated that an interaction with the following 
enzyme in the pathway could allow for direct metabolite transfer (Miles, Rhee and 
Davies 1999; Huang, Holden and Raushel 2001). However, no strong interaction has 
been observed between CobH and CobB so therefore any interaction is likely to be 
transient. Indeed, attempts to generate a crystal of a complex between CobH and 
CobB were not successful. However, stopped-flow analysis was used to investigate 
the occurrence of transient interactions between the two proteins (Toseland and 
Geeves 2014), since the absorbance spectrum of HBA to CobH differed from HBA 
bound to CobB.  
In this way it is possible, using HBA-loaded CobH, to follow the transfer of HBA to 
CobB. This provides the first evidence that a direct interaction between CobH and 




of that specific interaction, which is favoured if CobB is also loaded with ATP and Gln. 
Further investigations, involving mutagenesis of specific amino acid residues, would 
be required in order to understand fully the process that leads to the release of HBA 
from CobH. 
Obtaining structural and kinetic information on CobB has enabled a clearer insight of 
the mechanism by which the amidation process takes place during corrin ring 
synthesis. This project has, therefore, not only provided the first detailed structural 
characterisation of one of the amidases involved in cobalamin biogenesis but it has 
also opened the possibility of exploring, in molecular detail, the process by which the 
enzymes involved in the pathway are able to ensure that their precious biosynthetic 










Acuner Ozbabacan, S.E. et al. (2011). Transient proteinprotein interactions. Protein 
Engineering, Design and Selection 24:635–648. 
Astner, I. et al. (2005). Crystal structure of 5-aminolevulinate synthase, the first 
enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO Journal 
24:3166–3177. 
Bairagya, H.R. and Bansal, M. (2016). New insight into the architecture of oxy-anion 
pocket in unliganded conformation of GAT domains: A MD-simulation study. 
Proteins: Structure, Function and Bioinformatics 84:360–373. 
Banerjee, R. and Ragsdale, S.W. (2003a). The Many Faces of Vitamin B 12 : 
Catalysis by Cobalamin-Dependent Enzymes. Annual Review of Biochemistry 
72:209–247.  
Banerjee, R. and Ragsdale, S.W. (2003b). The Many Faces of Vitamin B 12 : Catalysis 
by Cobalamin-Dependent Enzymes. Annual Review of Biochemistry 72:209–
247. 
Barak, A.J., Beckenhauer, H.C. and Tuma, D.J. (2002). Methionine synthase. Alcohol 
26:65–67. 
Bartoschik, T. et al. (2018). and purification-free protein labeling for quantitative 
protein interaction analysis by MicroScale Thermophoresis. Nature 
Communications:1–10. 






Battersby, A.R. (1978). The discovery of nature’s biosynthetic pathways. Experientia  
34:1–13.  
Beale, S.I. and Castelfranco, P.A. (1973). 14C incorporation from exogenous 
compounds into δ-aminolevulinic acid by greening cucumber cotyledons. 
Biochemical and Biophysical Research Communications 52:143–149. 
Blanche, F. et al. (1991). Biosynthesis of Vitamin B12 : Stepwise Amidation of 
Carboxyl Groups b , d , e , and g of Cobyrinic Acid a , c-Diamide Is Catalyzed by 
One Enzyme in Pseudomonas denitrificans. Journal of Bacteriology 173:6046–
6051. 
Blanche, F. et al. (1993). Parallels and Decisive Differences in Vitamin B12 
Biosyntheses. Angewandte Chemie-international Edition - ANGEW CHEM INT 
ED 32:1651–1653. 
Blanche, F. et al. (1992). Precorrin-6x Reductase from Pseudomonas. Journal of 
Bacteriology 174:1036–1042. 
Blanche, F. et al. (1991). Purification , Characterization , and Molecular Cloning of S-
Adenosyl- L-Methionine : Uroporphyrinogen III Methyltransferase from 
Methanobacterium ivanovii. Journal of Bacteriology 173:4637–4645. 
Blanche, F. et al. (1995). Vitamin B12: How the Problem of Its Biosynthesis Was 
Solved. Angewandte Chemie International Edition in English 34:383–411.  
Bollivar, D.D. (2006). Recent advances in chlorophyll biosynthesis - Semantic 
Scholar. :173–194. 
Briani, C. et al. (2013). Cobalamin Deficiency: Clinical Picture and Radiological 





Bridwell-Rabb, J., Grell, T.A.J. and Drennan, C.L. (2018). A Rich Man, Poor Man 
Story of S-Adenosylmethionine and Cobalamin Revisited. Annual Review of 
Biochemistry 87:555–584.  
Broderick, J.B. (2001). Coenzymes and Cofactors. Encyclopedia of Life Sciences. 
Cameron, B. et al. (1991). Genetic analysis, nucleotide sequence, and products of 
two Pseudomonas denitrificans cob genes encoding nicotinate-nucleotide: 
dimethylbenzimidazole phosphoribosyltransferase and cobalamin (5’-
phosphate) synthase. Journal of Bacteriology 173:6066–6073. 
Coot: model-building tools for molecular graphics - Emsley - 2004 - Acta 
Crystallographica Section D. 
Cowtan, K. (2006). The Buccaneer software for automated model building. Acta 
Crystallographica 62:1002–1011. 
Crouzet, J. et al. (1991). Nucleotide Sequence and Genetic Analysis of a 13 . 1-
Kilobase-Pair Pseudomonas denitrificans DNA Fragment Containing Five cob 
Genes and Identification of Structural Genes Encoding Cob ( I ) alamin 
Adenosyltransferase , Cobyric Acid Synthase , and Bifuncti. Journal of 
Bacteriology 173:6074–6087. 
Dailey, H.A. (2013). Illuminating the black box of B12 biosynthesis. Proceedings of 
the National Academy of Sciences 110:14823–14824. 
Dailey, H.A. et al. (2017). Prokaryotic Heme Biosynthesis: Multiple Pathways to a 







Debuscche, L. et al. (1990). Purification and characterization of cobyrinic acid a,c-
diamide synthase from Pseudomonas denitrificans. Journal of Bacteriology 
172:6239–6244. 
Debussche, L. et al. (1992a). Assay, purification, and characterization of 
cobaltochelatase, a unique complex enzyme catalyzing cobalt insertion in 
hydrogenobyrinic acid a,c- diamide during coenzyme B12 biosynthesis in 
Pseudomonas denitrificans. Journal of Bacteriology 174:7445–7451. 
Debussche, L. et al. (1992b). Assay, purification, and characterization of 
cobaltochelatase, a unique complex enzyme catalyzing cobalt insertion in 
hydrogenobyrinic acid a,c- diamide during coenzyme B12biosynthesis in 
Pseudomonas denitrificans. Journal of Bacteriology 174:7445–7451. 
Debussche, L. et al. (1993). Biosynthesis of the Corrin Macrocycle of Coenzyme B12 
in Pseudomonas denitrificans NCO2H. Journal of Applied Crystallography 
175:7430–7440. 
Debussche, L. et al. (1990). Purification and Characterization of Cobyrinic Acid a , c-
Diamide Synthase from Pseudomonas denitrificans. Journal of Bacteriology 
172:6239–6244. 
Debussche, L. et al. (1991). Purification and Partial Characterization of Cob ( I ) 
alamin Adenosyltransferase from Pseudomonas denitrificans. Journal of Applied 
Crystallography 173:6300–6302. 
Deery, E. et al. (2012). An enzyme-trap approach allows isolation of intermediates in 






Deery, E. et al. (2013). Europe PMC Funders Group An enzyme-trap approach allows 
isolation of intermediates in cobalamin biosynthesis. Nat Chem Biol. 8:933–940. 
E. Neill. Marsh, G.D.R. (2012). Adenosylcobalamin enzymes: Theory and experiment 
begin to converge. Biochimica et Biophysica Acta - Biomembranes 11:1154–
1164. 
Eccleston, J.F., Martin, S.R. and Schilstra, M.J. (2008). Rapid Kinetic Techniques. In: 
Biophysical Tools for Biologists, Volume One: In Vitro Techniques. Academic 
Press, pp. 445–477.  
Emsley, P. and Cowtan, K. (2004). Coot: Model-building tools for molecular graphics. 
Acta Crystallographica Section D: Biological Crystallography 60:2126–2132. 
Eschenmoser, A. (1988). Vitamin B12: Experiments Concerning the Origin of Its 
Molecular Structure. Angewandte Chemie International Edition in English 27:5–
39. Eschenmoser, A. and Wintner, C.E. (1977). Natural product synthesis and 
vitamin B12. Science 196:1410 LP-1420. 
Evans, P. (2006). Scaling and assessment of data quality. Acta crystallographica. 
Section D, Biological crystallography 62:72–82.  
Fan, C. and Bobik, T.A. (2008). The PduX Enzyme of Salmonella enterica Is an L -
Threonine Kinase Used for Coenzyme B 12 Synthesis *. Journal of Biological 
Chemistry 283:11322–11329. 
Fang, H., Kang, J. and Zhang, D. (2017). Microbial production of vitamin B12: a 
review and future perspectives. Microbial Cell Factories 16:15.   
 
Ferreira, G. and Gong, J. (1995). 5-Aminolevulinate Synthase and the First Step of 




Frankenberg, N., Moser, J. and Jahn, D. (2003). Bacterial heme biosynthesis and its 
biotechnological application. Applied Microbiology and Biotechnology 63:115–
127. 
Fresquet, V., Williams, L. and Raushel, F.M. (2007). Partial Randomization of the 
Four Sequential Amidation Reactions Catalyzed by Cobyric Acid Synthetase 
with a Single Point Mutation †. Biochemistry:13983–13993. 
Fresquet, V., Williams, L.K. and Raushel, F.M. (2004). Mechanism of cobyrinic acid 
a,c-diamide synthetase from Salmonella typhimurium LT2. Biochemistry 
43:10619–10627. 
Galperin, M.Y. and Grishin, N. V. (2000). The synthetase domains of cobalamin 
biosynthesis amidotransferases CobB and CobQ belong to a new family of ATP-
dependent amidoligases, related to dethiobiotin synthetase. Proteins: Structure, 
Function and Genetics 41:238–247. 
Gherasim, C., Lofgren, M. and Banerjee, R. (2013). Navigating the B 12 Road : 
Assimilation , Delivery , and Disorders of Cobalamin *. Journal of Biological 
Chemistry 288:13186–13193. 
Gu, S. et al. (2015). Crystal structure of CobK reveals strand-swapping between 
Rossmann-fold domains and molecular basis of the reduced precorrin product 
trap. Scientific Reports  5:16943.  
Hamza, I. and Dailey, H.A. (2012). One ring to rule them all: Trafficking of heme and 
heme synthesis intermediates in the metazoans. Biochimica et Biophysica Acta 
- Molecular Cell Research 1823:1617–1632. 
Hennig, M. et al. (1997). Crystal structure of glutamate-1-semialdehyde 




in structure and active site reactivity. PNAS 94:4866–4871. 
Hodgkin, D.C. et al. (1955). Structure of Vitamin B12 : The Crystal Structure of the 
Hexacarboxylic Acid derived from B12 and the Molecular Structure of the 
Vitamin. Nature 176:325–328. 
Holden, H.M., Thoden, J.B. and Raushel, F.M. (1998). Carbamoyl phosphate 
synthetase: A tunnel runs through it. Current Opinion in Structural Biology:8:679-
685. 
Huang, D.D. et al. (1958). The enzymatic synthesis of d-aminolevulinic acid. J 
Biological Chemistry 233:1214–1219. 
Huang, X., Holden, H.M. and Raushel, F.M. (2001). Channeling of Substrates and 
Intermediates in Enzyme-Catalyzed Reactions. Annual Review of Biochemistry 
70:149–180.  
Jahn, D. and Heinz, D.W. (2009). Biosynthesis of 5-Aminolevulinic Acid BT - 
Tetrapyrroles: Birth, Life and Death. In: Warren, M. J. and Smith, A. G. eds. 
Springer New York. New York, NY: Springer New York, pp. 29–42. 
Jerabek-Willemsen, M. et al. (2014). MicroScale Thermophoresis: Interaction 
analysis and beyond. Journal of Molecular Structure 1077:101–113.  
Johnson, C.L. V et al. (2001). Functional Genomic , Biochemical , and Genetic 
Characterization of the Salmonella pduO Gene , an ATP : Cob ( I ) alamin 
Adenosyltransferase Gene †. Journal of Bacteriology 183:1577–1584. 
Jordan, P.M. and Berry, A. (1981). Mechanism of action of porphobilinogen 
deaminase. Biochemical Journal 1:177–181. 
Ko, Y.H., Hong, S. and Pedersen, P.L. (1999). Chemical Mechanism of ATP 




Koppenhagen, V.B. and Pfiffner, J. (1971). c11-(5,6 obamide and Its Copper and Zinc 
Analogues*. 246. 
Kranz, R.G. et al. (2009). Cytochrome c Biogenesis: Mechanisms for Covalent 
Modifications and Trafficking of Heme and for Heme-Iron Redox Control. 
Microbiology and Molecular Biology Reviews 73:510–528. 
Laemmli, U.K. (1970). Cleavage of Structural Proteins during the Assembly of the 
Head of Bacteriophage T4. Nature227:680–685.  
Lawrence, A.D. et al. (2008a). Identification , Characterization , and Structure / 
Function Analysis of a Corrin Reductase Involved in. JBC 283:10813–10821. 
Lawrence, A.D. et al. (2008b). JBC Papers in Press . Published on February 8 , 2008 
as Manuscript M710431200. The latest version is at 
http://www.jbc.org/cgi/doi/10.1074/jbc.M710431200. JBC:1–22. 
Leeper, J. (1987). The biosynthesis of porphyrins, chlorophylls, and vitamin B12. 
Natural Product Reports 2(6):561–580. 
Leisico, F. et al. (2018). First insights of peptidoglycan amidation in Gram-positive 
bacteria-The high-resolution crystal structure of Staphylococcus aureus 
glutamine amidotransferase GatD. Scientific Reports 8:1–13. 
LENHERT, P.G. and HODGKIN, D.C. (1961). Structure of the 5,6-
Dimethylbenzimidazolylcobamide Coenzyme. Nature 192:937–938.  
Leslie, A.G.W. (2006). The integration of macromolecular diffraction data. Acta 
Crystallographica Section D: Biological Crystallography 62:48–57. 
Lobo, S. a L. et al. (2015). Staphylococcus aureus haem biosynthesis: 





Louie, G. V et al. (1992). Structure of porphobilinogen deaminase reveals a flexible 
multidomain polymerase with a single catalytic site. Nature 359:33–39.  
Ludwig, M.L., Drennan, C.L. and Matthews, R.G. (1996). The reactivity of B12 
cofactors: The proteins make a difference. Structure 4:505–512. 
Lundqvist, J. et al. (2009). The AAA+ motor complex of subunits CobS and CobT of 
cobaltochelatase visualized by single particle electron microscopy. Journal of 
Structural Biology 167:227–234.  
Martens, J.H. et al. (2002). Microbial production of vitamin B12. Applied Microbiology 
and Biotechnology 58:275–285. 
Martens, J.H. et al. (2014). Microbial production of VitaminB Microbial production of 
vitamin B 12. Applied Microbiology and Biotechnology 58:275. 
Mathews, M.A.A. et al. (2001). Crystal structure of human uroporphyrinogen III 
synthase. EMBO Journal 20. 
McFerrin, M.B. and Snell, E.H. (2002). The development and application of a method 
to quantify the quality of cryoprotectant solutions using standard area-detector 
X-ray images. Journal of Applied Crystallography 35:538–545.  
Miles, E.W., Rhee, S. and Davies, D.R. (1999a). Channeling *. Journal of Biological 
Chemistry 274:12193–12197. 
Miles, E.W., Rhee, S. and Davies, D.R. (1999b). The molecular basis for substrate 
channeling. J Biol Chem 274:12193–12197. 
Moore, S.J. et al. (2012). Biochemical Society Annual Symposium No . 79 The 
anaerobic biosynthesis of vitamin B 12. :581–586. 




component of cobalamin (vitamin B12). Proceedings of the National Academy 
of Sciences of the United States of America 110:14906–11.  
Moore, S.J. et al. (2017). Elucidation of the biosynthesis of the methane catalyst 
coenzyme F 430. Nature 543:78–82. 
Moser, È. et al. (2001). V-shaped structure of glutamyl-tRNA reductase, the first 
enzyme of tRNA-dependent tetrapyrrole biosynthesis. EMBO Journal 20:6583–
6590. 
Mura, C. (2014). Development & Implementation of a PyMOL ‘putty’ Representation. 
Department of Chemistry & Biochemistry, UCSD:3–5.  
Murooka, Y. et al. (2005). Production of tetrapyrrole compounds and vitamin B12 
using genetically engineering of Propionibacterium freudenreichii . An overview 
To cite this version : HAL Id : hal-00895589 Production of tetrapyrrole 
compounds and vitamin B 12 using genetically engin. Le Lait, INRA Editions 
85:9–22. 
Nordlander, J.E. and Mccrary, T.J. (1974). Additions and Corrections: 
Stereochemistry and Mechanism of Acetolysis of 4,4-Dimethylcyclohexyl 
Tosylate (J. Am. Chem. Soc. (1972) 94(14) (5133–5135) 
(10.1021/ja00769a084)). Journal of the American Chemical Society 96:4066–
4067. 
O’Leary, F. and Samman, S. (2010). Vitamin B12 in health and disease. Nutrients 
2:299–316. 
Parsons, J.B. et al. (2010). Characterisation of pdus, the pdu metabolosome corrin 
reductase, and evidence of substructural organisation within the bacterial 




Pravda, L. et al. (2014). Anatomy of enzyme channels. BMC Bioinformatics 15:1–8. 
Quadros, E. (2010). Advances in the Understanding of Cobalamin Assimilation and 
Metabolism. Br J Haematol 148(2):195–204. 
Ragsdale, S.W. (2011). NIH Public Access. NIH Public Access 79:293–324. 
Raushel, F.M., Thoden, J.B. and Holden, H.M. (2003). Enzymes with molecular 
tunnels. Accounts of Chemical Research. 
Raushel, F.M., Thoden, J.B. and Holden, H.M. (1999). The amidotransferase family 
of enzymes: Molecular machines for the production and delivery of ammonia. 
Biochemistry 38:7891–7899. 
Raux, E., Lanois, A. and Levillayer, F. (1996). Salmonella typhimurium Cobalamin 
(Vitamin B12 ) Biosynthetic Genes: Functional Studies in S. typhimurium and 
Escherichia coli. J. Bacteriol. 178:753–767.  
Rehms, A.A. and Callis, P.R. (1993). Two-photon fluorescence excitation spectra of 
aromatic amino acids. Chemical Physics Letters 208:276–282.  
Reid, J.D. and Hunter, C.N. (2002). Current understanding of the function of 
magnesium chelatase. Biochemical Society Transactions 30:643–645.  
Reinbothe, S. et al. (1996). Evolution of chlorophyll biosynthesis - The challenge to 
survive photooxidation. Cell 86:703–705. 
Rickes, E.L. et al. (1948). Crystalline vitamin B12. Science 107:396–397. 
Rickes, E.L. et al. (1948). Crystalline Vitamin B12 | Science. Science 107:396–397. 
Robscheit, F.S., Hooper, C.W. and Whipple, G.H. (1920). Blood regeneration 
following simple anemia IV. Influence of meat, liver and various extractives, 




Roth, J.R. et al. (1993). Characterization of the cobalamin (vitamin B12) biosynthetic 
genes of Salmonella typhimurium. Journal of Bacteriology 175:3303–3316. 
Roth, J.R. et al. (1993). Characterization of the Cobalamin (Vitamin B12) Biosynthetic 
Genes of Salmonella typhimurium. Journal of Bacteriology 175:3303–3316. 
Sampson, E.M., Johnson, C.L. V and Bobik, T.A. (2005). Biochemical evidence that 
the pduS gene encodes a bifunctional cobalamin reductase. 151:1169–1177. 
Santos, S.P. et al. (2012). Thermofluor-based optimization strategy for the 
stabilization and crystallization of Campylobacter jejuni desulforubrerythrin. 
PROTEIN EXPRESSION AND PURIFICATION 81:193–200.  
Scott, A. et al. (1993). Biosynthesis of vitamin B12. Discovery of the enzymes for 
oxidative ring contraction and insertion of the fourth methyl group. FEBS Letters 
331:105–108. 
Senge, M.O. (2015). N-H Hydrogen Bonding in Porphyrins - from Conformational 
Design to Supramolecular Chemistry. ECS Transactions 66:1–10. 
Seyedarabi, A. et al. (2010). Cloning , purification and preliminary crystallographic 
analysis of cobalamin methyltransferases from Rhodobacter capsulatus 
crystallization communications Cloning , purification and preliminary 
crystallographic analysis of cobalamin methyltransferases fr. Acta 
Crystallographica F66:1652–1656. 
Shemin, D. and Kikuchi, G. (1958). ENZYMATIC SYNTHESIS OF δ-
AMINOLEVULINIC ACID*. Annals of the New York Academy of Sciences 
75:122–128.  
Shin, J.A. et al. (2007). 5-Aminolevulinic Acid Biosynthesis in Coexpressing NADP-





Shipman, L.W. et al. (2001). Crystal structure of precorrin-8x methyl mutase. 
Structure 9:587–596. 
Shorb, M. (1948). The effects of dissociation in Lactobascillus lactis cultures on the 
requirements for vitamin B12. J Biological Chemistry 1607:1463–1465. 
Smith L. (1948). pubmed_result. Nature 24:638. 
Spencer, J.B. et al. (1993). The Escherichia coli cysG gene encodes the 
multifunctional protein, siroheme synthase - Spencer - 19. FEBS Letters 335:57–
60. 
Suh, S.-J. and Escalante-Semerena, J.C. (1993). Cloning, sequencing and 
overexpression of cob A which encodes ATP:corrinoid adenosyltranferase in 
Salmonella typhimurium. Gene 129:93–97. 
Thauer, R.K. and Bonacker, L.G. (2007). Biosynthesis of Coenzyme F430, A Nickel 
Porphinoid Involved in Methanogenesis. In: Ciba Foundation Symposium 180 - 
The Biosynthesis of the Tetrapyrrole Pigments. John Wiley & Sons, Ltd, pp. 210–
227.  
Thibaut, D. et al. (1992). The final step in the biosynthesis of hydrogenobyrinic acid 
is catalyzed by the cobH gene product with precorrin-8x as the substrate. Journal 
of Bacteriology 174:1043–1049. 
Toseland, C.P. and Geeves, M.A. (2014). Rapid reaction kinetic techniques. In: 
Toseland, C. P. and Fili, N. eds. Fluorescent Methods Applied to Molecular 
Motors: From Single Molecules to Whole Cells. Springer, pp. 49–64.  
Tripathy, B.C., Sherameti, I. and Oelmüller, R. (2010). Siroheme: An essential 




Trotta, P.P. et al. (1974). Glutamine-Binding Subunit of Glutamate Synthase and 
Partial Reactions. Proceedings of the National Academy of Sciences 71:4607–
4611. 
Trzebiatowski, J.R., Toole, G.A.O. and Escalante-semerena, J.C. (1994). The cobT 
Gene of Salmonella typhimurium Encodes the NaMN : Responsible for the 
Synthesis of Nl- ( 5-Phospho-x-D-Ribosyl ) - 5 , 6-Dimethylbenzimidazole , an 
Intermediate in the Synthesis of the Nucleotide Loop of Cobalamin. Journal of 
Bacteriology 176:3568–3575. 
Vagin, A.A. et al. (2004). REFMAC5 dictionary: Organization of prior chemical 
knowledge and guidelines for its use. Acta Crystallographica Section D: 
Biological Crystallography 60:2184–2195. 
Vishnu, P. et al. (2013). A Method to Trap Transient and Weak Interacting A Method 
to Trap Transient and Weak Interacting Protein Complexes for Structural 
Studies. Vol. 0707. 
Walker, C. and Robert, W. (1997). Mechanism and regulation of Mg-chelatase. 
Biochem J 327:321–333. 
Walker, J.E. et al. (1982). Distantly related sequences in the alpha- and beta-subunits 
of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a 
common nucleotide binding fold. The EMBO Journal 1:945–951. 
Warren, M.J. et al. (1992). Enzymic synthesis and structure of precorrin-3, a 
trimethyldipyrrocorphin intermediate in vitamin B12 biosynthesis. Biochemistry 
31:603–609.  
Warren, M.J. et al. (2002). The biosynthesis of adenosylcobalamin (vitamin B12). 




Woalder Xiwei Zheng, Cong Bi, Zhao Li, Maria Podariu,  and D.S.H. (2017). NHS 
Public Access. Physiology & behavior 176:139–148. 
Woodward, R.B. (1973). The total synthesis of vitamin B12. Pure and Applied 
Chemistry 33(1):145–178. 
Zayas, C.L. and Escalante-semerena, J.C. (2007). Reassessment of the Late Steps 
of Coenzyme B 12 Synthesis in Salmonella enterica : Evidence that 
Dephosphorylation of Adenosylcobalamin-5 Ј -Phosphate by the CobC 
Phosphatase Is the Last Step of the Pathway. Journal of Bacteriology 189:2210–
2218. 
Zhoo, Q.K., Hartnett, M.S. and Slater, M.R. (2007). Selenomethionine Protein 
Labeling Using the Escherichia coli Strain KRX. Promega Corporation:24–26. 
 
